<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020195553A1-20021226-M00001.NB SYSTEM "US20020195553A1-20021226-M00001.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00001.TIF SYSTEM "US20020195553A1-20021226-M00001.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00002.NB SYSTEM "US20020195553A1-20021226-M00002.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00002.TIF SYSTEM "US20020195553A1-20021226-M00002.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00003.NB SYSTEM "US20020195553A1-20021226-M00003.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00003.TIF SYSTEM "US20020195553A1-20021226-M00003.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00004.NB SYSTEM "US20020195553A1-20021226-M00004.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00004.TIF SYSTEM "US20020195553A1-20021226-M00004.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00005.NB SYSTEM "US20020195553A1-20021226-M00005.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00005.TIF SYSTEM "US20020195553A1-20021226-M00005.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00006.NB SYSTEM "US20020195553A1-20021226-M00006.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00006.TIF SYSTEM "US20020195553A1-20021226-M00006.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00007.NB SYSTEM "US20020195553A1-20021226-M00007.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00007.TIF SYSTEM "US20020195553A1-20021226-M00007.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00008.NB SYSTEM "US20020195553A1-20021226-M00008.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00008.TIF SYSTEM "US20020195553A1-20021226-M00008.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00009.NB SYSTEM "US20020195553A1-20021226-M00009.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00009.TIF SYSTEM "US20020195553A1-20021226-M00009.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00010.NB SYSTEM "US20020195553A1-20021226-M00010.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00010.TIF SYSTEM "US20020195553A1-20021226-M00010.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00011.NB SYSTEM "US20020195553A1-20021226-M00011.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00011.TIF SYSTEM "US20020195553A1-20021226-M00011.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00012.NB SYSTEM "US20020195553A1-20021226-M00012.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00012.TIF SYSTEM "US20020195553A1-20021226-M00012.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00013.NB SYSTEM "US20020195553A1-20021226-M00013.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00013.TIF SYSTEM "US20020195553A1-20021226-M00013.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-M00014.NB SYSTEM "US20020195553A1-20021226-M00014.NB" NDATA NB>
<!ENTITY US20020195553A1-20021226-M00014.TIF SYSTEM "US20020195553A1-20021226-M00014.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00000.TIF SYSTEM "US20020195553A1-20021226-D00000.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00001.TIF SYSTEM "US20020195553A1-20021226-D00001.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00002.TIF SYSTEM "US20020195553A1-20021226-D00002.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00003.TIF SYSTEM "US20020195553A1-20021226-D00003.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00004.TIF SYSTEM "US20020195553A1-20021226-D00004.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00005.TIF SYSTEM "US20020195553A1-20021226-D00005.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00006.TIF SYSTEM "US20020195553A1-20021226-D00006.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00007.TIF SYSTEM "US20020195553A1-20021226-D00007.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00008.TIF SYSTEM "US20020195553A1-20021226-D00008.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00009.TIF SYSTEM "US20020195553A1-20021226-D00009.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00010.TIF SYSTEM "US20020195553A1-20021226-D00010.TIF" NDATA TIF>
<!ENTITY US20020195553A1-20021226-D00011.TIF SYSTEM "US20020195553A1-20021226-D00011.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020195553</doc-number>
<kind-code>A1</kind-code>
<document-date>20021226</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10165503</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020607</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>H01J003/14</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>H01J005/16</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>250</class>
<subclass>234000</subclass>
</uspc>
</classification-us-primary>
</classification-us>
<title-of-invention>High sensitivity deflection sensing device</title-of-invention>
</technical-information>
<continuity-data>
<division-of>
<parent-child>
<child>
<document-id>
<doc-number>10165503</doc-number>
<kind-code>A1</kind-code>
<document-date>20020607</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09166979</doc-number>
<document-date>19981006</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>PENDING</parent-status>
</parent-child>
</division-of>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Tilman</given-name>
<family-name>Schaffer</family-name>
</name>
<residence>
<residence-us>
<city>Santa Barbara</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Paul</given-name>
<middle-name>K.</middle-name>
<family-name>Hansma</family-name>
</name>
<residence>
<residence-us>
<city>Isla Vista</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>FULBRIGHT AND JAWORSKI L L P</name-1>
<name-2>PATENT DOCKETING 29TH FLOOR</name-2>
<address>
<address-1>865 SOUTH FIGUEROA STREET</address-1>
<city>LOS ANGELES</city>
<state>CA</state>
<postalcode>900172576</postalcode>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">A high sensitivity beam deflection sensing optical device, such as an atomic force microscope, including one or more of the following: specified means in the path of the incident beam for adjusting the size and/or power of the incident beam spot, means for moving the incident beam spot with movement of the object whereby to maintain the position of the spot on the object, and means for increasing the signal to noise ratio of the optical detector in which adjusted gains are applied to different segments of the optical detector. </paragraph>
</subdoc-abstract>
<subdoc-description>
<federal-research-statement>
<paragraph-federal-research-statement id="P-0001"><number>&lsqb;0001&rsqb;</number> This invention was made with Government support under Grant (or Contract) No. DMR9622169, awarded by the National Science Foundation. The government has certain rights in this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND </heading>
<paragraph id="P-0002" lvl="0"><number>&lsqb;0002&rsqb;</number> An atomic force microscope (AFM) is a deflection detection optical device in which, in a common implementation, forces are measured by means of a cantilever that deflects when forces act on it. The deflection of the cantilever is sensed by a detection system, commonly by focusing an incident beam as a spot onto a cantilever and directing the reflected beam onto a segmented detector. Conventionally, a two-segment detector, such as a split photodiode, is used. Whereas, only two segments are usually used to sense either vertical or horizontal cantilever deflections, the photo diode can have four segments for measuring cantilever deflections in both directions. Initially the beam spot must be positioned so as to be approximately equally incident on each of the segments. The deflection of the cantilever is detected as a difference between the incident powers on each segment. </paragraph>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> In the approximately twelve years since its invention, the AFM has become more and more advanced, measuring smaller and smaller forces and utilizing smaller and smaller cantilevers. This has introduced problems relating to forming appropriate incident light beam spots on such very small cantilevers and in detecting cantilever deflection during scanning as well as when different cantilevers are brought into position for different uses. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> In addition, a fundamental limit is the source of noise in the AFM, generally resulting from thermal noise of the cantilever. With the use of smaller cantilevers, this noise source can be reduced such that very small forces can be measured in principle. However, with smaller forces, the deflections of the cantilever become smaller and the detection noise becomes more and more significant. Therefore, it is important to have a reliable, low-noise detection system. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> The present invention provides a high sensitivity deflection detection device that uses a light spot, with improvements to reduce detection noise and thermal drift and allow for higher signal-to-noise ratios of measurements of the beam deflection. Such a device is illustrated by an atomic force microscope. The invention provides improvements involving the incident beam as well as a detection system. In particular, a high sensitivity atomic force microscope is provided including one or more of the following: means in the path of the incident beam for adjusting the size, shape and/or power of the incident beam spot, means for moving the incident beam spot with movement of the cantilever whereby to maintain the position of the spot on the cantilever, means for reducing the signal to noise ratio of the optical detector in which different gains are applied to different segments of the optical detector, and means for regulating the temperature of the environment of the atomic force microscope to limit thermal drift. The invention incorporates a variety of strategies that individually, and in particular in combination, provide higher sensitivity to the atomic force microscope. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> To adjust the size of the incident beam spot, one can place zoom optics in the path of the incident beam having a plurality of lenses chosen and arranged to provide an adjustable focal length. This can be combined with a viewing system that is confocal with the beam spot on the cantilever. One can selectively place one of a plurality of cantilevers in the path of the incident beam and, by placing a selected cylindrical lens in the light path, one can fit the spot to the selected cantilever. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> With collimated light, one can place an adjustable beam expander in the path of the incident beam, the expander having at least one lens that diverges or converges the collimated light, and at least one lens that re-collimates the diverged or converged light beam to a different size beam. Alternatively, when using a plurality of cantilevers, a removable and interchangeable lens can be placed at a distance from each particular cantilever to produce different size focus spots for respective selected cantilevers. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> To adjust the power of the incident beam spot, a mask of variable optical transmittance can be inserted in the path of the incident beam, preferably in an image plane with respect to the plane of the cantilever. The mask may be patterned to produce a desired irradiance distribution of the incident beam spot on the cantilever. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Other aspects of the invention provide control means for moving the incident beam spot with movement of the cantilever to maintain the position of the spot on the cantilever In particular, a change in position of the cantilever is determined which is compared to the position of the spot and the position of the spot is then adjusted until it corresponds to the position of the cantilever. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Detection noise is reduced by providing the segments of the optical detector with different gains optimized to maximize the signal to noise ratio of the particular measurement. The segments are arranged in an array, in a particular embodiment as the component of a CCD chip. A plurality of pre-amplifiers are associated with respective segments, and summing means are provided to receive the pre-amplified outputs of the segments. In one embodiment, the different gains are applied to the respective pre-amplifiers In another embodiment, the different gains are applied to the summing means. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Thermal drift of the instrument is limited by regulating the temperature of the environment, specifically by closing the atomic force microscope in a housing.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> The following briefly describes each of the drawings, in which components are generally schematic and in some cases greatly exaggerated for clarity of illustration. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> is a simplified schematic drawing of a prior art AFM; </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> displays the signal to noise ratio of a set cantilever deflection as a function of the width of the aperture in a prior art AFM with a 10 micrometer cantilever and a 40 micrometer cantilever; </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> schematically illustrates the insertion of various optics in the incident beam path. (A) a converging beam expander and recollimater, (B) a diverging beam expander and recollimater, and (C) zoom optics. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> FIGS. <highlight><bold>4</bold></highlight>(A) through (D) depict various configurations for zoom optics usable in the invention, </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> depicts the use of cylindrical lenses with cantilevers of different length/width aspect ratios; </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> depicts various configurations for a removable and interchangeable lower moving lens system and the focused spots associated therewith including: in (a) a depiction of a system not including the lower lens system of this invention and in (a&prime;) the spot therefore; and in (C) (E) and (G), a lower lens moving systems of this invention and in (b) (F) and (H) associated spots; </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> schematically depicts a feed-back system for keeping the incident spot optimized in a scanning cantilever microscope; </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 8</cross-reference> schematically depicts a variable density mask in (A) the incident beam and in (B) in the image plane of the incident beam; </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 9</cross-reference> schematically depicts a multi-element detector utilizing assigned gains; </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 10</cross-reference> depicts the (A) power distribution, (B) change in power of a nineteen element array detector, (C) simulation of a two-segment detector, and (D) gains for the optimized signal to noise ratio of the detector; and </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 11</cross-reference> is a schematic depiction of a housing enclosing the AFM to limit thermal drift.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION </heading>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> Referring to <cross-reference target="DRAWINGS">FIG. 1</cross-reference>, an AFM as known to the prior art is schematically illustrated, wherein an incident light beam <highlight><bold>10</bold></highlight>, which may be collimated, from a source not shown, is projected through an aperture <highlight><bold>12</bold></highlight>, a polarizing beamsplitter <highlight><bold>14</bold></highlight>, a quarterwave plate <highlight><bold>16</bold></highlight>, and a focusing lens system <highlight><bold>18</bold></highlight> to form a spot <highlight><bold>20</bold></highlight> on a cantilever <highlight><bold>22</bold></highlight> of the AFM. Light is reflected back from the cantilever <highlight><bold>22</bold></highlight> through the focusing lens system <highlight><bold>18</bold></highlight> and quarterwave plate <highlight><bold>16</bold></highlight> to reflect from the polarizing beamsplitter <highlight><bold>14</bold></highlight> onto a segmented photodetector <highlight><bold>24</bold></highlight>. Prior to the measurement, the reflected beam is centered on the segmented photodiode so that substantially equal amounts of light power falls on one segment as on the other. Thereafter, as the cantilever moves up and down, more or less of the light beam will fall on one or the other of the segments providing a signal tracking the height of the cantilever. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> Previous work has shown that the size of the focused spot on the cantilever in an AFM affects the signal to noise ratio of the cantilever deflection system and that the signal to noise ratio of the detection system is maximized when the focused spot approximately fills the cantilever. An AFM designed for use with different size cantilevers needs to be capable of producing different size focused spots in order to use each cantilever at its maximum detection signal to noise ratio A previous AFM developed by the inventors included an adjustable aperture in the incident beam path to chance the focused spot size on the cantilever. The diameter, w, of the focused spot on the cantilever is related to the wavelength, &lgr;, and to the effective numerical aperture, NA, of the incident beam by diffraction theory:  
<math-cwu id="MATH-US-00001">
<number>1</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>w</mi>
          <mo>~</mo>
          <mfrac>
            <mi>&lambda;</mi>
            <mrow>
              <mi>N</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>A</mi>
            </mrow>
          </mfrac>
        </mrow>
        <mo>.</mo>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>1</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00001" file="US20020195553A1-20021226-M00001.NB"/>
<image id="EMI-M00001" wi="216.027" he="18.00225" file="US20020195553A1-20021226-M00001.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> In the case of a collimated incident beam,  
<math-cwu id="MATH-US-00002">
<number>2</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>w</mi>
          <mo>~</mo>
          <mfrac>
            <mrow>
              <mi>&lambda;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>f</mi>
            </mrow>
            <mi>&alpha;</mi>
          </mfrac>
        </mrow>
        <mo>,</mo>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>2</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00002" file="US20020195553A1-20021226-M00002.NB"/>
<image id="EMI-M00002" wi="216.027" he="18.00225" file="US20020195553A1-20021226-M00002.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0027" lvl="7"><number>&lsqb;0027&rsqb;</number> where a is the diameter of the incident beam and f is the focal length of the lens/lens system. Therefore, a small aperture width decreases the incident beam diameter and thus increases the focused spot diameter on the cantilever. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> The measured signal to noise ratio of a set cantilever deflection for 10 &mgr;m and 40 &mgr;m cantilevers is displayed in <cross-reference target="DRAWINGS">FIG. 2</cross-reference> as a function of the aperture width. The signal to noise ratio with the 40 &mgr;m cantilever is about 3 times higher at an aperture width of a&cong;0.5 mm than it is at full aperture. This is due to the fact that the focused spot size matches the cantilever size better at a&cong;0.5 mm than it does at full aperture width. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> One disadvantage of an adjustable aperture is that light power is cut out from the incident beam and lost for the detection of the cantilever deflection. This lowers the sensitivity of the detection. In accordance with one embodiment of the invention, shown in FIGS. <highlight><bold>3</bold></highlight>(A) and <highlight><bold>3</bold></highlight>(B), the incident beam size is reduced without significantly reducing the incident beam power by placing a beam expander in the incident beam path. A beam expander is a lens system that first diverges or converges a collimated input beam and then re-collimates it to a different size output beam. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> In <cross-reference target="DRAWINGS">FIG. 3</cross-reference>(A) a converging lens <highlight><bold>26</bold></highlight> is combined with a diverging lens <highlight><bold>28</bold></highlight>, acting as a re-collimating lens, to reduce the diameter of the incident beam <highlight><bold>30</bold></highlight>. In <cross-reference target="DRAWINGS">FIG. 3</cross-reference>(B) a diverging lens <highlight><bold>32</bold></highlight> is combined with a converging lens <highlight><bold>34</bold></highlight> acting as a re-collimator to increase the diameter of the incident beam <highlight><bold>36</bold></highlight>. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> Alternatively, as shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>(C), zoom optics <highlight><bold>38</bold></highlight> can be used as part of the focusing lens system. Zoom optics are constituted by a lens system that has an adjustable focal length. Using the same input beam <highlight><bold>40</bold></highlight>, different size focused spots can be produced according to equation (2). Zoom optics do not necessarily require a collimated input beam. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> In a particular embodiment, the zoom optics would be common to the laser beam path and to a viewing system that is confocal with the laser beam. FIGS. <highlight><bold>4</bold></highlight>(A) through (D) illustrate variations on an AFM with zoom optics in which light from a laser diode <highlight><bold>42</bold></highlight> is projected successively through a beamsplitting plate <highlight><bold>44</bold></highlight>, zoom optics <highlight><bold>46</bold></highlight>, a polarizing beamsplitter <highlight><bold>48</bold></highlight>, a focusing system <highlight><bold>50</bold></highlight> and an objective <highlight><bold>52</bold></highlight> to form an incident beam spot on a cantilever <highlight><bold>54</bold></highlight>. In one of the embodiments, in <cross-reference target="DRAWINGS">FIG. 4</cross-reference>(C), a quarterwave plate <highlight><bold>56</bold></highlight> is interposed between the focusing system <highlight><bold>50</bold></highlight> and objective <highlight><bold>52</bold></highlight> In other embodiments, it is placed just below the beam splitter <highlight><bold>48</bold></highlight>. After being reflected from the cantilever <highlight><bold>54</bold></highlight>, the reflected beam travels back through the objective <highlight><bold>52</bold></highlight>, focusing system <highlight><bold>50</bold></highlight>, polarizing beamsplitter <highlight><bold>43</bold></highlight> and quarterwave plate <highlight><bold>56</bold></highlight> (in the order of its placement) to impinge on a photodiode detector <highlight><bold>58</bold></highlight>. In FIGS. <highlight><bold>4</bold></highlight>(A) and <highlight><bold>4</bold></highlight>(B), light from the laser diode goes in a straight line through the polarizing beamsplitter and is reflected on the beamsplitter on the return path to the photodiode detector <highlight><bold>58</bold></highlight>. In FIGS. <highlight><bold>4</bold></highlight>(C) and <highlight><bold>4</bold></highlight>(D), light from the laser diode is reflected by the polarizing beamsplitter <highlight><bold>48</bold></highlight> onto the cantilever <highlight><bold>54</bold></highlight> and the return beam travels directly through the polarizing beamsplitter <highlight><bold>48</bold></highlight> to the photodiode detector <highlight><bold>58</bold></highlight>. In each of the embodiments, reflected light traveling back through the zoom optics <highlight><bold>46</bold></highlight> is reflected by the beamsplitting plate <highlight><bold>44</bold></highlight> onto a CCD <highlight><bold>59</bold></highlight> for confocal observation of the cantilever <highlight><bold>54</bold></highlight>. The cantilever is illuminated by means of a source of illumination <highlight><bold>60</bold></highlight> and beamsplitting plate <highlight><bold>62</bold></highlight> located below the zoom optics <highlight><bold>46</bold></highlight> in FIGS. <highlight><bold>4</bold></highlight>(A), (B) and (D) and above the zoom optics in <cross-reference target="DRAWINGS">FIG. 4</cross-reference>(C). </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> The zoom optics can be set up so that adjustments to it would change the cantilever&apos;s magnification in the viewing system but would not de-focus the cantilever in the viewing system. Since the zoom optics is common to both laser beam path and viewing system path, the focused spot changes size, too, but the apparent size of the focused spot in the viewing system stays constant. Zoom optics also allows the user to zoom out to have a large field of view. The user could then zoom in on the cantilever of interest and bring it to a pre-set size in the viewing system, to automatically fit the focused spot in size to the cantilever. This size is set by the size of the focused spot in the viewing system (which is constant). </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> Optionally, one can allow for different magnifications in the directions along and across the cantilever with the help of cylindrical lenses or prisms to be able to fit the focused spot optimally to a range of cantilevers with different length/width aspect ratios. In effect, the arrangement is a one-dimensional beam expander, adjustable by moving the lenses. Referring to <cross-reference target="DRAWINGS">FIG. 5</cross-reference>(A) and (B),a simple lens <highlight><bold>68</bold></highlight> is used to focus a circular incident beam <highlight><bold>66</bold></highlight> onto a cantilever <highlight><bold>70</bold></highlight>. This produces a circularly shaped spot <highlight><bold>71</bold></highlight>, as shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>(B). To produce an elongated oval spot <highlight><bold>73</bold></highlight>, as shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>(D), the cylindrical lens (or lenses) <highlight><bold>69</bold></highlight> are used as a one dimensional beam expander, to increase the spot, to increase the spot length along the lengthwise direction of the cantilever <highlight><bold>75</bold></highlight>. This enables greater sensitivity of detection. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> Adjustments of the size of the incident beam and/or of the focal length of the lens system can be continuous or discrete. To implement discrete adjustments of the focused spot size, a removable focusing element and/or removable beam expander is placed in the incident beam path. Preferably, different lenses are mounted into different removable cantilever modules providing different focused spot sizes for use with different size cantilevers Removable, interchangeable focusing elements can be used to enable a scanning cantilever AFM to be used with small cantilevers. The total track length of the optics is fixed and pre-set such that the focused spot tracks the cantilever with the help of an upper moving lens system. To produce different size focused spots for use with different size cantilevers in the same scanning cantilever AFM, a lower moving lens system is provided that is removable and interchangeable. One can use a ray-tracing computer simulation program to design replaceable lower lens systems that have different focused spot sizes at a constant distance between the cantilever and the upper lens system. Referring to FIGS. <highlight><bold>6</bold></highlight>(A) and (B), with no lower lens system, the focused spot diameter is diffraction limited to about 15 &mgr;m. With various lower lens systems, focused spot diameters of 3 &mgr;m or smaller can be achieved. In <cross-reference target="DRAWINGS">FIG. 6</cross-reference>(C) and (D), a cylindrical lens system <highlight><bold>72</bold></highlight> is used In FIGS. <highlight><bold>6</bold></highlight>(E) and (G), different lens systems <highlight><bold>74</bold></highlight> and <highlight><bold>76</bold></highlight> are used, the lens system <highlight><bold>78</bold></highlight> of <cross-reference target="DRAWINGS">FIG. 6</cross-reference>(G) including a ball lens <highlight><bold>76</bold></highlight>. FIGS. <highlight><bold>6</bold></highlight>(F) and (H) are corresponding spots. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> In a further embodiment of the invention, the position of the cantilever and/or the focused spot in the viewing system is monitored to provide input to a feedback system that keeps the spot on the cantilever even when the cantilever moves, as in a scanning cantilever microscope Such a feedback system is shown in <cross-reference target="DRAWINGS">FIG. 7</cross-reference>. The position of the cantilever is determined at <highlight><bold>80</bold></highlight> and the position of the spot on the cantilever is determined at <highlight><bold>82</bold></highlight>. These are compared at <highlight><bold>84</bold></highlight> and if they are the same, the position of the cantilever is again compared. This repeats, as shown at <highlight><bold>86</bold></highlight>, until a comparison indicates that the position of the cantilever is not the same as the position of the spot. In that case, the spot is moved in the direction of movement of the cantilever, as indicated at <highlight><bold>88</bold></highlight>, whereupon the position of the spot is redetermined, as indicated at <highlight><bold>90</bold></highlight>, and the cycle repeats. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> Using a beam expander or zoom optics as described above is advantageous when one can use all of the available laser power in order to maximize the signal with respect to the shot noise. There is an upper limit, however, to the usable laser power on the cantilever, since the laser light heats up the cantilever. In the case of thin (&lt;&ap;100 nm) metal cantilevers, this heating can cause softening of the metal and subsequent irreversible curling of the cantilever. Therefore, the total laser power on the cantilever is limited. In accordance with another embodiment of this invention, the optical beam deflection sensitivity and the heat-conducting properties of the cantilever are taken into account in tailoring an optimum focused spot shape with an irradiance distribution I<highlight><subscript>c</subscript></highlight>(p,q), where p and q are coordinates in the cantilever plane. The required irradiance distribution (power per unit area) of the incident beam, I<highlight><subscript>I</subscript></highlight>(p,q), in order to produce I<highlight><subscript>c</subscript></highlight>(p,q) on the cantilever, can be calculated by diffraction theory:  
<math-cwu id="MATH-US-00003">
<number>3</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mrow>
            <msub>
              <mi>I</mi>
              <mi>i</mi>
            </msub>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mrow>
                <mi>x</mi>
                <mo>,</mo>
                <mi>y</mi>
              </mrow>
              <mo>)</mo>
            </mrow>
          </mrow>
          <mo>=</mo>
          <mrow>
            <mfrac>
              <mi>&alpha;</mi>
              <mrow>
                <msup>
                  <mi>&lambda;</mi>
                  <mn>2</mn>
                </msup>
                <mo>&it;</mo>
                <msup>
                  <mi>f</mi>
                  <mn>2</mn>
                </msup>
              </mrow>
            </mfrac>
            <mo>|</mo>
            <mrow>
              <munder>
                <mrow>
                  <mo>&Integral;</mo>
                  <mo>&Integral;</mo>
                </mrow>
                <mi>cantilever</mi>
              </munder>
              <mo>&it;</mo>
              <mrow>
                <mo>&dd;</mo>
                <mi>p</mi>
              </mrow>
              <mo>&it;</mo>
              <mrow>
                <mo>&dd;</mo>
                <mi>q</mi>
              </mrow>
              <mo>&it;</mo>
              <msqrt>
                <mrow>
                  <msub>
                    <mi>I</mi>
                    <mi>c</mi>
                  </msub>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mrow>
                      <mi>p</mi>
                      <mo>,</mo>
                      <mi>q</mi>
                    </mrow>
                    <mo>)</mo>
                  </mrow>
                </mrow>
              </msqrt>
              <mo>&it;</mo>
              <msup>
                <mi>&ee;</mi>
                <mrow>
                  <mrow>
                    <mo>-</mo>
                    <mn>2</mn>
                  </mrow>
                  <mo>&it;</mo>
                  <mi>&pi;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mrow>
                    <mi>i</mi>
                    <mo>/</mo>
                    <mi>&lambda;</mi>
                  </mrow>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mrow>
                    <mi>f</mi>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <mrow>
                          <mi>p</mi>
                          <mo>&it;</mo>
                          <mstyle>
                            <mtext>&emsp;</mtext>
                          </mstyle>
                          <mo>&it;</mo>
                          <mi>x</mi>
                        </mrow>
                        <mo>+</mo>
                        <mrow>
                          <mi>q</mi>
                          <mo>&it;</mo>
                          <mstyle>
                            <mtext>&emsp;</mtext>
                          </mstyle>
                          <mo>&it;</mo>
                          <mi>y</mi>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
              </msup>
            </mrow>
            <mo>&it;</mo>
            <msup>
              <mo>|</mo>
              <mn>2</mn>
            </msup>
          </mrow>
        </mrow>
        <mo>,</mo>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>3</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00003" file="US20020195553A1-20021226-M00003.NB"/>
<image id="EMI-M00003" wi="216.027" he="29.0304" file="US20020195553A1-20021226-M00003.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0038" lvl="7"><number>&lsqb;0038&rsqb;</number> where &lgr; is the wavelength of the light, f is the focal length of the lens system, &agr; is a loss factor due to absorption and stray reflection in the lens system, p and q are coordinates in the cantilever plane and x and y are coordinates in the aperture plane. In accordance with this embodiment, and referring to <cross-reference target="DRAWINGS">FIG. 8</cross-reference>(A), to produce this optimum irradiance distribution of the incident beam <highlight><bold>94</bold></highlight>, a mask <highlight><bold>92</bold></highlight> of variable optical transmittance T(x, y) is inserted in the path of the incident beam. This mask can be made, for example, from a liquid crystal device or from an optical filter. The mask can be patterned such that it produces the desired irradiance distribution I<highlight><subscript>I</subscript></highlight>(x, y) of an appropriately intense and large incident beam that in return produces, through the lens system <highlight><bold>96</bold></highlight>, the desired focused spot irradiance distribution on the cantilever <highlight><bold>98</bold></highlight>. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> In another embodiment, shown in <cross-reference target="DRAWINGS">FIG. 8</cross-reference>(B), an alternate implementation is obtained by creating an image plane <highlight><bold>100</bold></highlight> with respect to the cantilever plane. By placing the variable density mask <highlight><bold>92</bold></highlight> in this image plane <highlight><bold>100</bold></highlight>, an image of this mask is projected through the lens system <highlight><bold>96</bold></highlight>, onto the cantilever <highlight><bold>98</bold></highlight>. Therefore, by utilizing this embodiment of the invention, the design of a mask that produces a desired focused spot shape on the cantilever becomes especially easy. To produce an irradiance distribution I<highlight><subscript>c</subscript></highlight>(p, q) on the cantilever, the optical transmittance T(x, y) of the mask must be:  
<math-cwu id="MATH-US-00004">
<number>4</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mrow>
            <mi>T</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mrow>
                <mi>x</mi>
                <mo>,</mo>
                <mi>y</mi>
              </mrow>
              <mo>)</mo>
            </mrow>
          </mrow>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <msub>
                <mi>I</mi>
                <mi>c</mi>
              </msub>
              <mo>&af;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mrow>
                    <mi>m</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>x</mi>
                  </mrow>
                  <mo>,</mo>
                  <mrow>
                    <mi>m</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>y</mi>
                  </mrow>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
            <mrow>
              <msub>
                <mi>I</mi>
                <mn>0</mn>
              </msub>
              <mo>&af;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>x</mi>
                  <mo>,</mo>
                  <mi>y</mi>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mfrac>
        </mrow>
        <mo>,</mo>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>4</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00004" file="US20020195553A1-20021226-M00004.NB"/>
<image id="EMI-M00004" wi="216.027" he="18.96615" file="US20020195553A1-20021226-M00004.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0040" lvl="7"><number>&lsqb;0040&rsqb;</number> where I<highlight><subscript>c</subscript></highlight>(x, y) is the irradiance distribution of the light incident on the mask and m is the magnification of the lower lens system and I<highlight><subscript>o</subscript></highlight>(x, y)&gE;I<highlight><subscript>c</subscript></highlight>(mx, my) for all x, y. In such an arrangement it can be particularly easy to produce multiple focused spots at different locations on the cantilever or on different, neighboring cantilevers. Also, a variable density mask can be used in conjunction with adjustable beam expander or zoom optics to produce an optimum focused spot on the cantilever. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> In another embodiment of the invention, shown in <cross-reference target="DRAWINGS">FIG. 9</cross-reference>, the signal to noise ratio of the optical detector can be markedly improved by using an array of n detector segments <highlight><bold>102</bold></highlight>, where n is three or more and each segment <highlight><bold>102</bold></highlight> can be assigned an individual gain factor. For an undeflected cantilever, the power P<highlight><subscript>i </subscript></highlight>is incident on the i&apos;th detector segment and measured. All P<highlight><subscript>i </subscript></highlight>are weighted by the gain factors g<highlight><subscript>i </subscript></highlight>and added together:  
<math-cwu id="MATH-US-00005">
<number>5</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>P</mi>
          <mrow>
            <mi>z</mi>
            <mo>=</mo>
            <mn>0</mn>
          </mrow>
        </msub>
        <mo>=</mo>
        <mrow>
          <munderover>
            <mo>&Sum;</mo>
            <mrow>
              <mi>i</mi>
              <mo>=</mo>
              <mn>1</mn>
            </mrow>
            <mi>n</mi>
          </munderover>
          <mo>&it;</mo>
          <mrow>
            <msub>
              <mi>g</mi>
              <mi>i</mi>
            </msub>
            <mo>&it;</mo>
            <mrow>
              <msub>
                <mi>P</mi>
                <mi>i</mi>
              </msub>
              <mo>.</mo>
            </mrow>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>5</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00005" file="US20020195553A1-20021226-M00005.NB"/>
<image id="EMI-M00005" wi="216.027" he="24.01245" file="US20020195553A1-20021226-M00005.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0042" lvl="7"><number>&lsqb;0042&rsqb;</number> When the cantilever tip is deflected vertically by the distance z, the incident powers P<highlight><subscript>i </subscript></highlight>change due to motion of the spot on the detector: </paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>P</italic></highlight><highlight><subscript>i</subscript></highlight><highlight><italic>&rarr;P</italic></highlight><highlight><subscript>i</subscript></highlight><highlight><italic>&plus;&Dgr;P</italic></highlight><highlight><subscript>i</subscript></highlight>, </in-line-formula></paragraph>
<paragraph id="P-0043" lvl="7"><number>&lsqb;0043&rsqb;</number> where &Dgr;P<highlight><subscript>i </subscript></highlight>is the change in the power on each segment. The weighted sum now becomes:  
<math-cwu id="MATH-US-00006">
<number>6</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>P</mi>
          <mrow>
            <mi>z</mi>
            <mo>=</mo>
            <mn>0</mn>
          </mrow>
        </msub>
        <mo>=</mo>
        <mrow>
          <mrow>
            <munderover>
              <mo>&Sum;</mo>
              <mrow>
                <mi>i</mi>
                <mo>=</mo>
                <mn>1</mn>
              </mrow>
              <mi>n</mi>
            </munderover>
            <mo>&it;</mo>
            <mrow>
              <msub>
                <mi>g</mi>
                <mi>i</mi>
              </msub>
              <mo>&af;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <msub>
                    <mi>P</mi>
                    <mi>i</mi>
                  </msub>
                  <mo>+</mo>
                  <mrow>
                    <mi>&Delta;</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <msub>
                      <mi>P</mi>
                      <mi>i</mi>
                    </msub>
                  </mrow>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
          <mo>=</mo>
          <mrow>
            <mrow>
              <munderover>
                <mo>&Sum;</mo>
                <mrow>
                  <mi>i</mi>
                  <mo>=</mo>
                  <mn>1</mn>
                </mrow>
                <mi>n</mi>
              </munderover>
              <mo>&it;</mo>
              <mrow>
                <msub>
                  <mi>g</mi>
                  <mi>i</mi>
                </msub>
                <mo>&it;</mo>
                <msub>
                  <mi>P</mi>
                  <mi>i</mi>
                </msub>
              </mrow>
            </mrow>
            <mo>+</mo>
            <mrow>
              <munderover>
                <mo>&Sum;</mo>
                <mrow>
                  <mi>i</mi>
                  <mo>=</mo>
                  <mn>1</mn>
                </mrow>
                <mi>n</mi>
              </munderover>
              <mo>&it;</mo>
              <mrow>
                <msub>
                  <mi>g</mi>
                  <mi>i</mi>
                </msub>
                <mo>&it;</mo>
                <mi>&Delta;</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <msub>
                    <mi>P</mi>
                    <mi>i</mi>
                  </msub>
                  <mo>.</mo>
                </mrow>
              </mrow>
            </mrow>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>7</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00006" file="US20020195553A1-20021226-M00006.NB"/>
<image id="EMI-M00006" wi="216.027" he="24.01245" file="US20020195553A1-20021226-M00006.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0044" lvl="7"><number>&lsqb;0044&rsqb;</number> The first sum in eq.(7) is a constant and can be subtracted off. Thus we get for the signal of the measurement of the cantilever&apos;s deflection:  
<math-cwu id="MATH-US-00007">
<number>7</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msubsup>
          <mi>P</mi>
          <mi>z</mi>
          <mi>S</mi>
        </msubsup>
        <mo>=</mo>
        <mrow>
          <munderover>
            <mo>&Sum;</mo>
            <mrow>
              <mi>i</mi>
              <mo>=</mo>
              <mn>1</mn>
            </mrow>
            <mi>n</mi>
          </munderover>
          <mo>&it;</mo>
          <mrow>
            <msub>
              <mi>g</mi>
              <mi>i</mi>
            </msub>
            <mo>&it;</mo>
            <mi>&Delta;</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mrow>
              <msub>
                <mi>P</mi>
                <mi>i</mi>
              </msub>
              <mo>.</mo>
            </mrow>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>8</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00007" file="US20020195553A1-20021226-M00007.NB"/>
<image id="EMI-M00007" wi="216.027" he="24.01245" file="US20020195553A1-20021226-M00007.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0045" lvl="7"><number>&lsqb;0045&rsqb;</number> Physically, the limiting noise in the measurement of P<highlight><subscript>i </subscript></highlight>is the shot noise due to the quantum nature of light:  
<math-cwu id="MATH-US-00008">
<number>8</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <msubsup>
            <mi>P</mi>
            <mi>i</mi>
            <mi>N</mi>
          </msubsup>
          <mo>=</mo>
          <mrow>
            <mi>&gamma;</mi>
            <mo>&it;</mo>
            <msqrt>
              <msub>
                <mi>P</mi>
                <mi>i</mi>
              </msub>
            </msqrt>
          </mrow>
        </mrow>
        <mo>,</mo>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>9</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00008" file="US20020195553A1-20021226-M00008.NB"/>
<image id="EMI-M00008" wi="216.027" he="11.99205" file="US20020195553A1-20021226-M00008.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0046" lvl="7"><number>&lsqb;0046&rsqb;</number> where &ggr; is a factor dependent on the wavelength of the light and on the bandwidth of the measurement. We will neglect &ggr; in the following analysis. The P<highlight><subscript>i</subscript></highlight><highlight><superscript>N </superscript></highlight>of each element is weighted and added together. But since the noise fluctuations of the different segments are incoherent, they add in quadrature:  
<math-cwu id="MATH-US-00009">
<number>9</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msup>
          <mi>P</mi>
          <mi>N</mi>
        </msup>
        <mo>=</mo>
        <mrow>
          <msqrt>
            <mrow>
              <munderover>
                <mo>&Sum;</mo>
                <mrow>
                  <mi>i</mi>
                  <mo>=</mo>
                  <mn>1</mn>
                </mrow>
                <mi>n</mi>
              </munderover>
              <mo>&it;</mo>
              <mrow>
                <msubsup>
                  <mi>g</mi>
                  <mi>i</mi>
                  <mn>2</mn>
                </msubsup>
                <mo>&it;</mo>
                <msub>
                  <mi>P</mi>
                  <mi>i</mi>
                </msub>
              </mrow>
            </mrow>
          </msqrt>
          <mo>.</mo>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>10</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00009" file="US20020195553A1-20021226-M00009.NB"/>
<image id="EMI-M00009" wi="216.027" he="24.01245" file="US20020195553A1-20021226-M00009.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0047" lvl="7"><number>&lsqb;0047&rsqb;</number> Here we assume that &Dgr;P<highlight><subscript>i</subscript></highlight><highlight><italic>&lt;&lt;P</italic></highlight><highlight><subscript>i </subscript></highlight>and that it is thus sufficient to neglect the &Dgr;P<highlight><subscript>i </subscript></highlight>in the noise. Using (8) and (10), we can write for the signal-to-noise ratio of the measurement:  
<math-cwu id="MATH-US-00010">
<number>10</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>S</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mi>N</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mi>R</mi>
        </mrow>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <msubsup>
              <mi>P</mi>
              <mi>z</mi>
              <mi>S</mi>
            </msubsup>
            <msup>
              <mi>P</mi>
              <mi>N</mi>
            </msup>
          </mfrac>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <munderover>
                <mo>&Sum;</mo>
                <mrow>
                  <mi>i</mi>
                  <mo>=</mo>
                  <mn>1</mn>
                </mrow>
                <mi>n</mi>
              </munderover>
              <mo>&it;</mo>
              <mrow>
                <msub>
                  <mi>g</mi>
                  <mi>i</mi>
                </msub>
                <mo>&it;</mo>
                <mi>&Delta;</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msub>
                  <mi>P</mi>
                  <mi>i</mi>
                </msub>
              </mrow>
            </mrow>
            <msqrt>
              <mrow>
                <munderover>
                  <mo>&Sum;</mo>
                  <mrow>
                    <mi>i</mi>
                    <mo>=</mo>
                    <mn>1</mn>
                  </mrow>
                  <mi>n</mi>
                </munderover>
                <mo>&it;</mo>
                <mrow>
                  <msubsup>
                    <mi>g</mi>
                    <mi>i</mi>
                    <mn>2</mn>
                  </msubsup>
                  <mo>&it;</mo>
                  <msub>
                    <mi>P</mi>
                    <mi>i</mi>
                  </msub>
                </mrow>
              </mrow>
            </msqrt>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>11</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00010" file="US20020195553A1-20021226-M00010.NB"/>
<image id="EMI-M00010" wi="216.027" he="47.03265" file="US20020195553A1-20021226-M00010.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0048" lvl="7"><number>&lsqb;0048&rsqb;</number> The goal now is to choose the n gains, g<highlight><subscript>i</subscript></highlight>, that maximize the signal to noise ratio. There are n simultaneous conditions:  
<math-cwu id="MATH-US-00011">
<number>11</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mrow>
              <mo>&PartialD;</mo>
              <mi>S</mi>
            </mrow>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>N</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>R</mi>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>g</mi>
              <mi>j</mi>
            </msub>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mn>0</mn>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>12</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00011" file="US20020195553A1-20021226-M00011.NB"/>
<image id="EMI-M00011" wi="216.027" he="19.93005" file="US20020195553A1-20021226-M00011.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0049" lvl="7"><number>&lsqb;0049&rsqb;</number> that lead to  
<math-cwu id="MATH-US-00012">
<number>12</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <msub>
            <mi>g</mi>
            <mi>j</mi>
          </msub>
          <mo>=</mo>
          <mrow>
            <mi>c</mi>
            <mo>&it;</mo>
            <mi>&Delta;</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mfrac>
              <msub>
                <mi>P</mi>
                <mi>j</mi>
              </msub>
              <msub>
                <mi>P</mi>
                <mi>j</mi>
              </msub>
            </mfrac>
          </mrow>
        </mrow>
        <mo>,</mo>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>13</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00012" file="US20020195553A1-20021226-M00012.NB"/>
<image id="EMI-M00012" wi="216.027" he="19.93005" file="US20020195553A1-20021226-M00012.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0050" lvl="7"><number>&lsqb;0050&rsqb;</number> where c is an arbitrary positive constant. Therefore, if the g<highlight><subscript>i </subscript></highlight>are chosen according to eq. (13), the signal to noise ratio will be maximized in the case of shot noise. The constant c can be chosen to restrict the range of the gains to &minus;1&lE;g<highlight><subscript>i</subscript></highlight>&lE;1 by setting c equal to the inverse of the largest element of the set of the absolute values of the gains: c&equals;1/max&lcub;&verbar;g<highlight><subscript>J</subscript></highlight>&verbar;&rcub;. These n gains could be assigned to the n pre-amplifiers <highlight><bold>104</bold></highlight> remotely, for example by means of analog switches or digital to analog converters. Once the gains are set, the optimized deflection signal is present at the output of the summing stage <highlight><bold>106</bold></highlight> and can be used for feedback just like the deflection signal in a 2-segment detector. By such means, the signal to noise ratio of the optical detector can be improved. The addition of the signals from at least three segments detects a change of position or shape of the spot as the reflected beam traverses three or more segments. &ldquo;Traverse&rdquo; is meant to include not only completely crossing the segment but also partially crossing it. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> It is also possible to have different electronic setups, for example one could include the gains in the summing stage. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> The following example demonstrates that a multi-segment detector is of advantage over a two-segment detector. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE </heading>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> A home-made, prototype AFM was used to focus an incident beam onto a cantilever and the reflected beam was directed onto a detector. The cantilever was periodically deflected by vibrating it at its resonance frequency. To simulate a 19-element array detector, a slit-aperture was moved through the spot at the detector and P<highlight><subscript>i </subscript></highlight>and &Dgr;P<highlight><subscript>i </subscript></highlight>were measured at each position of the aperture that would represent an array element. &Dgr;P<highlight><subscript>i </subscript></highlight>was measured at maximum positive deflection of the cantilever. The result is displayed in FIGS. <highlight><bold>10</bold></highlight>(A) and (B). The power distribution in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>(A) represents the shape of the spot at the detector (the scale of &Dgr;P<highlight><subscript>i </subscript></highlight>in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>(B) is much smaller than that of P<highlight><subscript>i </subscript></highlight>in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>(A)). The gains g<highlight><subscript>i </subscript></highlight>were then chosen according to equation (13) with c&equals;0.235: (g<highlight><subscript>1</subscript></highlight>, g<highlight><subscript>2</subscript></highlight>, . . . , g<highlight><subscript>19</subscript></highlight>)&equals;(0, 0, 0, 0.46, 1, 0.35, &minus;0.26, &minus;0.40, 0.55, 0.05, &minus;0.44, &minus;0.72, &minus;0.95, &minus;0.21, &minus;0.13, 0, 0, 0, 0) as shown in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>(D), and used in equation (11), to calculate the signal to noise ratio of the optimized 19-segment detector:  
<math-cwu id="MATH-US-00013">
<number>13</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>S</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mi>N</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <msub>
            <mi>R</mi>
            <mn>19</mn>
          </msub>
        </mrow>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>166.4</mn>
            <msqrt>
              <mn>707.2</mn>
            </msqrt>
          </mfrac>
          <mo>=</mo>
          <mrow>
            <mn>6.26</mn>
            <mo>.</mo>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>14</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00013" file="US20020195553A1-20021226-M00013.NB"/>
<image id="EMI-M00013" wi="216.027" he="21.12075" file="US20020195553A1-20021226-M00013.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> A regular 2-segment detector can be simulated by setting g<highlight><subscript>i</subscript></highlight>&equals;1 for i&lt;&equals;m (forming the first segment) and setting g<highlight><subscript>i</subscript></highlight>&equals;&minus;1 for i&gt;m (forming the second segment) as shown in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>(C). One typically chooses m such that the same power is incident on each of the two &ldquo;segments&rdquo;. In the example, m&equals;8 and the g<highlight><subscript>i</subscript></highlight>&apos;s are (g<highlight><subscript>1</subscript></highlight>, g<highlight><subscript>2</subscript></highlight>, . . . , g<highlight><subscript>19</subscript></highlight>)&equals;(1, 1, 1, 1, 1, 1, 1, 1, &minus;1, &minus;1, &minus;1, &minus;1, &minus;1, &minus;1, &minus;1, &minus;1, &minus;1, &minus;1, &minus;1). The signal to noise ratio of the 2-segment detector calculates to  
<math-cwu id="MATH-US-00014">
<number>14</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>S</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mi>N</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <msub>
            <mi>R</mi>
            <mn>2</mn>
          </msub>
        </mrow>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>87</mn>
            <msqrt>
              <mn>3051</mn>
            </msqrt>
          </mfrac>
          <mo>=</mo>
          <mrow>
            <mn>1.58</mn>
            <mo>.</mo>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>15</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00014" file="US20020195553A1-20021226-M00014.NB"/>
<image id="EMI-M00014" wi="216.027" he="21.12075" file="US20020195553A1-20021226-M00014.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0055" lvl="7"><number>&lsqb;0055&rsqb;</number> From equations 14 and (15) it follows that the signal to noise ratio of the optimized 19-segment detector is 4.0 times higher than the signal to noise ratio of a regular 2-segment detector. Also, the usual procedure of centering the spot on a 2-segment detector was eliminated in the case of the multi-element detector. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> In the described case of shot noise, the optimizing g<highlight><subscript>i</subscript></highlight>&apos;s have a particularly simple dependence on the P<highlight><subscript>i </subscript></highlight>and &Dgr;P<highlight><subscript>i </subscript></highlight>(equation (13)). In practice, there may be other noise sources and/or the signal of interest may be defined differently from equation (8). For example, one might want to choose the g, to suppress a spurious signal. Different definitions of signal, noise and the &ldquo;merit&rdquo; function that is to be optimized can lead to more complex conditions for the g, than equation (13). The optimum gains g<highlight><subscript>i </subscript></highlight>may have to be found numerically in those cases. Also, one can consider other or additional measurements with the individual detector segments before deciding on the values for the g<highlight><subscript>i</subscript></highlight>&apos;s, such as vibrating the cantilever at different normal modes. </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> In another implementation of using a multi-element detector with individual gains, a 2-dimensional array of detector elements (a CCD-chip, for example) can be used that further increase the signal to noise ratio or that allow for the detection of additional measurement signals. No constraint need be made to size and shape of the individual elements. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> The above optimizing method does not distinguish between an optical beam deflection setup and interferometric setup and therefore can be used interchangeably for both and in particular with a combined optical beam deflection-interferometric setup. Additionally, any signal extracted from the multi element detector can provide input to a feedback system for regulating certain tasks, such as dynamically optimizing the g<highlight><subscript>i</subscript></highlight>&apos;s (for example to account for drift of the spot on the detector) or even to dynamically adjust the position/size/shape of the focus spot on the cantilever. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> We are aware that a four segment detector has often been used to enable an AFM to measure lateral cantilever deflections next to its vertical deflections. Such use of three or more segments per se is not a part of the invention. </paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> Referring to <cross-reference target="DRAWINGS">FIG. 11, a</cross-reference> housing <highlight><bold>108</bold></highlight> can be provided thermally isolating the AFM <highlight><bold>110</bold></highlight> and can be equipped, as is common with isolating enclosures with expandable manipulation gloves <highlight><bold>112</bold></highlight> or, in the alternative, can be operated remotely. By so isolating the AFM, the temperature of the environment of the AFM is regulated, thereby limiting thermal drift. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">We claim: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. In a beam deflection sensing optical device, having a light source providing an incident beam, a lens for focusing the incident beam to a spot on an object and an optical detector for receiving the beam when reflected from the object the improvement whereby the sensitivity of the optical device is increased, comprising providing: 
<claim-text>(a) control means in the path of the incident beam for adjusting the size of the incident beam spot and including one or more objects placeable in the path of the incident beam and a plurality of movable, or interchangeable lenses, whereby to produce different size focused spots for respective selected objects; and/or </claim-text>
<claim-text>(b) control means in the path of the incident beam for adjusting the power of the incident beam spot including a mask inserted in the path of the incident beam having adjacent regions through which the beam is transmitted, said adjacent regions having either different optical transmission characteristics or different shapes; and/or </claim-text>
<claim-text>(c) means for viewing the spot and the object, and spot position control means based on imaging the object and the spot through the viewing means for moving the incident beam spot with movement of the object whereby to maintain the position of the spot on the object; and/or </claim-text>
<claim-text>(d) control means for increasing the control signal to noise ratio of the optical detector, in which the optical detector has an array of three or more segments generating signals with gains adjusted based on evaluation of one or more segment signals, and means for adding the signals from said three or more segments to detect a change of position or shape of the spot as the reflected beam traverses said three or more segments. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which said beam deflection sensing optical device is an atomic force microscope. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which said light source is a source of collimated light and comprising control means in the path of the incident beam for adjusting the size of the incident beam spot including an adjustable beam expander or zoom optics in the path of the incident beam. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00003">claim 3</dependent-claim-reference> including a viewing system confocal with the spot on the cantilever, said beam expander or zoom optics being also in the path of said confocal viewing system. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> including a plurality of cantilevers selectively placeable in the path of said beam, and including a plurality of cylindrical lenses or prisms, each cylindrical lens or prism associated with a cantilever. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> including said control means for adjusting the power of the incident beam and including a cantilever disposed in a predetermined plane and means for forming an image plane, with respect to the plane of the cantilever, in the path of the incident beam, said mask being inserted in said image plane whereby to produce a desired spot shape. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> including said control means for adjusting the power of the incident beam, said mask being patterned whereby to produce a desired spot irradiance distribution on the cantilever. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> comprising said spot position control means, and means for determining a change in position of the object, comparing it to the position of the spot, and adjusting the position of the spot until it corresponds to the position of the object. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> comprising said control means for increasing the control signal to noise ratio of the optical detector, the amplification of the signal from each segment being adjusted to optimize the control signal. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> in which said array of segments is a CCD chip or a photodiode array. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> including a plurality of pre-amplifiers associated with respective segments and summing means to receive the pre-amplified outputs thereof. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> wherein said different gains are applied to the respective pre-amplifiers. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> wherein said different gains are applied to the summing means. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> comprising thermal drift limiting means for regulating the temperature of the environment of said optical device. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The improvement of <dependent-claim-reference depends_on="CLM-00011">claim 14</dependent-claim-reference> in which said thermal drift limiting means comprises a housing enclosing said optical device. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. In a beam deflection sensing optical device having a light source providing an incident beam, a lens for focusing the incident beam to a spot on an object, and an optical detector for receiving the beam when reflected from the object, the improvement whereby the sensitivity of the optical device is increased, comprising providing 
<claim-text>(a) control means in the path of the incident beam for adjusting the size and power of the incident beam spot; and including one or more objects placeable in the path of the incident beam and a plurality of moveable, removable or interchangeable lenses, whereby to produce different size focused spots for respective selected objects; and/or </claim-text>
<claim-text>(b) means for viewing the spot and the objects and spot position control means based on imaging the object and the spot through the viewing means for moving the incident beam spot with movement of the object whereby to maintain the position of the spot on the object; and </claim-text>
<claim-text>(c) control means for increasing the control signal to noise ratio of the optical detector, in which the optical detector has an array of three or more segments generating signals with gains adjusted based on evaluation of one or more segment signals, and means for adding the signals from said three or more segments to detect a change os position or shape of the spot as the reflected beam traverses said three or more segments. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A method for improving the sensitivity of a beam deflection sensing optical device having a light source providing an incident beam, a lens for focusing the incident beam to a spot on an object, and an optical detector having an array of three or more segments for receiving the beam when reflected from the object, comprising: 
<claim-text>(a) modifying the incident beam to adjust the size of the incident beam spot, said optical device including one or more objects placeable in the path of the incident beam, comprising the step of discretely adjusting the size of the incident beam spot whereby to produce different size focused spots for respective selected objects; and/or </claim-text>
<claim-text>(b) adjusting the power of the incident beam spot by inserting a mask in the path of the incident beam said mask having adjacent regions through which the beam is transmitted, said adjacent regions having either different optical transmission characteristics or different shapes; and or </claim-text>
<claim-text>(c) moving the incident beam spot with movement of the object whereby to maintain the position of the spot on the object; and/or </claim-text>
<claim-text>(d) adjusting the gains of different segments of the optical detector based on an evaluation of one or more segment signals and adding the signals from said three or more segments to detect a change of position or shape of the spot as the reflected beam traverses said three or more segments whereby to increase the signal to noise ratio of the optical detector. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference> in which said beam deflection sensing optical device is an atomic force microscope. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference> in which said light source is a source of collimated light, and including the step of adjusting the size of the incident beam spot by diverging or converging said collimated light beam and then re-collimating said diverged or converged light beam to a different size spot. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference> in which optical device includes a cantilever disposed in a predetermined plane and means for forming an image plane, with respect to the plane of the cantilever, in the path of the incident beam, comprising the step of inserting said mask in said image plane whereby to produce a desired spot shape. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference> in which said mask is patterned, and controlling said incident beam whereby to produce a desired spot irradiance distribution on the cantilever. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference> adjusting the power of the incident beam by inserting said mark in its path, and determining a change in position of the object, comparing it to the position of the spot, and adjusting the position of the spot until it corresponds to the position of the object. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference> in which the optical detector has an array of segments generating signals, including the step of applying different gains to different segments to amplify the signals from respective segments, the signal from each segment being amplified by adjusting it to optimize the control signal. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> in which said array of segments is a CCD chip on a photodiode array. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> in which said optical detector includes a plurality of pre-amplifiers associated with respective segments and summing means to receive the pre-amplified outputs thereof, comprising the step of applying said different gains to the respective pre-amplifiers. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> in which said optical detector includes a plurality of pre-amplifiers associated with respective segments and summing means to receive the pre-amplified outputs thereof, comprising the step of applying said different gains to the summing means. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference> comprising regulating the temperature of the environment of the optical device to limit thermal drift. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference> in which the regulating step comprises enclosing said optical device in a housing. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. A method for improving the sensitivity of a beam detection sensing optical device having a light source providing an incident beam, a lens for focusing the incident beam to a spot on an object, and an optical detector having an array of segments for receiving the beam when reflected from the object, comprising: 
<claim-text>(a) modifying the incident beam to adjust the size of the incident beam spot, said optical device including one or more objects placeable in the path of the incident beam, comprising the step of discretely adjusting the size of the incident beam spot whereby to produce different size focused spots for respective selected objects; </claim-text>
<claim-text>(b) adjusting the power of the incident beam spot by inserting a mask in the path of the incident beam, said mask having adjacent regions through which the beam is transmitted, said adjacent regions having either different optical transmission characteristics or different shapes. </claim-text>
<claim-text>(c) moving the incident beam spot with movement of the object whereby to maintain the position of the spot on the object; and </claim-text>
<claim-text>(d) adjusting the gains of different segments of the optical detector based on an evaluation of one or more segment signals and adding the signals from said one or more segments to detect a change of position or shape of the spot as the reflected beam traverses said three or more segments, whereby to increase the signal to noise ratio of the optical detector.</claim-text>
</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>4A</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020195553A1-20021226-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020195553A1-20021226-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020195553A1-20021226-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020195553A1-20021226-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020195553A1-20021226-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020195553A1-20021226-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00006">
<image id="EMI-D00006" file="US20020195553A1-20021226-D00006.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00007">
<image id="EMI-D00007" file="US20020195553A1-20021226-D00007.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00008">
<image id="EMI-D00008" file="US20020195553A1-20021226-D00008.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00009">
<image id="EMI-D00009" file="US20020195553A1-20021226-D00009.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00010">
<image id="EMI-D00010" file="US20020195553A1-20021226-D00010.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00011">
<image id="EMI-D00011" file="US20020195553A1-20021226-D00011.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020197297A1-20021226-D00000.TIF SYSTEM "US20020197297A1-20021226-D00000.TIF" NDATA TIF>
<!ENTITY US20020197297A1-20021226-D00001.TIF SYSTEM "US20020197297A1-20021226-D00001.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020197297</doc-number>
<kind-code>A1</kind-code>
<document-date>20021226</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10150752</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020517</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>A61L002/00</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>A61K038/18</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>A61K048/00</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>B05D003/00</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>424</class>
<subclass>423000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>514</class>
<subclass>012000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>427</class>
<subclass>002260</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>514</class>
<subclass>044000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Method to improve hydroxyapatite implantation and stimulate bone regeneration</title-of-invention>
</technical-information>
<continuity-data>
<continuations>
<continuation-in-part-of>
<parent-child>
<child>
<document-id>
<doc-number>10150752</doc-number>
<kind-code>A1</kind-code>
<document-date>20020517</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09808721</doc-number>
<document-date>20010312</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>PENDING</parent-status>
</parent-child>
</continuation-in-part-of>
</continuations>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Subhash</given-name>
<middle-name>H.</middle-name>
<family-name>Risbud</family-name>
</name>
<residence>
<residence-us>
<city>Davis</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Nancy</given-name>
<middle-name>E.</middle-name>
<family-name>Rashid</family-name>
</name>
<residence>
<residence-us>
<city>Davis</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>A.</given-name>
<middle-name>Hari</middle-name>
<family-name>Reddi</family-name>
</name>
<residence>
<residence-us>
<city>El Macero</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<assignee>
<organization-name>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California Corporation</organization-name>
<address>
<address-1>1111 Franklin Street</address-1>
<address-2>Twelfth Floor</address-2>
<city>Oakland</city>
<state>CA</state>
<postalcode>94607-5200</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
<assignee-type>02</assignee-type>
</assignee>
<correspondence-address>
<name-1>TOWNSEND AND TOWNSEND AND CREW, LLP</name-1>
<name-2></name-2>
<address>
<address-1>TWO EMBARCADERO CENTER</address-1>
<address-2>EIGHTH FLOOR</address-2>
<city>SAN FRANCISCO</city>
<state>CA</state>
<postalcode>94111-3834</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">Hydroxyapatite is treated by a combination of nitridation and the application of bone morphogenetic protein or DNA encoding such a protein to improve the tissue compatibility and affinity of the hydroxyapatite, rendering the hydroxyapatite more useful as a material for biomedical implants. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">CROSS REFERENCE TO RELATED APPLICATION </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application is a continuation-in-part of co-pending application Ser. No. 09/808,721, filed Mar. 12, 2001, the contents of which are incorporated herein in their entirety.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<heading lvl="1">STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT </heading>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This invention was made with Government support under Grant No. DMR 97-30019, awarded by the National Science Foundation. The Government has certain rights in this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> 1. Field of the Invention </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> This invention relates to biomedical and orthopedic implants and prostheses and to their use of hydroxyapatite. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> 2. Description of the Prior Art </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> Implants and prostheses are commonly used in the medical profession to replace or reinforce diseased or injured hard tissues that are either fractured, damaged, or degenerated. These devices and materials are used, for example, as heart valve replacements, hip implant stems or anchorages, dental implants, knee prostheses, and vertebral spacers. Implants are also used as bone graft substitutes, as alignment maintenance devices in spinal fusion procedures, and as reinforcements for bone weakened by tumor metastases. In some cases, the implants are organs or sections of bone that are transplanted from other portions of the patient&apos;s body, while in others, synthetic bones or organs are used. For rigid parts such as bone, fixation is typically achieved by screws, cement, or both. Softer organ and tissue implants are secured by stitching the implants to the surrounding tissues with thread. Still other implants such as breast implants and pacemakers are not securely fixed, but instead rely on natural tissue formation around the implant for securement. In all cases, the success of the implant often depends on its compatibility with, and incorporation into, the biological system, and for those intended for harder tissue, the ability of the implant to form a secure bond to the neighboring healthy tissue. The surface properties of the implant are of primary importance in achieving these goals. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> Synthetic materials when used as implants offer certain advantages over transplanted materials in certain applications of this invention. In bone grafts, for instance, the use of a synthetic material rather than a portion of the patient&apos;s own iliac crest offers a lower morbidity rate at the donor site and a further advantage for growing children, who have less native bone stock available for use. In spinal fusions, synthetic hydroxyapatite offers an advantage over hydroxyapatite formed by heating coral, since synthetic hydroxyapatite can be manufactured in a less porous and hence stronger form. In cancer patients, bones that have become weakened by tumor metastasis can be replaced or reinforced by a bone graft of synthetic material, again avoiding the need for native bone stock. In other applications of the invention, porosity is desirable. These applications are those where ingrowth of blood vessels and soft tissue are desirable, i.e., those in which the implant is intended to function in a manner comparable to natural bone. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> A synthetic material that demonstrates a high level of compatibility with bone and other hard tissue as well as stability in the physiological environment is hydroxyapatite. Hydroxyapatite is a calcium phosphate with the same elemental components as natural bone. Hydroxyapatite is in fact the primary mineral constituent of mammalian bone, constituting 43% by weight of bone composition. The synthetic hydroxyapatite that is used for implants differs from natural bone hydroxyapatite by having fewer impurities and a higher degree of crystallization. Some of the impurities occur as substitutions in the crystal structure. The calcium ions, for example, may be substituted by sodium, potassium, magnesium, lead, manganese, cadmium, strontium, or zinc ions; the hydroxyl sites by halide, oxygen, carbonate, and water; and the phosphate ions by arsenate, sulfate, and carbonate. Deviations from the hydroxyapatite crystal structure form further impurities. These deviations are introduced during synthesis since calcium phosphates can assume many forms and a pure hydroxyapatite material is difficult to synthesize based on the stoichiometric composition. Even though hydroxyapatite is the only calcium phosphate that is stable under normal physiological conditions and other calcium phosphate phases tend to convert to the more stable hydroxyapatite, the transition occurs slowly, allowing the less stable calcium phosphate phases to resorb into the surrounding tissue at rates that vary with their porosity and composition. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Unstable calcium phosphate phases also tend to degenerate into grains which, when released into the body, induce adverse metabolic responses such as a foreign body giant cell response or encapsulation in fibrous tissue. Small particles can also induce an immune response and at times a massive phagocytic cell response. The latter can cause the displacement of normal tissue with a weak, structureless mass of inflamed tissue, leading to the loosening of the implant. Cells that resorb damaged bone (osteoclasts) and those that rebuild bone (osteoblasts) are also affected by the release of small implant particles as the implant deteriorates: small particles tend to activate the osteoclasts and decrease the population of the osteoblasts, the net result being a loss of bone mass. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Other shortcomings of synthetic hydroxyapatite are its flexural strength, strain-to-failure ratio, and fracture toughness, all of which are low relative to bone. Synthetic hydroxyapatite is thus relatively brittle and has low fatigue resistance, and for these reasons is not used in load-bearing locations. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Various methods have been used in the prior art for modifying hydroxyapatite and other implant materials to improve their bone adhesion and other properties. Among these methods are the use of bone morphogenetic proteins as a coating on the implant surface to improve cell adhesion and subsequent tissue attachment. Methods of applying these coatings and their effects are reported in references cited by Zeng, H., et al., <highlight><italic>Biomaterials </italic></highlight>20 (1999): 377-384. To improve the hardness of the implant material and its chemical inertia to the biological environment, nitrogen atoms have been introduced into the material by nitridation. This has been reported for both hydroxyapatite and titanium implants by Habelitz, S., et al., <highlight><italic>J. European Ceramic Society </italic></highlight>19 (1999): 2685-2694, and Torrisi, L., <highlight><italic>Metallurgical Science and Technology </italic></highlight>17(1) (1999): 27-32. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> It has now been discovered that hydroxyapatite, upon receiving the combined treatment of nitridation and a bone morphogenetic protein or an analog thereof, or DNA encoding such a protein or analog, is unexpectedly favorable to tissue growth of the contacting tissue, with the two treatments displaying a synergistic effect. As a result, the affinity of a hydroxyapatite component or a hydroxyapatite-coated component of a biomedical implant for native bone or tissue is increased, the result being greater than the sum of the effects of either nitridation or treatment with the protein alone. In some cases, in fact, the nitridation when applied alone actually lessens the affinity of the surface to the adjacent tissue. Thus, it is particularly surprising that the combined treatment has such a beneficial effect. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> The present invention thus resides in a method of improving hydroxyapatite-containing biomedical implants by applying the two treatments in combination. The invention also resides in novel biomedical implant materials that include either a hydroxyapatite component or coating that has undergone the combination treatment. The invention further resides in various surgical methods that involve the placement or implantation of hydroxyapatite materials in the human or mammalian body, the performance of the materials being improved by having been subjected to the combination treatment prior to implantation. These procedures and methods are discussed in more detail below.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> is a bar graph showing the results of a series of comparisons to demonstrate the synergistic effect of the combination treatment of the present invention.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION AND SPECIFIC EMBODIMENTS </heading>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> Bone morphogenetic proteins (BMPs) are members of a family of structurally and functionally related morphogenetic proteins that belong to the Transforming Growth Factor-Beta (TGF-&bgr;) superfamily. At least fifteen BMPs have been identified to date, and they are numbered consecutively, i.e., &ldquo;BMP-1,&rdquo; &ldquo;BMP-2,&rdquo; etc. Originally identified as protein regulators of cartilage and bone formation, BMPs have also been shown to regulate the growth, differentiation, chemotaxis, and apoptosis of various cell types, including mesenchymal cells, epithelial cells, hematopoietic cells, and neuronal cells. The BMPs have molecular weights of approximately 25 kD and are expressed as secretory polypeptide precursors that share a highly conserved bioactive cysteine domain located near their C-termini. The C-terminal domains of BMP-3, BMP-5, BMP-6, and BMP-7 (also known as OP-1 or &ldquo;osteogenic protein-1&rdquo;) are about 60% identical to that of BMP-2, and the C-terminal domains of BMP-6 and BMP-7 are 87% identical. The BMPs also share a propensity to form homo- and heterodimers. The BMPs are highly conserved across species as well. At the amino acid sequence level, for example, mature human and mouse BMP-4 are 98% and 100% identical, respectively, to mature rat BMP-4, mature human and mouse BMP-5 are 97% identical, mature human and mouse BMP-6 are 96% identical, and mature human, mouse and rat BMP-2 are 100% identical. BMPs of particular interest in the practice of this invention are BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, and BMP-7. BMP-4, BMP-6, and BMP-7 are particularly preferred. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> BMPs have been isolated from biological sources using purification techniques coupled with bioassays. BMPs have also been isolated and cloned by virtue of DNA sequence homologies within conserved regions that are common to the BMP family. Synthetic BMPs and recombinant BMPs have also been prepared. A disclosure of one method of isolating BMPs from bone tissue is Urist, M. R., U.S. Pat. No. 4,294,753, issued Oct. 13, 1981, and incorporated herein by reference. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> Transforming Growth Factor-Beta 1 (&ldquo;TGF-&bgr;1&rdquo;) is a close structural analog of the BMPs. The various TGF-&bgr;s are dimers containing two identical polypeptide chains, each dimer having a molecular mass of about 25 kD. The TGF-&bgr;s, including TGF-&bgr;1, can be isolated from mammalian species in general and from bone, platelets, or placenta, and purified for use in recombinant cell culture. Methods of isolating and purifying these proteins are reported in the literature, such as for example European Patent Application No. 200 341, published Dec. 10, 1986, European Patent Application No. 169 016, published Jan. 22, 1986, and U.S. Pat. No. 4,774,322, issued Sep. 27, 1988. The contents of each of these documents are incorporated herein by reference. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> The inclusion of the bone morphogenetic protein or analog in the treatment of the hydroxyapatite is achieved by applying to the hydroxyapatite either the protein itself or DNA that encodes the protein. The DNA can be supplied in any form that is known to be capable of transforming mammalian cells upon contact and expression in the cells thus transformed. If DNA is applied, a high level of expression can be obtained by subcloning the DNA into an expression vector that contains a strong promoter to direct transcription, a transcription unit or expression cassette, a transcription/translation terminator, and a ribosome-binding site for translational initiation. Bacterial expression systems and eukaryotic expression systems are well known in the art and commercially available. The transcription unit or expression cassette contains the elements required for the expression of the DNA in a host cell, which typically include a promoter linked to the nucleic acid sequence, signals for the efficient polyadenylation of the transcript, ribosome binding sites, and translation termination, and if desired, enhancers and introns. Preferred expression vectors are plasmids, and preferred plasmids for the practice of the present invention are those for BMP-4 and BMP-7, both of which are known. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> Methods for direct application of either the protein or its encoding DNA are known and will be readily apparent to those skilled in the art. A common method is the simple deposition of the protein or the DNA or an appropriate vector containing the DNA from a liquid solution. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> Nitridation processes are likewise disclosed in the literature, and include the use of dry ammonia, aqueous ammonia, and nitrogen monoxide. Gaseous molecular nitrogen can be ionized by the action of electrical discharges to form an ionic plasma. Thermal nitridation with nitrogen-containing gas is another option, whereby the hydroxyapatite is placed with the gas in a heated chamber at temperatures between 300&deg; C. and 1100&deg; C. These and other nitridation methods are disclosed for example by Habelitz et al. and Torrisi, referenced above. The degree of nitridation is not critical to the invention and may vary. In most applications, best results will be obtained with nitridation within the range of about 1% by weight to about 4% by weight. In the preferred practice of this invention, the nitridation is performed prior to the protein treatment. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> Hydroxyapatite is a crystal form of calcium phosphate having the empirical formula Ca<highlight><subscript>10</subscript></highlight>(PO<highlight><subscript>4</subscript></highlight>)<highlight><subscript>6</subscript></highlight>(OH)<highlight><subscript>2</subscript></highlight>. Dense hydroxyapatite is made by compressing calcium phosphate solids from a very fine powder into a pellet which is then heat treated to fuse the powder particles together. A disclosure of this process is provided by Jarcho, M., <highlight><italic>J. Mater. Sci. </italic></highlight>11: 2027 (1976). </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> Hydroxyapatite that has been treated in accordance with this invention can be used as components or coatings for dental implants, knee prostheses, vertebral spacers, hip implants, heart valve replacements, and any of a variety of other orthopedic or biomedical implants that would benefit from an improved affinity to the neighboring tissue, whether the tissue be bone, cartilage, or soft tissue. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> In bone graft surgery, hydroxyapatite treated in accordance with this invention avoids the problems associated with autografts and allografts. Autografts offer a high fusion rate, but are commonly accompanied by complications and a high rate of morbidity at the harvesting site. Allografts offer an alternative that addresses some of these problems, but only with a significantly lower fusion rate, a high resorption rate, the potential for disease transmission, and limited availability of bone stock worldwide. Synthetic hydroxyapatite treated with both nitridation and bone morphogenetic protein can be directly substituted for the harvested bone of both autograft and allograft, avoiding many, if not all, of these problems. The surgical procedure remains otherwise the same. This invention extends to bone grafts such as those in interbody fusion procedures of the spine, as well as those in long bones. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> Spinal fusions are generally used to treat injuries to the spinal vertebrae, protrusions or degeneration of the cushioning disk between vertebrae (i.e., slipped or herniated disks), abnormal curvatures of the spine, and weak or unstable spines caused by infections or tumors. The treated hydroxyapatite of this invention can also be used in the fusions and also as a cast applied against the spine for maintaining alignment of the spine, thereby replacing or supplementing internal fixation devices such as rods. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> Hydroxyapatite treated in accordance with this invention can also be used in stabilizing, reinforcing, or replacing bone that has been weakened or deteriorated by metastatic deposits from tumors such as those arising from breast cancer and prostate cancer. The weakening is due to an increased rate of bone resorption caused by the deposits, and typically occurs in the spine, ribs, pelvis, and proximal long bones. Orthopedic procedures for stabilizing the weakened bones are well known and widely used. In the practice of the present invention, the treated hydroxyapatite is used in place of the conventional bone graft materials, the procedure itself being otherwise substantially the same. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> The following examples are offered for illustrative purposes only. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> This example demonstrates the synergistic effect of bone morphogenetic protein and nitridation on hydroxyapatite implants, using BMP-7 as the bone morphogenetic protein. Detection of the effect was based on the rate of bone formation at the implant site, using alkaline phosphatase (ALP) activity as an indicator of bone formation. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> Pure hydroxyapatite powder was obtained from Johnson Matthey Catalog Co. (Ward Hill, Mass., USA) and nitrided by exposure to flowing dry ammonia gas at 800&deg; C. for three hours. The nitrided powder was pressed into pellets measuring 6 mm in diameter and 2-3 mm in thickness, using an hydraulic press and a pressure of 1000 psi. The pellets were then sintered at 800&deg; C. in flowing dry ammonia gas for ten hours, resulting in a nitrogen content of 0.88% by weight, as determined by Galbraith Laboratories (Knoxville, Tenn., USA), using the Leco method. In the Leco method, the sample is placed in a tin capsule and combusted in an oxygen atmosphere at 950&deg; C. The combustion products are swept away with helium and gross water is removed by thermoelectric cooling. Oxygen is removed and nitrous oxides are reduced through the use of hot copper. Carbon dioxide and any remaining water are then removed and the remaining N<highlight><subscript>2 </subscript></highlight>is measured by sweeping the gas through a thermal conductivity cell. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> Additional pellets of pure, unnitrided hydroxyapatite powder were pressed and sintered in an air atmosphere at 800&deg; C. for ten hours. The pure pellets were divided into two groups. The first group was nitrided by nitrogen ion implantation, whereby the pellets were bombarded by nitrogen ions at room temperature in two steps: 60 keV at a dose of 1.5&times;10<highlight><superscript>17 </superscript></highlight>nitrogen ions per square centimeter, followed by 35 keV at a dose of 5&times;10<highlight><superscript>16 </superscript></highlight>nitrogen ions per square centimeter. The ion implanted samples had a nitrogen content of 3.55&plusmn;0.21 weight percent, as determined by electron microprobe analysis conducted at 10 keV using a 20 nA electron beam defocused to a diameter of 20-30 microns. The second group of pellets was left unnitrided. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> The study was then performed in two halves. In the first half, pellets from each of the three groups (ammonia-nitrided, nitrided by nitrogen ion implantation, and unnitrided) were implanted in rats, with two pellets from the same group in each rat. The pellets were placed subcutaneously at bilateral sites over the pectoralis fascia. After thirteen days, the rats were sacrificed by overdose of ethyl ether, and the implants were harvested. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> In the second half of the study, pellets from each of the three groups were treated with BMP-7, obtained from Creative Biomolecules, inc., of Cambridge, Mass., USA. The BMP-designated pellets were placed in a dry petri dish at room temperature (the ion-implanted pellets were placed with the ion-treated side up). Buffered saline solution (10 &mgr;L) containing 10 &mgr;g of BMPs was delivered by pipet to the center of the hydroxyapatite pellet surface and allowed to dry. These pellets were then implanted in rats in the same manner as the first half of the study, i.e., the group that did not receive the BMP-7 treatment. Three pairs of tests were thus performed, all in parallel fashion with eight pellets for each test, or a total of 48 pellets. In the first pair of tests, unnitrided pellets were used; in the second pair, pellets nitrided by ammonia treatment were used; and in the third pair, pellets nitrided by nitrogen ion implantation were used. One member of each pair had been exposed to BMP treatment while the other had not. Two rats were used in each test, for a total of 24 rats, with two identical pellets implanted in each rat. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> Once the implants were harvested from the sacrificed rats, the implant sites were surveyed for immune response, and one pellet of the eight pellets from each of the six sample sets was placed in a formaldehyde-type solution for histology. The remaining seven pellets from each of the six sample sets were placed in a test tube containing 2.0 mL of a neutral saline solution to be used as the homogenization buffer in an alkaline phosphatase assay. The pellets were homogenized in the test tubes for ten seconds, using a Brinkman Polytron homogenizer at maximum speed, and the process was performed three times with a 5-second pause between each repetition. Between samples, the homogenizer was rinsed with water and any remaining tissue was removed from the blades. The homogenate was then centrifuged at 20,000&times; g for fifteen minutes at 4&deg; C. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> Supernatants from the centrifuged samples were then placed in test tubes. Three test tubes were prepared for each sample, one to serve as a blank and the remaining two as duplicates for the alkaline phosphatase (ALP) measurement. Prior to adding the supernatants, each tube was charged with 1.0 mL barbital buffer, 0.5 mL p-nitrophenol substrate, and 0.3 mL distilled water. The tubes designated to serve as blanks were incubated at 37&deg; C. in a water bath for thirty minutes, then filled with 2.0 mL of 0.1 N NaOH stop solution, mixed by vortexing, and kept at room temperature. The tubes designated to serve as duplicates for the ALP measurement were simply placed in the 37&deg; C. water bath. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> The amount of supernatants added to each sample duplicate tube was 0.2 mL, except in the case of samples where high enzyme activity was anticipated, in which case only 0.05 mL of supernatant was used in order to maintain the data within the range of the spectrophotometer. Once the supernatants were added, the tubes were mixed by vortexing. After exactly thirty minutes of reaction time, the reaction in each of the ALP duplicate was stopped by adding 2.0 mL of the 0.1 N NaOH stop solution. All tubes were then equilibrated to room temperature, and optical density (OD) was read on a spectrophotometer at 410 nm for each blank and each duplicate. An average was taken of each pair of duplicates and then subtracted from the blank. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> Alkaline phosphatase (ALP) activity was reported in ALP units per mg of protein. The amount of protein in each sample was determined by the Lowry Protein Assay. Additional supernatant fluid from each sample was used to measure the amount of protein present in the sample relative to known standards of bovine serum albumin (BSA), using alkaline copper solution and Folin Ciocalteau Reagent, with spectrophotometer readings at 500 nm. Protein concentrations were obtained by standard curve linear regression. The number of ALP units per mg of protein was obtained by multiplying the change in optical density by 218.58 (the average of the duplicates minus the blank) and dividing by the mg of protein per 0.2 mL aliquot of sample. The results are shown in bar graph form in <cross-reference target="DRAWINGS">FIG. 1</cross-reference>. The vertical axis in the figure represents the ALP absorbance, and the horizontal bars represent (left to right): </paragraph>
<paragraph id="P-0036" lvl="2"><number>&lsqb;0036&rsqb;</number> (1) Hydroxyapatite pellets with no nitridation and no BMP treatment </paragraph>
<paragraph id="P-0037" lvl="2"><number>&lsqb;0037&rsqb;</number> (2) Hydroxyapatite pellets with no nitridation but having been treated with BMP-7 </paragraph>
<paragraph id="P-0038" lvl="2"><number>&lsqb;0038&rsqb;</number> (3) Hydroxyapatite pellets nitrided with ammonia gas and no BMP treatment: the bar is of negligible height, indicating essentially no ALP activity </paragraph>
<paragraph id="P-0039" lvl="2"><number>&lsqb;0039&rsqb;</number> (4) Hydroxyapatite pellets nitrided with ammonia gas but having been treated with BMP-7 </paragraph>
<paragraph id="P-0040" lvl="2"><number>&lsqb;0040&rsqb;</number> (5) Hydroxyapatite pellets nitrided by ion implantation and no BMP treatment: the bar is too small to be visible on the chart, indicating no ALP activity </paragraph>
<paragraph id="P-0041" lvl="2"><number>&lsqb;0041&rsqb;</number> (6) Hydroxyapatite pellets nitrided by ion implantation but having been treated with BMP-7 </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> A comparison of bars (3) and (5) with bar (1) indicates that nitridation, whether by ammonia treatment or ion implantation, actually decreases the ALP activity. Nitridation of the implant by itself is thus detrimental to bone growth at the implant site. A comparison of bar (4) with bar (2) indicates that BMP-7 treatment when combined with nitridation produces greater ALP activity and hence greater bone growth than BMP-7 treatment alone. A comparison of bar (6) with bar (2) leads to the same conclusion, indicating that the result is consistent regardless of how nitridation is achieved. Finally, comparing bars (4) and (6) individually with the sum of bars (2) and (3) and also with the sum of bars (2) and (5) indicates that the ALP activity with the combined treatment (using either type of nitridation) achieves results that are greater than the sum of the results obtained with the individual treatments. Synergism is thus demonstrated. </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> The results of the immune response tests and histology studies were consistent with the alkaline phosphatase activity results. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> This example also demonstrates the synergistic effect of bone morphogenetic protein and nitridation on hydroxyapatite implants, this time using BMP-4 as the bone morphogenetic protein. The BMP-4 protein was obtained from R &amp; D Systems of Minneapolis, Minn., USA, and the test protocols were the same as those described above for use with BMP-7. Likewise, the same results were obtained. </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> The foregoing is offered primarily for purposes of illustration. Further modifications, variations, and substitutions that are still within the spirit and scope of the invention will be readily apparent to those skilled in the art. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A method of increasing the affinity of a hydroxyapatite component of a biomedical implant for native bone or tissue, said method comprising the following steps in any order: 
<claim-text>(a) nitriding said hydroxyapatite component in a region adjacent to the surface of said hydroxyapatite component, and </claim-text>
<claim-text>(b) treating the surface of said hydroxyapatite component with a protein selected from the group consisting of bone morphogenetic proteins and transforming growth factor-beta <highlight><bold>1</bold></highlight> or with DNA encoding said protein. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which step (b) comprises adsorbing said protein or said DNA onto said surface. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which step (b) comprises treating said surface with said protein. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which step (a) is performed prior to step (b). </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which said protein is a bone morphogenetic protein. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which said protein is a member selected from the group consisting of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, and BMP-7. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which said protein is BMP-4. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which said protein is BMP-6. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which said protein is BMP-7. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which step (a) is performed by treating said surface with a member selected from the group consisting of a plasmid of BMP-4 and a plasmid of BMP-7. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which step (a) is performed by contacting said hydroxyapatite component with ammonia. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> in which step (a) is performed by contacting said hydroxyapatite component with ionized molecular nitrogen. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. A biomedical implant having a hydroxyapatite component with a surface configured for contact with native bone or tissue, said surface having been treated with a protein selected from the group consisting of bone morphogenetic proteins and transforming growth factor-beta 1 or with DNA encoding said protein, and a region of said hydroxyapatite component adjacent to said surface having been nitrided. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. A biomedical implant in accordance with <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> in which said protein is adsorbed onto said surface. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. A biomedical implant in accordance with <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> in which said surface has been treated with a protein selected from the group consisting of bone morphogenetic proteins and transforming growth factor-beta 1. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. A biomedical implant in accordance with <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> in which said protein is a bone morphogenetic protein. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A biomedical implant in accordance with <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> in which said protein is a member selected from the group consisting of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, and BMP-7. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. A biomedical implant in accordance with <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> in which said protein is BMP-4. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A biomedical implant in accordance with <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> in which said protein is BMP-6. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. A biomedical implant in accordance with <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> in which said protein is BMP-7. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. A biomedical implant in accordance with <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> in which said surface has been treated with BMP-4. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. A biomedical implant in accordance with <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> in which said surface has been treated with BMP-7. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. A method of performing a bone graft on a patient in need thereof, said method comprising joining to a bone where such graft is needed a synthetic hydroxyapatite bone graft whose surface has been treated with a protein selected from the group consisting of bone morphogenetic proteins and transforming growth factor-beta 1 or with DNA encoding said protein, said synthetic hydroxyapatite bone graft having been nitrided in a region adjacent to said surface. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> in which said protein is adsorbed onto said surface. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> in which said surface has been treated with a protein selected from the group consisting of bone morphogenetic proteins and transforming growth factor-beta 1. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> in which said surface has been treated with a bone morphogenetic protein. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00022">claim 26</dependent-claim-reference> in which said bone morphogenetic protein is a member selected from the group consisting of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, and BMP-7. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00022">claim 26</dependent-claim-reference> in which said bone morphogenetic protein is BMP-4. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00022">claim 26</dependent-claim-reference> in which said bone morphogenetic protein is BMP-6. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00022">claim 26</dependent-claim-reference> in which said bone morphogenetic protein is BMP-7. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. A method for maintaining alignment of a spine during spinal fusion, said method comprising immobilizing said spine with a hydroxyapatite cast whose surface has been treated with a protein selected from the group consisting of bone morphogenetic proteins and transforming growth factor-beta 1 or with DNA encoding said protein, said hydroxyapatite cast having been nitrided in a region adjacent to said surface. </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 31</dependent-claim-reference> in which said protein is adsorbed onto said surface. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 31</dependent-claim-reference> in which said surface has been treated with a protein selected from the group consisting of bone morphogenetic proteins and transforming growth factor-beta 1. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference> in which said bone morphogenetic protein is a member selected from the group consisting of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, and BMP-7. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference> in which said bone morphogenetic protein is BMP-4. </claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference> in which said bone morphogenetic protein is BMP-6. </claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference> in which said bone morphogenetic protein is BMP-7. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. A method for stabilizing a bone weakened by tumor metastases, said method comprising reinforcing said bone by grafting thereon a synthetic hydroxyapatite bone graft whose surface has been treated with a protein selected from the group consisting of bone morphogenetic proteins and transforming growth factor-beta 1 or with DNA encoding said protein, said synthetic hydroxyapatite bone graft having been nitrided in a region adjacent to said surface. </claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 38</dependent-claim-reference> in which said protein is a bone morphogenetic protein. </claim-text>
</claim>
<claim id="CLM-00040">
<claim-text><highlight><bold>40</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference> in which said bone morphogenetic protein is a member selected from the group consisting of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, and BMP-7. </claim-text>
</claim>
<claim id="CLM-00041">
<claim-text><highlight><bold>41</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference> in which said bone morphogenetic protein is BMP-4. </claim-text>
</claim>
<claim id="CLM-00042">
<claim-text><highlight><bold>42</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference> in which said bone morphogenetic protein is BMP-6. </claim-text>
</claim>
<claim id="CLM-00043">
<claim-text><highlight><bold>43</bold></highlight>. A method in accordance with <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference> in which said bone morphogenetic protein is BMP-7.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>1</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020197297A1-20021226-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020197297A1-20021226-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020197854A1-20021226-D00000.TIF SYSTEM "US20020197854A1-20021226-D00000.TIF" NDATA TIF>
<!ENTITY US20020197854A1-20021226-D00001.TIF SYSTEM "US20020197854A1-20021226-D00001.TIF" NDATA TIF>
<!ENTITY US20020197854A1-20021226-D00002.TIF SYSTEM "US20020197854A1-20021226-D00002.TIF" NDATA TIF>
<!ENTITY US20020197854A1-20021226-D00003.TIF SYSTEM "US20020197854A1-20021226-D00003.TIF" NDATA TIF>
<!ENTITY US20020197854A1-20021226-D00004.TIF SYSTEM "US20020197854A1-20021226-D00004.TIF" NDATA TIF>
<!ENTITY US20020197854A1-20021226-D00005.TIF SYSTEM "US20020197854A1-20021226-D00005.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020197854</doc-number>
<kind-code>A1</kind-code>
<document-date>20021226</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10147364</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020516</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>H01L021/4763</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>H01L021/44</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>438</class>
<subclass>644000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>438</class>
<subclass>654000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Selective deposition of materials for the fabrication of interconnects and contacts on semiconductor devices</title-of-invention>
</technical-information>
<continuity-data>
<non-provisional-of-provisional>
<document-id>
<doc-number>60291503</doc-number>
<document-date>20010516</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Allen</given-name>
<middle-name>J.</middle-name>
<family-name>Bard</family-name>
</name>
<residence>
<residence-us>
<city>Austin</city>
<state>TX</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Chong-Yang</given-name>
<family-name>Liu</family-name>
</name>
<residence>
<residence-us>
<city>Austin</city>
<state>TX</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>Edwin S. Flores</name-1>
<name-2>Gardere Wynne Sewell LLP</name-2>
<address>
<address-1>3000 Thanksgiving Tower</address-1>
<address-2>1601 Elm Street, Suite 3000</address-2>
<city>Dallas</city>
<state>TX</state>
<postalcode>75201-4767</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">One form of the present invention is a method for mask-less selective deposition made up of the steps of contacting a first portion of a substrate with a chemical agent that binds to the substrate to affect the susceptibility of the portion of the substrate to deposition. Following the treatment with the chemical agent, a first layer of a first material is deposited on a second portion of the surface. The first and second portions of the substrate may in fact be the same portion. That is to say, that the chemical agent may enhance or inhibit the deposition of the material of a portion of the substrate. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims priority from Provisional Application Serial No.: 60/291,503, filed on May 16, 2001.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> The United States Government may own certain rights in this invention under National Science Foundation (NSF), Project Grant No. CHE9876855.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> Selective deposition of materials to form interconnects and contacts for semiconductor devices is of great interest and importance. As the size of these devices continues to decrease, the ability to form the necessary electrical connections between the components that make up the devices becomes more and more difficult. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> Additionally, the techniques that are currently being used to allow for the selective deposition of materials have, for the most part, used masks that form a physical barrier between the desired site of deposition and those areas where no deposition is desired. The preparation of these masks is often time consuming and technologically challenging, and there are physical limitations as to how small they can ultimately be made. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> There is currently great interest in the semiconductor device manufacture industry related to the electrodeposition of copper as an interconnect metal. In the fabrication of devices, copper is often first deposited on a barrier layer material (such as tantalum oxide or titanium nitride) by a process like chemical vapor deposition, vacuum evaporation or sputtering. However such a treatment frequently leaves portions of the barrier layer with no copper deposits. Ideally, one would like to electrodeposit copper on the barrier layer material without deposition of appreciable amounts of copper on the copper layer already present. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> It would be desirable to have a method that would allow selective deposition of materials onto a semiconductor surface that would not require the formation or use of a mask. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> One form of the present invention is a method for mask-less selective deposition made up of the steps of contacting a first portion of a substrate with a chemical agent that binds to the substrate to affect the susceptibility of the portion of the substrate to deposition. Following the treatment with the chemical agent, a first layer of a first material is deposited on a second portion of the substrate. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> The first and second portions of the substrate may in fact be the same portion. That is to say, that the chemical agent may enhance or inhibit the deposition of the material of a portion of the substrate. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Another form of the invention is a method for mask-less selective deposition made up of the steps of contacting a first portion of a substrate with a chemical agent that binds to the substrate to enhance the susceptibility of the first portion of the substrate to deposition and depositing a first layer of a first material on the first portion of the substrate. Still another form of the present invention is a method for mask-less selective deposition made up of the steps of contacting a first portion of a substrate with a chemical agent that binds to the substrate to inhibit the susceptibility of the first portion of the substrate to deposition, and depositing of a first layer of a first material on a second portion of the substrate.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE FIGURES </heading>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> The above and further advantages of the invention may be better understood by referring to the following detailed description in conjunction with the accompanying drawings in which: </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> depicts a schematic of a process in accordance with the present invention; </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> depicts a graph of copper deposition before and after treatment in accordance with the present invention; </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> depicts a sample before treatment in accordance with the present invention; </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> depicts a sample following treatment in accordance with the present invention; </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> depicts another view of the sample in <cross-reference target="DRAWINGS">FIG. 4</cross-reference>; </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> depicts another sample before and after treatment in accordance with the present invention; and </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> depicts a scheme for selective deposition of copper contacts and interconnects in accordance with the present invention.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> While the making and using of various embodiments of the present invention are discussed herein in terms of selective deposition of copper, it should be appreciated that the present invention provides many applicable inventive concepts that can be embodied in a wide variety of specific contexts. The specific embodiments discussed herein are merely illustrative of specific ways to make and use the invention and are not meant to limit the scope of the invention in any manner. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> The present invention modifies the selectivity of a material&apos;s surface with respect to the ability of the surface to accept or reject the deposition of a material upon it. Such selectivity is accomplished through an appropriate chemical treatment or modification, altering the properties of the material surface. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> depicts a schematic diagram illustrating the processes; In this example, three different materials share the same substrate. Without any treatment, deposition could occur simultaneously on all three materials. Through an appropriate surface treatment, however, deposition takes place on only one of them, such as material <highlight><bold>1</bold></highlight>, as shown in <cross-reference target="DRAWINGS">FIG. 1</cross-reference>. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> Following another treatment, deposition on material III may be accomplished, and an overall deposition could occur on the entire surface after yet another treatment. It is of note that the source substance for each deposition does not have to be the same. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> In general, all the materials and the substrate are subjected to the same treatment at the same time. Since different materials have different chemistry, they react differently to the same chemical treatment and, therefore, are differentiated from each other with respect to selective deposition. This is particularly important for certain applications including interconnect and contact formation for microelectronic fabrications. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> The method of the present invention relies on the variation of chemistry on the material surface and does not require a mask, mold, stamp, templates or the like to be used in patterning or printing a desired structure on a substrate. Therefore, the present method does not suffer from the disadvantages of existing methods, such as lithography. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> Once the surface chemistry of a given material has been modified, conventional methods including chemical vapor deposition (CVD), plasma vapor deposition (PVD), vacuum deposition (VD), sputtering deposition, and electrochemical plating can be used for the deposition. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> The chemical treatment of the present invention involves absorption or reaction of certain chemical species on the material&apos;s surface to either activate or deactivate the surface toward a deposition. The absorbed species may be removed with a subsequent treatment to restore the original chemical properties of the material&apos;s surface. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> Thus, the surface reactivity of a material may be turned on and off in a controlled manner, making it possible to select one material to be susceptible to deposition initially, and then for another material to be made susceptible subsequently. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> Materials suitable for such treatment include metals, semiconductors, and insulators. An example of a chemical species for surface treatment are the alkane thiols, which feature variable chain lengths, and are capable of spontaneous absorption on the surface of a given material, such as copper, to modify its properties. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> The treatment to passivate a material surface involves immersion of the sample, into a solution containing one or more chemical species for a certain period of time (seconds to days depending on the materials and the species). The material is reactivated by a treatment that removes the adsorbed species from the surface by methods including ultraviolet light irradiation, a potential (voltage) pulse application, chemical treatment, ion bombardment, high temperature treatment and the like. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> Electrochemical deposition of copper on a copper surface before and after the chemical treatment is shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>. The deposition was carried out in a solution of 1M CuSO<highlight><subscript>4 </subscript></highlight>in water with a three-electrode system. Copper rods were used as both counter and reference electrodes. The scan rate was 20 mV/s. It can be seen that the deposition current was at &tilde;mA level for bare copper surface before chemical treatment and a uniform deposition of copper was seen with or without an optical microscope. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> However, after the sample was immersed into a solution of ethanol containing 1 mM 1-dodecanethiol (98&plus;%, Aldrich) overnight, the electrochemical deposition current diminished to negligible levels (the baseline) even after the current was amplified by 10,000 times under the same experimental conditions. No trace of copper deposition was observed under the optical microscope, indicating a successful suppression of copper deposition on copper surface by the chemical treatment. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> shows images from a sample with copper structures surrounded by a barrier layer of tantalum. Without any chemical treatment, electrochemical deposition of copper occurred only on copper surface as shown in <cross-reference target="DRAWINGS">FIG. 4</cross-reference>. When copper and barrier layers coexist on the same substrate, copper generally will deposit more easily on the copper surface. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> depicts images (382 &mgr;m&times;500 &mgr;m) from a sample that show copper structures surrounded by a barrier layer at two different locations. <cross-reference target="DRAWINGS">FIG. 4</cross-reference> depicts an image (382 &mgr;m&times;500 &mgr;m) of the same sample after copper deposition without pre-chemical treatment. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> After the sample was immersed into a solution of ethanol containing 1 mM 1-dodecanethiol (98&plus;%, Aldrich) for 4 hours, electrochemical deposition of copper occurred only on the barrier layer as shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>. In this case, the chemical absorption of the alkanethiol on the copper surface modified its properties and greatly decreased the rate of copper deposition on this surface, making it possible for copper deposition to occur preferentially on the barrier layer. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> A similar result is seen on the micrometer scale as shown in <cross-reference target="DRAWINGS">FIG. 6</cross-reference>. In this case, the less than one micrometer wide copper line clearly separates the two deposited copper zones, which are rough and higher than the copper line. These images demonstrate that the chemical treatment of the present invention for selective deposition functions well even on an extremely small scale. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> To demonstrate the reversibility of the chemical application, a negative potential was applied to the test surface. Specifically, after applying a negative potential pulse of 1.3V for 0.2 second, the chemically modified copper surface was restored to its original form. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> This action removes the adsorbed chemical species and electrochemical deposition of copper on the reactivated copper layer was observed. Both the copper deposition current and the surface appearance were approximately the same as that observed for the original (untreated) copper surface. These results demonstrate the capability of the method of the present invention to reversibly alter the chemistry of a copper surface towards the copper deposition. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> One particular application of the method of the present invention is to fabricate interconnects and contacts for electronic device as shown in <cross-reference target="DRAWINGS">FIG. 7</cross-reference>. The leftmost image in <cross-reference target="DRAWINGS">FIG. 7</cross-reference> depicts a barrier layer that covers the surface of an SiO<highlight><subscript>2 </subscript></highlight>substrate with a desired structure of trenches and vias. A copper layer produced by chemical vapor deposition (CVD) covers all locations except the bottoms and walls in the structure. This is a typical result due to technical limitations in uniform surface coverage into valleys and trenches using CVD. The gaps in the copper deposits will prevent formation of good copper contacts and interconnects in any subsequent electrodeposition step, given the tendency of copper to preferentially electrodeposit on the existing copper. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> The method of the present invention can be used to fill the gaps in the trenches and vias with copper through a chemical treatment, so that copper may be selectively deposited on the bare barrier surface by electrochemical plating as shown in the center image in <cross-reference target="DRAWINGS">FIG. 7</cross-reference>. Another treatment may then reverse the copper surface modification and deposit copper over the entire surface to complete the fabrication of contacts and interconnects. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> Although this invention has been described and disclosed in relation to certain preferred embodiments, obvious equivalent modifications and alterations thereof will become apparent to one of ordinary skill in this art upon reading and understanding this specification and the claims appended hereto. Accordingly, the presently disclosed invention is intended to cover all such modifications and alterations, and is limited only by the scope of the claims that follow. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A method for mask-less selective deposition comprising the steps: 
<claim-text>contacting a first portion of a substrate with a chemical agent that binds to the substrate to affect the susceptibility of the first portion of the substrate to deposition; and </claim-text>
<claim-text>depositing of a first layer of a first material on a second portion of the substrate. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the first and second portions are the same portion of the substrate. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the contacting comprises immersion in a solution further comprising the chemical agent. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the contacting comprises exposure to a vapor further comprising the chemical agent. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the contacting inhibits deposition of the material on the first portion of the substrate. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the contacting enhances deposition of the material on the first portion of the substrate. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the chemical agent comprises a sulfur-containing compound. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the chemical agent comprises an alkyl- or aryl-thiol compound. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference>, wherein the thiol compound comprises 2 to 20 carbon atoms. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference>, wherein the thiol compound comprises 10 to 50 carbon atoms. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference>, wherein the thiol compound comprises dodecanethiol. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the chemical agent comprises a disulfide compound. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the depositing step comprises electrochemical deposition. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the depositing step comprises chemical vapor deposition. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the depositing step comprises plasma vapor deposition. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the depositing step comprises vacuum deposition. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the depositing step comprises sputtering deposition. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the contacting activates the first portion of the substrate to deposition. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the contacting deactivates the first portion of the substrate to deposition. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, further comprising the step of reversal of the contacting. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference>, wherein the reversal comprises removal of the chemical agent. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference>, wherein the reversal comprises a reaction that neutralizes the effect of the chemical agent. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, further comprising the step of depositing of a second layer of a second material. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference>, wherein the first and second materials are the same material. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference>, wherein the first and second layers are portions of the same layer. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the substrate comprises a metal. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the substrate comprises a semiconductor. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the substrate comprises an insulator. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein the removal comprises exposure to a radiation source. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein the removal comprises exposure to ultraviolet light. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein the removal comprises exposure to a pulse application. </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein the removal comprises exposure to ion bombardment. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein the removal comprises exposure to heat. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. A method for mask-less selective deposition comprising the steps: 
<claim-text>contacting a first portion of a substrate with a chemical agent that binds to the substrate to enhance the susceptibility of the first portion of the substrate to deposition; and </claim-text>
<claim-text>depositing of a first layer of a first material on the first portion of the substrate. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00033">claim 34</dependent-claim-reference>, wherein the contacting comprises immersion in a solution further comprising the chemical agent. </claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. A method for mask-less selective deposition comprising the steps: 
<claim-text>contacting a first portion of a substrate with a chemical agent that binds to the substrate to inhibit the susceptibility of the first portion of the substrate to deposition; and </claim-text>
<claim-text>depositing of a first layer of a first material on a second portion of the substrate. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00033">claim 36</dependent-claim-reference>, wherein the contacting comprises immersion in a solution further comprising the chemical agent. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00033">claim 36</dependent-claim-reference>, wherein the chemical agent comprises a sulfur-containing compound. </claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00033">claim 36</dependent-claim-reference>, wherein the chemical agent comprises an alkyl- or aryl-thiol compound. </claim-text>
</claim>
<claim id="CLM-00040">
<claim-text><highlight><bold>40</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference>, wherein the thiol compound comprises 2 to 20 carbon atoms. </claim-text>
</claim>
<claim id="CLM-00041">
<claim-text><highlight><bold>41</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference>, wherein the thiol compound comprises 10 to 50 carbon atoms. </claim-text>
</claim>
<claim id="CLM-00042">
<claim-text><highlight><bold>42</bold></highlight>. The method recited in <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference>, wherein the thiol compound comprises dodecanethiol</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>1</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020197854A1-20021226-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020197854A1-20021226-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020197854A1-20021226-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020197854A1-20021226-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020197854A1-20021226-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020197854A1-20021226-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020198095A1-20021226-D00001.TIF SYSTEM "US20020198095A1-20021226-D00001.TIF" NDATA TIF>
<!ENTITY US20020198095A1-20021226-D00002.TIF SYSTEM "US20020198095A1-20021226-D00002.TIF" NDATA TIF>
<!ENTITY US20020198095A1-20021226-D00003.TIF SYSTEM "US20020198095A1-20021226-D00003.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020198095</doc-number>
<kind-code>A1</kind-code>
<document-date>20021226</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>09885214</doc-number>
</application-number>
<application-number-series-code>09</application-number-series-code>
<filing-date>20010620</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C04B035/10</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C04B035/505</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C04B035/56</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C04B035/565</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>501</class>
<subclass>087000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>501</class>
<subclass>088000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>501</class>
<subclass>152000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Ceramic matrix composite cutting tool material</title-of-invention>
</technical-information>
<inventors>
<first-named-inventor>
<name>
<given-name>Tai-ll</given-name>
<family-name>Mah</family-name>
</name>
<residence>
<residence-us>
<city>Centerville</city>
<state>OH</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Triplicane</given-name>
<middle-name>A.</middle-name>
<family-name>Parthasarathy</family-name>
</name>
<residence>
<residence-us>
<city>Beavercreek</city>
<state>OH</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Michael</given-name>
<middle-name>K.</middle-name>
<family-name>Cinibulk</family-name>
</name>
<residence>
<residence-us>
<city>Bellbrook</city>
<state>OH</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>Killworth, Gottman, Hagan &amp; Schaeff, L.L.P.</name-1>
<name-2></name-2>
<address>
<address-1>Suite 500</address-1>
<address-2>One Dayton Center</address-2>
<city>Dayton</city>
<state>OH</state>
<postalcode>45402-2023</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">A reinforcing material is uniformly dispersed in a yttrium aluminum garnet matrix material for use as a machine tool material specially suited for machining Ti or a Ti alloy. The matrix material and the reinforcing material are present in proportions selected such that the machine tool material is substantially resistant to transfer of impurities to a Ti or Ti alloy by way of either chemical reaction with or diffusion into the Ti or Ti alloy material to be machined. The matrix material preferably comprises Y<highlight><subscript>3</subscript></highlight>Al<highlight><subscript>5</subscript></highlight>O<highlight><subscript>12</subscript></highlight>. The reinforcing material may comprise SiC<highlight><subscript>w</subscript></highlight>, TiC, TiN, TiB<highlight><subscript>2</subscript></highlight>, or combinations thereof and is preferably present in an amount sufficient to enable electrical discharge machining of the machine tool material. In addition, the machine tool material defines a thermodynamically stable phase at relatively high machining temperatures. </paragraph>
</subdoc-abstract>
<subdoc-description>
<federal-research-statement>
<heading lvl="1">STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT </heading>
<paragraph-federal-research-statement id="P-0001"><number>&lsqb;0001&rsqb;</number> This invention was made with government support under Contract No. DMI-9860390 awarded by the National Science Foundation. The Government has certain rights in this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0002" lvl="0"><number>&lsqb;0002&rsqb;</number> The present invention relates to machine tool design, fabrication and, more specifically, to the composition and microstructure of a specialized material for machining titanium or a titanium alloy. </paragraph>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> Titanium alloys are widely used in the aerospace industry because of their superior mechanical properties. Unfortunately, titanium and titanium alloys are very difficult to machine. In fact, the machinability of these materials has become the most significant process limitation in manufacturing many aerospace related components. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> Typically, titanium and titanium alloys cannot be machined at high cutting speeds (&gt;200 m/sec) because they have low thermal conductivity and high work-hardening characteristics. As a result, cutting temperatures typically rise rapidly to 1100&deg; C., even at low cutting speeds (&lt;50m/min) and associated production is time consuming and costly. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> Many ceramic machining materials have proven to be ineffective in machining titanium or titanium alloys because of their high degree of reactivity with titanium. As a result, there are few viable alternatives to conventional cemented carbide machine tool materials for titanium or titanium alloy machining and there is a continuing need for a material that may be utilized to achieve effective, high speed machining of titanium or titanium alloys. </paragraph>
</section>
<section>
<heading lvl="1">BRIEF SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> This need is met by the present invention wherein a machine tool material is provided comprising a yttrium aluminum garnet matrix material and a reinforcing material uniformly dispersed in the matrix material. In accordance with one embodiment of the present invention, a machine tool material is provided comprising a matrix material and a reinforcing material. The matrix material comprises a yttrium aluminum garnet (YAG). The reinforcing material is uniformly dispersed in the matrix material. The matrix material and the reinforcing material are present in proportions selected such that the machine tool material is substantially resistant to transfer of impurities to Ti or a Ti alloy, by way of either chemical reaction with or diffusion into the Ti or Ti alloy material to be machined. The matrix material preferably comprises Y<highlight><subscript>3</subscript></highlight>Al<highlight><subscript>5</subscript></highlight>O<highlight><subscript>12</subscript></highlight>. The reinforcing material may comprise SiC<highlight><subscript>w</subscript></highlight>, TiC, TiN, TiB<highlight><subscript>2</subscript></highlight>, or combinations thereof. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> The matrix material and the reinforcing material are preferably present in proportions selected such that the machine tool material is resistant to the transfer of impurities through chemical reaction with or dissolution into Ti or a Ti alloy. Preferably, the machine tool material is characterized by a low solubility in Ti, or a Ti alloy and defines a thermodynamically stable phase at temperatures up to about 1200&deg; C. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> The reinforcing material preferably comprises a material present in a proportion selected to enhance the characteristic electrical conductivity of the machine tool material and enable electrical discharge machining of the machine tool material. The reinforcing material is also preferably provided to enhance the hardness and the fracture toughness of the matrix material. By way of illustration and not by way of limitation, it is noted that measured properties of a sample material yielded flexural strength values of about 650 to about 750 MPa and fracture toughness values of about 4.15 to about 4.2 MPa(m<highlight><superscript>&frac12;</superscript></highlight>) and about 5.45 to about 5.5 MPa(m<highlight><superscript>&frac12;</superscript></highlight>). </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> In accordance with another embodiment of the present invention, a machine tool material is provided comprising a matrix material and a reinforcing material. The matrix material comprises a yttrium aluminum garnet and the reinforcing material comprises a material present in proportions selected to enhance the characteristic electrical conductivity of the machine tool material. Preferably, the electrical conductivity is enhanced to an extent sufficient to enable electrical discharge machining of the machine tool material. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> In accordance with yet another embodiment of the present invention, a machine tool is configured to cause frictional engagement of a workpiece and a workpiece machining element as the workpiece and the machining element move relative to one another. The workpiece machining element is formed of a machine tool material comprising a matrix material and a reinforcing material. The matrix material comprises a yttrium aluminum garnet. The reinforcing material is uniformly dispersed in the matrix material. The matrix material and the reinforcing material are present in proportions selected such that the machine tool material is substantially resistant to transfer of impurities through chemical reaction with or diffusion into Ti or a Ti alloy to be machined. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Accordingly, it is an object of the present invention to provide a material for effective, high speed machining of titanium or titanium alloys. Other objects of the present invention will be apparent in light of the description of the invention embodied herein.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS </heading>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> The following detailed description of the preferred embodiments of the present invention can be best understood when read in conjunction with the following drawings, where like structure is indicated with like reference numerals and in which: </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> is an illustration of a machine tool and workpiece according to one embodiment of the present invention; </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> is an illustration of a machine tool and workpiece according to another embodiment of the present invention; </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> is an illustration of a contact region of a machine tool and workpiece according to one embodiment of the present invention; </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> illustrates an optical photomicrograph of a sample of a material according to the present invention; and </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> illustrates a scanning electron micrograph of a surface of cutting tool material surface after EDM machining of the material. </paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION </heading>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> The present invention may be described referring collectively to FIGS. <highlight><bold>1</bold></highlight>-<highlight><bold>5</bold></highlight>. The machine tool material <highlight><bold>10</bold></highlight> of the present invention comprises a matrix material <highlight><bold>12</bold></highlight> and a reinforcing material <highlight><bold>14</bold></highlight>. The matrix material <highlight><bold>12</bold></highlight> comprises a yttrium aluminum garnet, preferably Y<highlight><subscript>3</subscript></highlight>Al<highlight><subscript>5</subscript></highlight>O<highlight><subscript>12</subscript></highlight>. The reinforcing material <highlight><bold>14</bold></highlight> is uniformly dispersed in the matrix material <highlight><bold>12</bold></highlight> and may comprise any one of a number of suitable reinforcing materials, including, for example, SiC, TiC, TiN, TiB<highlight><subscript>2</subscript></highlight>, or combinations thereof. The identity of the particular reinforcing material utilized according to the present invention depends upon the design considerations associated with the application of the present invention at hand, the properties associated with a particular reinforcing material and the design preferences of those practicing the present invention. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> The machine tool material <highlight><bold>10</bold></highlight> of the present invention may be used to form a variety of machine tools. For example, the machine tool material <highlight><bold>10</bold></highlight> may be used to form cutting tools or other types of machining elements, extrusion dies, drawing dies, or other types of dies, wear parts, etc. Two examples of typical machine tools <highlight><bold>40</bold></highlight> are illustrated in <cross-reference target="DRAWINGS">FIGS. 1 and 2</cross-reference>. In <cross-reference target="DRAWINGS">FIG. 1</cross-reference>, the machine tool <highlight><bold>40</bold></highlight> comprises a drill press and the machine tool material <highlight><bold>10</bold></highlight> is presented in the form of a drilling bit driven in rotary motion, relative to the workpiece <highlight><bold>30</bold></highlight>. It is contemplated that the machine tool material of the present invention may merely be embedded at the tip of the machine tool <highlight><bold>40</bold></highlight>. In <cross-reference target="DRAWINGS">FIG. 2</cross-reference>, the machine tool <highlight><bold>40</bold></highlight> comprises a lathe and the machine tool material <highlight><bold>10</bold></highlight> is presented in the form of a cutting bit or tool bit insert held stationary as the workpiece <highlight><bold>30</bold></highlight> is rotated relative to the cutting bit. In any case, the machine tool <highlight><bold>40</bold></highlight> is typically configured to cause frictional engagement of a workpiece <highlight><bold>30</bold></highlight> and the machine tool material <highlight><bold>10</bold></highlight> of the machining element as the workpiece <highlight><bold>30</bold></highlight> and the machining element move relative to one another. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> The matrix material <highlight><bold>12</bold></highlight> and the reinforcing material <highlight><bold>14</bold></highlight> are present in proportions selected such that the machine tool material is substantially resistant to transfer of impurities to Ti or a Ti alloy workpiece. Specifically, the machine tool material is resistant to chemical reaction with and diffusion into Ti or a Ti alloy. In this manner, the machine tool material <highlight><bold>10</bold></highlight> may be utilized in machining elements specially suited for machining Ti or Ti alloys <highlight><bold>30</bold></highlight>. Primarily, it is preferable to select and present the matrix material <highlight><bold>12</bold></highlight> and the reinforcing material <highlight><bold>14</bold></highlight> in proportions such that the machine tool material <highlight><bold>10</bold></highlight> is resistant to chemical reaction with Ti or a Ti alloy. It is also preferable to select and present the matrix material <highlight><bold>12</bold></highlight> and the reinforcing material <highlight><bold>14</bold></highlight> in proportions such that the machine tool material <highlight><bold>10</bold></highlight> is resistant to the transfer of impurities through dissolution into Ti or a Ti alloy and is characterized by a low solubility in Ti or a Ti alloy. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> The matrix material <highlight><bold>12</bold></highlight> and the reinforcing material <highlight><bold>14</bold></highlight> are present in proportions selected such that the machine tool material <highlight><bold>10</bold></highlight> defines a thermodynamically stable phase at temperatures up to about 1200&deg; C. In this manner, a machining element according to the present invention may be used in high temperature, high machining rate applications without degradation of the physical and mechanical properties of the machine tool material <highlight><bold>10</bold></highlight>. An example of the microstructure of such a material is shown in <cross-reference target="DRAWINGS">FIG. 4</cross-reference>, where the light-colored material is TiC, the gray-colored material is SiC<highlight><subscript>w </subscript></highlight>and the dark-colored material is Y<highlight><subscript>3</subscript></highlight>Al<highlight><subscript>5</subscript></highlight>O<highlight><subscript>12</subscript></highlight>. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> As is illustrated in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>, the matrix material <highlight><bold>12</bold></highlight> and the reinforcing material <highlight><bold>14</bold></highlight> may be selected and presented in proportions such that the machine tool material <highlight><bold>10</bold></highlight> tends to form a Y<highlight><subscript>2</subscript></highlight>O<highlight><subscript>3 </subscript></highlight>barrier layer <highlight><bold>16</bold></highlight> on the machine tool material <highlight><bold>10</bold></highlight> along a surface of frictional contact with a titanium or titanium alloy workpiece <highlight><bold>30</bold></highlight>. The barrier layer <highlight><bold>16</bold></highlight> limits the transfer of impurities from the machine tool material <highlight><bold>10</bold></highlight> to the workpiece <highlight><bold>30</bold></highlight>. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> Machining elements are commonly fabricated or manufactured through electrical discharge machining (EDM), a process where the material to be machined must be electrically conductive. Accordingly, to enable EDM of the machine tool material <highlight><bold>10</bold></highlight> of the present invention, the reinforcing material <highlight><bold>14</bold></highlight> is selected and presented in a proportion selected to enhance the characteristic electrical conductivity of the machine tool material <highlight><bold>10</bold></highlight> to enable electrical discharge machining of the machine tool material <highlight><bold>10</bold></highlight>. The reinforcing material <highlight><bold>14</bold></highlight> is also typically selected and presented in an amount sufficient to enhance the hardness and fracture toughness of the matrix material <highlight><bold>12</bold></highlight>. An example of the material after EDM machining is shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>, where the left side of the view illustrates the as-ground billet surface and the right side of the view illustrates the machined surface. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> Improvements in conductivity, hardness, fracture toughness, phase stability, and resistance to transfer of impurities may be obtained by ensuring that the reinforcing material <highlight><bold>14</bold></highlight> defines a mean particle size of between about 1 &mgr;m and about 3 &mgr;m. More specifically, where the reinforcing material <highlight><bold>14</bold></highlight> comprises SiC, it preferably takes the form of an elongate whisker (SiC<highlight><subscript>w</subscript></highlight>) defining a mean particle diameter of between about 1 &mgr;m and about 3 &mgr;m and an aspect ratio of about <highlight><bold>10</bold></highlight>. For example, a reinforcing whisker according to the present invention may define a 2 &mgr;m diameter and a length of about 20 &mgr;m. It is also advantageous to utilize a matrix material <highlight><bold>12</bold></highlight> defining a mean particle size of less than about 2 &mgr;m. It is contemplated that fine particle sizes (mean particle size of about 1.8 &mgr;m) and narrow particle size distributions (where 90% of all particles are less than 3 &mgr;m and the largest particles are less than 8 &mgr;m) will be advantageous in practicing the present invention. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> The reinforcing material <highlight><bold>14</bold></highlight> may be provided as a powder, as whiskers, or as is illustrated in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>, as a combination of both. The reinforcing material <highlight><bold>14</bold></highlight> may be uniformly dispersed in a matrix of Y<highlight><subscript>3</subscript></highlight>Al<highlight><subscript>5</subscript></highlight>O<highlight><subscript>12 </subscript></highlight>powder. The composite may then be hot pressed at temperatures ranging from about 1400&deg; C. to about 1800&deg; C. to form the dense machine tool material <highlight><bold>10</bold></highlight> of the present invention. Alternatively or additionally, the composite may be sintered and subject to hot isostatic pressing at temperatures ranging from about 1400&deg; C. to about 1800&deg; C. to form the dense machine tool material <highlight><bold>10</bold></highlight> of the present invention. The density of the machine tool material <highlight><bold>10</bold></highlight> can be optimized by manipulating the hot pressing process parameters, including the heating rate, the final temperature, the residence time at the final temperature, and the pressure. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> Preferably, the machine tool material <highlight><bold>10</bold></highlight> comprises at least about 30% and as much as about 60% yttrium aluminum garnet by volume. More specifically, the machine tool material <highlight><bold>10</bold></highlight> comprises between about 40% and about 45% yttrium aluminum garnet by volume. In a specific embodiment of the present invention, the reinforcing material comprises SiC whiskers (SiC<highlight><subscript>w</subscript></highlight>) and TiC particles and the machine tool material <highlight><bold>10</bold></highlight> comprises, by volume, about 43% yttrium aluminum garnet, about 33% SiC<highlight><subscript>w</subscript></highlight>, and about 24% TiC. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> It is contemplated that the machine tool material of the present invention may be particularly advantageous in the machining of materials other than Ti or Ti alloys. For example, the machine tool material of the present invention may be utilized in the machining of Nickel-based alloys or ferrous alloys. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> Having described the invention in detail and by reference to preferred embodiments thereof, it will be apparent that modifications and variations are possible without departing from the scope of the invention defined in the appended claims. More specifically, although some aspects of the present invention are identified herein as preferred or particularly advantageous, it is contemplated that the present invention is not necessarily limited to these preferred aspects of the invention</paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A machine tool material comprising a matrix material and a reinforcing material, wherein: 
<claim-text>said matrix material comprises a yttrium aluminum garnet; </claim-text>
<claim-text>said reinforcing material is uniformly dispersed in said matrix material; and </claim-text>
<claim-text>said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is substantially resistant to transfer of impurities to Ti or a Ti alloy. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said matrix material comprises Y<highlight><subscript>3</subscript></highlight>Al<highlight><subscript>12</subscript></highlight>O<highlight><subscript>12</subscript></highlight>. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is resistant to chemical reaction with Ti or a Ti alloy. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is resistant to dissolution into Ti or a Ti alloy. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is characterized by a low solubility in Ti or a Ti alloy. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material defines a thermodynamically stable phase at temperatures up to about 1200&deg; C. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material tends to form a Y<highlight><subscript>2</subscript></highlight>O<highlight><subscript>3 </subscript></highlight>barrier layer along a surface of frictional contact with a titanium workpiece. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said machine tool material defines a characteristic electrical conductivity and said reinforcing material comprises a material present in a proportion selected to enhance said characteristic electrical conductivity of said machine tool material. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference> wherein said electrical conductivity enhancing reinforcing material is present in an amount sufficient to enable electrical discharge machining of said machine tool material. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said reinforcing material is present in an amount sufficient to enhance the hardness of said matrix material. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said reinforcing material is present in an amount sufficient to enhance the fracture toughness of said matrix material. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said reinforcing material comprises a plurality of distinct components. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said reinforcing material defines a mean particle size of less than about 2 &mgr;m. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said matrix material defines a mean particle size of less than about 2 &mgr;m. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said machine tool material comprises at least about 30% yttrium aluminum garnet by volume. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference> wherein said reinforcing material is uniformly dispersed within said matrix material. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said machine tool material comprises between about 30% and about 60% yttrium aluminum garnet by volume. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said machine tool material comprises less than about 60% yttrium aluminum garnet by volume. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said reinforcing material comprises SiC and TiC. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference> wherein said machine tool material comprises, by volume, about 43% yttrium aluminum garnet, about 33% SiC<highlight><subscript>w</subscript></highlight>, and about 24% TiC. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said reinforcing material comprises SiC<highlight><subscript>W</subscript></highlight>, TiC, TiN, TiB<highlight><subscript>2</subscript></highlight>, or combinations thereof. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein said reinforcing material comprises an elongate whisker defining a mean particle diameter of between about 1 &mgr;m and about 3 &mgr;m and an aspect ratio of about 10. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. A machine tool material comprising a matrix material and a reinforcing material, wherein: 
<claim-text>said matrix material comprises a yttrium aluminum garnet; </claim-text>
<claim-text>said machine tool material defines a characteristic electrical conductivity; and </claim-text>
<claim-text>said reinforcing material comprises a material present in proportions selected to enhance said characteristic electrical conductivity of said machine tool material. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> wherein said electrical conductivity enhancing reinforcing material is present in an amount sufficient to enable electrical discharge machining of said machine tool material. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is substantially resistant to transfer of impurities to Ti or a Ti alloy. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material defines a thermodynamically stable phase at temperatures up to about 1200&deg; C. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is resistant to reaction with Ti or a Ti alloy. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is resistant to dissolution into Ti or a Ti alloy. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> wherein said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is characterized by a low solubility in Ti or a Ti alloy. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. A machine tool configured to cause frictional engagement of a workpiece and a workpiece machining element as said workpiece and said machining element move relative to one another, wherein: 
<claim-text>said workpiece machining element i s for med of a machine tool material comprising a matrix material and a reinforcing material; </claim-text>
<claim-text>said matrix material comprises a yttrium aluminum garnet; </claim-text>
<claim-text>said reinforcing material is uniformly dispersed in said matrix material; and </claim-text>
<claim-text>said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is substantially resistant to transfer of impurities to Ti or a Ti alloy. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. A machine tool material comprising a matrix material and a reinforcing material, wherein: 
<claim-text>said matrix material comprises a yttrium aluminum garnet; </claim-text>
<claim-text>said reinforcing material is uniformly dispersed in said matrix material; and </claim-text>
<claim-text>said matrix material and said reinforcing material are present in proportions selected such that said machine tool material is substantially resistant to transfer of impurities to a material to be machined. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00033">claim 31</dependent-claim-reference> wherein said material to be machined comprises a nickel-based alloy. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00033">claim 31</dependent-claim-reference> wherein said material to be machined comprises a ferrous alloy. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. A machine tool material as claimed in <dependent-claim-reference depends_on="CLM-00033">claim 31</dependent-claim-reference> wherein said material to be machined comprises Ti or a Ti alloy.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>NONE</representative-figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020198095A1-20021226-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020198095A1-20021226-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020198095A1-20021226-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020198383A1-20021226-C00001.CDX SYSTEM "US20020198383A1-20021226-C00001.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00001.MOL SYSTEM "US20020198383A1-20021226-C00001.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00001.TIF SYSTEM "US20020198383A1-20021226-C00001.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00002.CDX SYSTEM "US20020198383A1-20021226-C00002.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00002.MOL SYSTEM "US20020198383A1-20021226-C00002.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00002.TIF SYSTEM "US20020198383A1-20021226-C00002.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00003.CDX SYSTEM "US20020198383A1-20021226-C00003.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00003.MOL SYSTEM "US20020198383A1-20021226-C00003.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00003.TIF SYSTEM "US20020198383A1-20021226-C00003.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00004.CDX SYSTEM "US20020198383A1-20021226-C00004.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00004.MOL SYSTEM "US20020198383A1-20021226-C00004.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00004.TIF SYSTEM "US20020198383A1-20021226-C00004.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00005.CDX SYSTEM "US20020198383A1-20021226-C00005.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00005.MOL SYSTEM "US20020198383A1-20021226-C00005.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00005.TIF SYSTEM "US20020198383A1-20021226-C00005.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00006.CDX SYSTEM "US20020198383A1-20021226-C00006.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00006.MOL SYSTEM "US20020198383A1-20021226-C00006.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00006.TIF SYSTEM "US20020198383A1-20021226-C00006.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00007.CDX SYSTEM "US20020198383A1-20021226-C00007.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00007.MOL SYSTEM "US20020198383A1-20021226-C00007.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00007.TIF SYSTEM "US20020198383A1-20021226-C00007.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00008.CDX SYSTEM "US20020198383A1-20021226-C00008.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00008.MOL SYSTEM "US20020198383A1-20021226-C00008.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00008.TIF SYSTEM "US20020198383A1-20021226-C00008.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00009.CDX SYSTEM "US20020198383A1-20021226-C00009.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00009.MOL SYSTEM "US20020198383A1-20021226-C00009.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00009.TIF SYSTEM "US20020198383A1-20021226-C00009.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00010.CDX SYSTEM "US20020198383A1-20021226-C00010.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00010.MOL SYSTEM "US20020198383A1-20021226-C00010.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00010.TIF SYSTEM "US20020198383A1-20021226-C00010.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00011.CDX SYSTEM "US20020198383A1-20021226-C00011.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00011.MOL SYSTEM "US20020198383A1-20021226-C00011.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00011.TIF SYSTEM "US20020198383A1-20021226-C00011.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00012.CDX SYSTEM "US20020198383A1-20021226-C00012.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00012.MOL SYSTEM "US20020198383A1-20021226-C00012.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00012.TIF SYSTEM "US20020198383A1-20021226-C00012.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00013.CDX SYSTEM "US20020198383A1-20021226-C00013.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00013.MOL SYSTEM "US20020198383A1-20021226-C00013.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00013.TIF SYSTEM "US20020198383A1-20021226-C00013.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00014.CDX SYSTEM "US20020198383A1-20021226-C00014.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00014.MOL SYSTEM "US20020198383A1-20021226-C00014.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00014.TIF SYSTEM "US20020198383A1-20021226-C00014.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00015.CDX SYSTEM "US20020198383A1-20021226-C00015.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00015.MOL SYSTEM "US20020198383A1-20021226-C00015.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00015.TIF SYSTEM "US20020198383A1-20021226-C00015.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00016.CDX SYSTEM "US20020198383A1-20021226-C00016.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00016.MOL SYSTEM "US20020198383A1-20021226-C00016.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00016.TIF SYSTEM "US20020198383A1-20021226-C00016.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00017.CDX SYSTEM "US20020198383A1-20021226-C00017.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00017.MOL SYSTEM "US20020198383A1-20021226-C00017.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00017.TIF SYSTEM "US20020198383A1-20021226-C00017.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00018.CDX SYSTEM "US20020198383A1-20021226-C00018.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00018.MOL SYSTEM "US20020198383A1-20021226-C00018.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00018.TIF SYSTEM "US20020198383A1-20021226-C00018.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00019.CDX SYSTEM "US20020198383A1-20021226-C00019.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00019.MOL SYSTEM "US20020198383A1-20021226-C00019.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00019.TIF SYSTEM "US20020198383A1-20021226-C00019.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00020.CDX SYSTEM "US20020198383A1-20021226-C00020.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00020.MOL SYSTEM "US20020198383A1-20021226-C00020.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00020.TIF SYSTEM "US20020198383A1-20021226-C00020.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00021.CDX SYSTEM "US20020198383A1-20021226-C00021.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00021.MOL SYSTEM "US20020198383A1-20021226-C00021.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00021.TIF SYSTEM "US20020198383A1-20021226-C00021.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00022.CDX SYSTEM "US20020198383A1-20021226-C00022.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00022.MOL SYSTEM "US20020198383A1-20021226-C00022.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00022.TIF SYSTEM "US20020198383A1-20021226-C00022.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00023.CDX SYSTEM "US20020198383A1-20021226-C00023.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00023.MOL SYSTEM "US20020198383A1-20021226-C00023.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00023.TIF SYSTEM "US20020198383A1-20021226-C00023.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00024.CDX SYSTEM "US20020198383A1-20021226-C00024.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00024.MOL SYSTEM "US20020198383A1-20021226-C00024.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00024.TIF SYSTEM "US20020198383A1-20021226-C00024.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00025.CDX SYSTEM "US20020198383A1-20021226-C00025.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00025.MOL SYSTEM "US20020198383A1-20021226-C00025.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00025.TIF SYSTEM "US20020198383A1-20021226-C00025.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00026.CDX SYSTEM "US20020198383A1-20021226-C00026.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00026.MOL SYSTEM "US20020198383A1-20021226-C00026.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00026.TIF SYSTEM "US20020198383A1-20021226-C00026.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00027.CDX SYSTEM "US20020198383A1-20021226-C00027.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00027.MOL SYSTEM "US20020198383A1-20021226-C00027.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00027.TIF SYSTEM "US20020198383A1-20021226-C00027.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00028.CDX SYSTEM "US20020198383A1-20021226-C00028.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00028.MOL SYSTEM "US20020198383A1-20021226-C00028.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00028.TIF SYSTEM "US20020198383A1-20021226-C00028.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00029.CDX SYSTEM "US20020198383A1-20021226-C00029.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00029.MOL SYSTEM "US20020198383A1-20021226-C00029.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00029.TIF SYSTEM "US20020198383A1-20021226-C00029.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00030.CDX SYSTEM "US20020198383A1-20021226-C00030.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00030.MOL SYSTEM "US20020198383A1-20021226-C00030.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00030.TIF SYSTEM "US20020198383A1-20021226-C00030.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00031.CDX SYSTEM "US20020198383A1-20021226-C00031.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00031.MOL SYSTEM "US20020198383A1-20021226-C00031.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00031.TIF SYSTEM "US20020198383A1-20021226-C00031.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00032.CDX SYSTEM "US20020198383A1-20021226-C00032.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00032.MOL SYSTEM "US20020198383A1-20021226-C00032.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00032.TIF SYSTEM "US20020198383A1-20021226-C00032.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00033.CDX SYSTEM "US20020198383A1-20021226-C00033.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00033.MOL SYSTEM "US20020198383A1-20021226-C00033.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00033.TIF SYSTEM "US20020198383A1-20021226-C00033.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00034.CDX SYSTEM "US20020198383A1-20021226-C00034.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00034.MOL SYSTEM "US20020198383A1-20021226-C00034.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00034.TIF SYSTEM "US20020198383A1-20021226-C00034.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00035.CDX SYSTEM "US20020198383A1-20021226-C00035.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00035.MOL SYSTEM "US20020198383A1-20021226-C00035.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00035.TIF SYSTEM "US20020198383A1-20021226-C00035.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00036.CDX SYSTEM "US20020198383A1-20021226-C00036.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00036.MOL SYSTEM "US20020198383A1-20021226-C00036.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00036.TIF SYSTEM "US20020198383A1-20021226-C00036.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00037.CDX SYSTEM "US20020198383A1-20021226-C00037.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00037.MOL SYSTEM "US20020198383A1-20021226-C00037.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00037.TIF SYSTEM "US20020198383A1-20021226-C00037.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00038.CDX SYSTEM "US20020198383A1-20021226-C00038.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00038.MOL SYSTEM "US20020198383A1-20021226-C00038.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00038.TIF SYSTEM "US20020198383A1-20021226-C00038.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00039.CDX SYSTEM "US20020198383A1-20021226-C00039.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00039.MOL SYSTEM "US20020198383A1-20021226-C00039.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00039.TIF SYSTEM "US20020198383A1-20021226-C00039.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00040.CDX SYSTEM "US20020198383A1-20021226-C00040.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00040.MOL SYSTEM "US20020198383A1-20021226-C00040.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00040.TIF SYSTEM "US20020198383A1-20021226-C00040.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00041.CDX SYSTEM "US20020198383A1-20021226-C00041.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00041.MOL SYSTEM "US20020198383A1-20021226-C00041.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00041.TIF SYSTEM "US20020198383A1-20021226-C00041.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00042.CDX SYSTEM "US20020198383A1-20021226-C00042.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00042.MOL SYSTEM "US20020198383A1-20021226-C00042.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00042.TIF SYSTEM "US20020198383A1-20021226-C00042.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00043.CDX SYSTEM "US20020198383A1-20021226-C00043.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00043.MOL SYSTEM "US20020198383A1-20021226-C00043.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00043.TIF SYSTEM "US20020198383A1-20021226-C00043.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00044.CDX SYSTEM "US20020198383A1-20021226-C00044.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00044.MOL SYSTEM "US20020198383A1-20021226-C00044.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00044.TIF SYSTEM "US20020198383A1-20021226-C00044.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00045.CDX SYSTEM "US20020198383A1-20021226-C00045.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00045.MOL SYSTEM "US20020198383A1-20021226-C00045.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00045.TIF SYSTEM "US20020198383A1-20021226-C00045.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00046.CDX SYSTEM "US20020198383A1-20021226-C00046.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00046.MOL SYSTEM "US20020198383A1-20021226-C00046.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00046.TIF SYSTEM "US20020198383A1-20021226-C00046.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00047.CDX SYSTEM "US20020198383A1-20021226-C00047.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00047.MOL SYSTEM "US20020198383A1-20021226-C00047.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00047.TIF SYSTEM "US20020198383A1-20021226-C00047.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00048.CDX SYSTEM "US20020198383A1-20021226-C00048.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00048.MOL SYSTEM "US20020198383A1-20021226-C00048.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00048.TIF SYSTEM "US20020198383A1-20021226-C00048.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00049.CDX SYSTEM "US20020198383A1-20021226-C00049.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00049.MOL SYSTEM "US20020198383A1-20021226-C00049.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00049.TIF SYSTEM "US20020198383A1-20021226-C00049.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00050.CDX SYSTEM "US20020198383A1-20021226-C00050.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00050.MOL SYSTEM "US20020198383A1-20021226-C00050.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00050.TIF SYSTEM "US20020198383A1-20021226-C00050.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00051.CDX SYSTEM "US20020198383A1-20021226-C00051.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00051.MOL SYSTEM "US20020198383A1-20021226-C00051.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00051.TIF SYSTEM "US20020198383A1-20021226-C00051.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00052.CDX SYSTEM "US20020198383A1-20021226-C00052.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00052.MOL SYSTEM "US20020198383A1-20021226-C00052.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00052.TIF SYSTEM "US20020198383A1-20021226-C00052.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00053.CDX SYSTEM "US20020198383A1-20021226-C00053.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00053.MOL SYSTEM "US20020198383A1-20021226-C00053.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00053.TIF SYSTEM "US20020198383A1-20021226-C00053.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00054.CDX SYSTEM "US20020198383A1-20021226-C00054.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00054.MOL SYSTEM "US20020198383A1-20021226-C00054.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00054.TIF SYSTEM "US20020198383A1-20021226-C00054.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00055.CDX SYSTEM "US20020198383A1-20021226-C00055.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00055.MOL SYSTEM "US20020198383A1-20021226-C00055.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00055.TIF SYSTEM "US20020198383A1-20021226-C00055.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00056.CDX SYSTEM "US20020198383A1-20021226-C00056.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00056.MOL SYSTEM "US20020198383A1-20021226-C00056.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00056.TIF SYSTEM "US20020198383A1-20021226-C00056.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00057.CDX SYSTEM "US20020198383A1-20021226-C00057.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00057.MOL SYSTEM "US20020198383A1-20021226-C00057.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00057.TIF SYSTEM "US20020198383A1-20021226-C00057.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00058.CDX SYSTEM "US20020198383A1-20021226-C00058.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00058.MOL SYSTEM "US20020198383A1-20021226-C00058.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00058.TIF SYSTEM "US20020198383A1-20021226-C00058.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00059.CDX SYSTEM "US20020198383A1-20021226-C00059.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00059.MOL SYSTEM "US20020198383A1-20021226-C00059.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00059.TIF SYSTEM "US20020198383A1-20021226-C00059.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00060.CDX SYSTEM "US20020198383A1-20021226-C00060.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00060.MOL SYSTEM "US20020198383A1-20021226-C00060.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00060.TIF SYSTEM "US20020198383A1-20021226-C00060.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00061.CDX SYSTEM "US20020198383A1-20021226-C00061.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00061.MOL SYSTEM "US20020198383A1-20021226-C00061.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00061.TIF SYSTEM "US20020198383A1-20021226-C00061.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00062.CDX SYSTEM "US20020198383A1-20021226-C00062.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00062.MOL SYSTEM "US20020198383A1-20021226-C00062.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00062.TIF SYSTEM "US20020198383A1-20021226-C00062.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00063.CDX SYSTEM "US20020198383A1-20021226-C00063.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00063.MOL SYSTEM "US20020198383A1-20021226-C00063.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00063.TIF SYSTEM "US20020198383A1-20021226-C00063.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00064.CDX SYSTEM "US20020198383A1-20021226-C00064.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00064.MOL SYSTEM "US20020198383A1-20021226-C00064.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00064.TIF SYSTEM "US20020198383A1-20021226-C00064.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00065.CDX SYSTEM "US20020198383A1-20021226-C00065.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00065.MOL SYSTEM "US20020198383A1-20021226-C00065.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00065.TIF SYSTEM "US20020198383A1-20021226-C00065.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00066.CDX SYSTEM "US20020198383A1-20021226-C00066.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00066.MOL SYSTEM "US20020198383A1-20021226-C00066.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00066.TIF SYSTEM "US20020198383A1-20021226-C00066.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00067.CDX SYSTEM "US20020198383A1-20021226-C00067.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00067.MOL SYSTEM "US20020198383A1-20021226-C00067.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00067.TIF SYSTEM "US20020198383A1-20021226-C00067.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00068.CDX SYSTEM "US20020198383A1-20021226-C00068.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00068.MOL SYSTEM "US20020198383A1-20021226-C00068.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00068.TIF SYSTEM "US20020198383A1-20021226-C00068.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00069.CDX SYSTEM "US20020198383A1-20021226-C00069.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00069.MOL SYSTEM "US20020198383A1-20021226-C00069.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00069.TIF SYSTEM "US20020198383A1-20021226-C00069.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00070.CDX SYSTEM "US20020198383A1-20021226-C00070.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00070.MOL SYSTEM "US20020198383A1-20021226-C00070.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00070.TIF SYSTEM "US20020198383A1-20021226-C00070.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00071.CDX SYSTEM "US20020198383A1-20021226-C00071.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00071.MOL SYSTEM "US20020198383A1-20021226-C00071.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00071.TIF SYSTEM "US20020198383A1-20021226-C00071.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00072.CDX SYSTEM "US20020198383A1-20021226-C00072.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00072.MOL SYSTEM "US20020198383A1-20021226-C00072.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00072.TIF SYSTEM "US20020198383A1-20021226-C00072.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00073.CDX SYSTEM "US20020198383A1-20021226-C00073.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00073.MOL SYSTEM "US20020198383A1-20021226-C00073.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00073.TIF SYSTEM "US20020198383A1-20021226-C00073.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00074.CDX SYSTEM "US20020198383A1-20021226-C00074.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00074.MOL SYSTEM "US20020198383A1-20021226-C00074.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00074.TIF SYSTEM "US20020198383A1-20021226-C00074.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00075.CDX SYSTEM "US20020198383A1-20021226-C00075.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00075.MOL SYSTEM "US20020198383A1-20021226-C00075.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00075.TIF SYSTEM "US20020198383A1-20021226-C00075.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00076.CDX SYSTEM "US20020198383A1-20021226-C00076.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00076.MOL SYSTEM "US20020198383A1-20021226-C00076.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00076.TIF SYSTEM "US20020198383A1-20021226-C00076.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00077.CDX SYSTEM "US20020198383A1-20021226-C00077.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00077.MOL SYSTEM "US20020198383A1-20021226-C00077.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00077.TIF SYSTEM "US20020198383A1-20021226-C00077.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00078.CDX SYSTEM "US20020198383A1-20021226-C00078.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00078.MOL SYSTEM "US20020198383A1-20021226-C00078.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00078.TIF SYSTEM "US20020198383A1-20021226-C00078.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00079.CDX SYSTEM "US20020198383A1-20021226-C00079.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00079.MOL SYSTEM "US20020198383A1-20021226-C00079.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00079.TIF SYSTEM "US20020198383A1-20021226-C00079.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00080.CDX SYSTEM "US20020198383A1-20021226-C00080.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00080.MOL SYSTEM "US20020198383A1-20021226-C00080.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00080.TIF SYSTEM "US20020198383A1-20021226-C00080.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00081.CDX SYSTEM "US20020198383A1-20021226-C00081.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00081.MOL SYSTEM "US20020198383A1-20021226-C00081.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00081.TIF SYSTEM "US20020198383A1-20021226-C00081.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00082.CDX SYSTEM "US20020198383A1-20021226-C00082.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00082.MOL SYSTEM "US20020198383A1-20021226-C00082.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00082.TIF SYSTEM "US20020198383A1-20021226-C00082.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00083.CDX SYSTEM "US20020198383A1-20021226-C00083.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00083.MOL SYSTEM "US20020198383A1-20021226-C00083.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00083.TIF SYSTEM "US20020198383A1-20021226-C00083.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00084.CDX SYSTEM "US20020198383A1-20021226-C00084.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00084.MOL SYSTEM "US20020198383A1-20021226-C00084.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00084.TIF SYSTEM "US20020198383A1-20021226-C00084.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00085.CDX SYSTEM "US20020198383A1-20021226-C00085.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00085.MOL SYSTEM "US20020198383A1-20021226-C00085.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00085.TIF SYSTEM "US20020198383A1-20021226-C00085.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00086.CDX SYSTEM "US20020198383A1-20021226-C00086.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00086.MOL SYSTEM "US20020198383A1-20021226-C00086.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00086.TIF SYSTEM "US20020198383A1-20021226-C00086.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00087.CDX SYSTEM "US20020198383A1-20021226-C00087.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00087.MOL SYSTEM "US20020198383A1-20021226-C00087.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00087.TIF SYSTEM "US20020198383A1-20021226-C00087.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00088.CDX SYSTEM "US20020198383A1-20021226-C00088.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00088.MOL SYSTEM "US20020198383A1-20021226-C00088.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00088.TIF SYSTEM "US20020198383A1-20021226-C00088.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00089.CDX SYSTEM "US20020198383A1-20021226-C00089.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00089.MOL SYSTEM "US20020198383A1-20021226-C00089.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00089.TIF SYSTEM "US20020198383A1-20021226-C00089.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00090.CDX SYSTEM "US20020198383A1-20021226-C00090.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00090.MOL SYSTEM "US20020198383A1-20021226-C00090.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00090.TIF SYSTEM "US20020198383A1-20021226-C00090.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00091.CDX SYSTEM "US20020198383A1-20021226-C00091.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00091.MOL SYSTEM "US20020198383A1-20021226-C00091.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00091.TIF SYSTEM "US20020198383A1-20021226-C00091.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-C00092.CDX SYSTEM "US20020198383A1-20021226-C00092.CDX" NDATA CDX>
<!ENTITY US20020198383A1-20021226-C00092.MOL SYSTEM "US20020198383A1-20021226-C00092.MOL" NDATA MOL>
<!ENTITY US20020198383A1-20021226-C00092.TIF SYSTEM "US20020198383A1-20021226-C00092.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-D00000.TIF SYSTEM "US20020198383A1-20021226-D00000.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-D00001.TIF SYSTEM "US20020198383A1-20021226-D00001.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-D00002.TIF SYSTEM "US20020198383A1-20021226-D00002.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-D00003.TIF SYSTEM "US20020198383A1-20021226-D00003.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-D00004.TIF SYSTEM "US20020198383A1-20021226-D00004.TIF" NDATA TIF>
<!ENTITY US20020198383A1-20021226-D00005.TIF SYSTEM "US20020198383A1-20021226-D00005.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020198383</doc-number>
<kind-code>A1</kind-code>
<document-date>20021226</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>09949467</doc-number>
</application-number>
<application-number-series-code>09</application-number-series-code>
<filing-date>20010907</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>B01J031/00</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C07F001/00</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>546</class>
<subclass>005000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>502</class>
<subclass>162000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Catalytic compositions and methods for asymmetric allylic alkylation</title-of-invention>
</technical-information>
<continuity-data>
<continuations>
<continuation-in-part-of>
<parent-child>
<child>
<document-id>
<doc-number>09949467</doc-number>
<kind-code>A1</kind-code>
<document-date>20010907</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09498701</doc-number>
<document-date>20000207</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>PENDING</parent-status>
</parent-child>
</continuation-in-part-of>
</continuations>
<division-of>
<parent-child>
<child>
<document-id>
<doc-number>09498701</doc-number>
<document-date>20000207</document-date>
<country-code>US</country-code>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09213395</doc-number>
<document-date>19981215</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>GRANTED</parent-status>
<parent-patent>
<document-id>
<doc-number>6130349</doc-number>
<country-code>US</country-code>
</document-id>
</parent-patent>
</parent-child>
</division-of>
<non-provisional-of-provisional>
<document-id>
<doc-number>60068128</doc-number>
<document-date>19971219</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Barry</given-name>
<middle-name>M.</middle-name>
<family-name>Trost</family-name>
</name>
<residence>
<residence-us>
<city>Los Altos</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Iwao</given-name>
<family-name>Hachiya</family-name>
</name>
<residence>
<residence-non-us>
<city>Tsu</city>
<country-code>JP</country-code>
</residence-non-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>PERKINS COIE LLP</name-1>
<name-2></name-2>
<address>
<address-1>P.O. BOX 2168</address-1>
<city>MENLO PARK</city>
<state>CA</state>
<postalcode>94026</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">Complexes of a selected class of chiral ligands with molybdenum, tungsten or chromium, preferably molybdenum, are effective as catalysts in highly enantioselective and regioselective alkylation of allylic substrates. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application is a continuation-in-part of U.S. Ser. No. 09/498,701, filed Feb. 7, 2000, which is divisional of U.S. Ser. No. 09/213,395, filed Dec. 15, 1998, now U.S. Pat. No. 6,130,349, which claims the priority of U.S. Provisional Serial No. 60/068,128, filed Dec. 19, 1997, all of which are incorporated herein by reference in their entirety.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This invention was made with government support under National Institutes of Health Grant No. 5R37 GM13598-30 and National Science Foundation Grant No. CHE-9501472. Accordingly, the United States Government has certain rights in this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">FIELD OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> The present invention relates to catalytic methods and compositions for use in highly regioselective and enantioselective alkylations of allylic substrates. Molybdenum, tungsten and chromium complexes of chiral ligands having such catalytic activity, particularly the molybdenum complexes, are described, along with methods for their use. </paragraph>
</section>
<section>
<heading lvl="1">REFERENCES </heading>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> Adolfsson, H. and Moberg, C., <highlight><italic>Tetrahedron: Asymmetry </italic></highlight>6:2023 (1995). </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> Dvorak, D. et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>117:6130 (1995) and references cited therein. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> Fenton, R. R. et al., <highlight><italic>J. Coord. Chem. </italic></highlight>23:291 (1991). </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> Godleski, S. A., in &ldquo;Comprehensive Organic Synthesis,&rdquo; Trost, B. M., Fleming, I., and Semmelhack, M. F., eds.; Permagon Press, Oxford, 1991, Vol. 4, pp 585-662. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> Hammen, P. D. et al., <highlight><italic>Synth. Commun. </italic></highlight>21:2157 (1991). </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Merlic, C. A., Ph.D. Thesis, University of Wisconsin (1988). </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Pr&eacute;tot, R. and Pfalz, A., <highlight><italic>Angew. Chem. Int. Ed. Engl. </italic></highlight>37:323 (1998). </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Rubio, A. and Liebeskind, L. S., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>115:891 (1993). </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> Saigo, K. et al., <highlight><italic>Bull. Chem. Soc. Japan </italic></highlight>59(3):931 (1986). </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> Trost, B. M. et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>109:2176 (1987). </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> Trost, B. M. and Hachiya, I., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>120:1104(1998). </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> Trost, B. M. and Hung, M.-H., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>105:7757 (1983). </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> Trost, B. M. and Lautens, M., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>104:5543 (1982). </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> Trost, B. M. and Lautens, M., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>109:1469 (1987). </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> Trost, B. M. and Lautens, M., <highlight><italic>Tetrahedron </italic></highlight>43:4817 (1987). </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> Trost, B. M. and Merlic, C. A., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>112:9590 (1990). </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> Interest in molybdenum- and tungsten-catalyzed reactions of allyl substrates with nucleophiles has been promoted by the regioselectivity shown by these complexes, as compared to that of palladium complexes. See, for example, for molybdenum, Trost and Merlic, 1990, Rubio and Liebeskind, 1993, Trost and Hachiya, 1998; and for tungsten, Trost and Hung, 1983, and Trost et al., 1987. Palladium catalyzed reactions generally provide products from attack at the less substituted terminus. This regiochemistry (shown at eq <highlight><bold>1</bold></highlight>, path a in <cross-reference target="DRAWINGS">FIG. 1</cross-reference>) is particularly favored for alkylation of aryl-substituted allyl systems, even with catalysts having chiral ligands (Godleski, 1991). Molybdenum and tungsten catalysts, on the other hand, generally favor attack at the more substituted terminus (eq <highlight><bold>1</bold></highlight>, path b). Complexes of these metals are also less costly than palladium catalysts. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> Products of the type shown in reaction path (b), having high optical purity, find great value as building blocks in the synthesis of biologically useful compounds. A low-cost, versatile, stereoselective catalytic route to such compounds would thus be desirable. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> In one aspect, the invention provides a catalytic organometallic composition, effective to catalyze the enantioselective alkylation of an allyl group bearing a leaving group at an allylic position. The composition comprises a metal atom selected from the group consisting of molybdenum, tungsten, and chromium, which is preferably molybdenum or tungsten and most preferably molybdenum, and coordinated thereto, a chiral ligand L<highlight><superscript>1</superscript></highlight>. The chiral ligand comprises a chiral component derived from a chiral diamine, and having first and second carbon atoms each bearing a binding group &mdash;NH&mdash;(C&boxH;O)&mdash;B, wherein: </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> the above-referenced carbon atoms are connected by a direct bond or by a chain of one to three atoms comprising linkages selected from alkyl, alkyl ether, alkyl amino, and combinations thereof, </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> each group B is independently selected from alkyl, cycloalkyl, heterocycle, aryl, and aralkyl, as defined herein; </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> at least one group B is a N-heterocyclic or N-heteroaryl group CyN having an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen atom effective to coordinate to said metal atom, and </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> at least one of the above-referenced carbon atoms is a chiral carbon atom bearing a further substituent effective to create a conformationally biased system containing the carbon atoms and the binding groups. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> In preferred embodiments, the substituent (or substituents) on the above-referenced carbon atom(s) are independently selected from aryl, aralkyl, carbocycle, heterocycle, and secondary or tertiary alkyl having 3 or more, preferably 4 or more, carbon atoms. In one such embodiment, the substituents are aryl groups. In another embodiment, where both of the above-referenced carbon atoms are chiral and are adjacent, the substituents on these carbon atoms may together form a ring. This ring is typically a 5- to 7-membered carbocyclic ring, or a 5- to 7-membered heterocyclic ring having 1-3, preferably 1-2, ring atoms selected from oxygen, nitrogen and sulfur, and the remaining ring atoms carbon. It may be fused to one or more additional rings, preferably no more than two, and more preferably one or none. The ring or other substituents, particularly the cyclic substituents, may themselves be substituted with one or more groups selected from alkyl, alkenyl, aryl, aralkyl, alkoxy, aryloxy, acyl, acyloxy, carboxylic ester, amide, tertiary amine, nitro, and halogen. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> In further embodiments, each said group B is a group CyN as defined above, and/or each said carbon atom is a chiral carbon atom bearing a substituent effective to create a conformationally biased system containing said carbon atoms and said binding groups. The carbon atoms are preferably connected by a direct bond. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> Examples of the groups B described above as CyN, which may be the same or different on a given ligand, include, but are not limited to, pyridyl, quinolinyl, isoquinolyl, pyrimidyl, triazinyl, tetrazinyl, pyrazinyl, pyrazolyl, triazolyl, tetrazolyl, oxazinyl, oxazolyl, thiazolyl, imidazolyl, benzoxazole, benzimidazole, and dihydro derivatives of the above. N-heteroaryl groups are generally preferred. In one embodiment, at least one group B is a group CyN having an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen which is &agr; to a ring carbon atom which is linked to the carbonyl (C&boxH;O) carbon of the binding group (referred to herein as an &ldquo;&agr;-linked&rdquo; CyN). Examples of these groups include 2-pyridyl, 2-quinolinyl, 1- or 3-isoquinolyl, 2- or 4-pyrimidyl, 2-triazinyl, 4-tetrazinyl, 2-pyrazinyl, 3- or 5-pyrazolyl, 3- or 5-triazolyl, 2-tetrazolyl, 2-oxazinyl, 2- or 5-oxazolyl, 2- or 5-thiazolyl, 2- or 4-imidazolyl, 2-benzoxazole, 2-benzimidazole, and dihydro derivatives of the above. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> The above-referenced carbon atoms of the chiral component are connected by a direct bond or by a chain of one to three atoms comprising linkages selected from alkyl, alkyl ether, alkyl amino, and combinations thereof. Preferably, they are connected by a direct bond, such that the chiral scaffold is derived from a 1,2-diamine. Examples of chiral 1,2-diamines that may be used as chiral scaffolds include 1R,2R-trans-diaminocyclohexane, 1R,2R-trans-diphenyl-1,2-ethanediamine, 3R,4R-trans-3,4-diamino-N-benzylpyrrolidine, 1R,2R-trans-diaminocycloheptane, 5R,6R-trans-5,6-diaminoindan, 1S-phenyl-1,2-ethanediamine, and the mirror image counterpart of any of the above. Examples of chiral ligands of the invention include those represented herein as ligands I-XV and their mirror image counterparts. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> The catalytic organometallic composition of the invention is the product of a process which comprises contacting, in a suitable solvent, a chiral ligand L<highlight><superscript>1</superscript></highlight>, as defined above, with a complex (also referred to herein as the starting complex or precomplex) of a metal selected from tungsten (0), chromium (0), and molybdenum(0), ligands which form a stable complex with the metal and are displaceable by ligand L<highlight><superscript>1 </superscript></highlight>under the conditions of said contacting. Such ligands include CO, cycloheptatriene, lower alkyl nitrile, and lower alkyl isonitrile. Preferred precomplexes for the preparation of the molybdenum catalysts include Mo(h<highlight><superscript>3&minus;</superscript></highlight>C<highlight><subscript>7</subscript></highlight>H<highlight><subscript>8</subscript></highlight>)(CO)<highlight><subscript>3 </subscript></highlight>(cycloheptatriene molybdenum tricarbonyl), Mo(CO)<highlight><subscript>3</subscript></highlight>(CH<highlight><subscript>3</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>CN)<highlight><subscript>3</subscript></highlight>, and Mo(CO)<highlight><subscript>6</subscript></highlight>. Tungsten and molybdenum complexes are preferred, with molybdenum being particularly preferred. Upon such contacting, the complex undergoes a ligand exchange reaction, such that L<highlight><superscript>1 </superscript></highlight>becomes coordinated to the metal atom. The resulting composition is effective to catalyze the enantioselective alkylation of an allyl group bearing a leaving group at its allylic position. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> In the above process, the molar ratio of the ligand L<highlight><superscript>1 </superscript></highlight>added to the hexacoordinate precomplex is generally between about 2:1 and about 1:1, and preferably between about 1.1:1 and about 1.5:1. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> In another aspect, the invention provides a method of selectively alkylating an allyl group bearing a leaving group at the allylic position, under conditions effective to produce an alkylated product which is enriched in one of the possible isomeric products of such alkylation. The alkylation method comprises reacting the allyl group with an alkylating agent, in the presence of a catalytic amount of an alkylating catalyst. The alkylating catalyst is an organometallic complex having a metal atom selected from the group consisting of molybdenum, tungsten, and chromium, and coordinated thereto, a chiral ligand L<highlight><superscript>1</superscript></highlight>, as defined above. The metal atom is preferably molybdenum or tungsten, and more preferably molybdenum. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> In a related aspect, the method comprises reacting such a substrate with an alkylating agent in the presence of a catalytic composition formed by contacting, in a suitable solvent, catalytic amounts of (i) a complex of a metal selected from the group consisting of molybdenum (0), tungsten (0), and chromium (0), having ligands which form a stable complex with the metal and are displaceable by ligand L<highlight><superscript>1 </superscript></highlight>under the conditions of said contacting, and (ii) a chiral ligand L<highlight><superscript>1</superscript></highlight>, as defined above. Such ligands include CO, cycloheptatriene, lower alkyl nitrile, and lower alkyl isonitrile. The mole percent of said catalyst with respect to said substrate is preferably between about 0.5% and about 15%, and more preferably between about 1% and about 10%. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> The reaction is carried out under conditions effective to produce an alkylated product which is enriched in one of the possible isomeric products of such alkylation. In one aspect, the alkylation is enantioselective, and preferably produces an alkylated product having an enantiomeric excess greater than 75%, preferably greater than 85% and more preferably greater than 95%. In another aspect, when the allyl group is nonsymmetrically substituted at its termini, the alkylation is regioselective, such that said allyl group is alkylated at its more sterically hindered terminus. Preferably, the regioselectivity of alkylation, defined as the ratio of product alkylated at the more sterically hindered terminus to product alkylated at the less sterically hindered terminus, is greater than 3:1, and more preferably greater than 9:1. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> Preferred allyl substrates for the reaction are those in which the allyl group is substituted at one terminus with a substituent selected from aryl, heteroaryl, alkenyl, alkynyl, and alkyl. The reaction is especially useful for substrates in which neither allyl terminus is aryl substituted. This includes those in which one terminus is substituted with an alkyl group or with a non-aromatic conjugated polyene or enyne. In another embodiment of the method, where the allyl group has identical non-hydrogen substituents at its termini (with the exception of the leaving group), the alkylation is enantioselective with respect to the new chiral center formed at the alkylated terminus of said allyl group. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> The alkylating agent is a preferably a stabilized carbanion, such as a carbanion of the form EE&prime;RC<highlight><superscript>&minus;</superscript></highlight> M<highlight><superscript>&plus;</superscript></highlight>, where M<highlight><superscript>&plus;</superscript></highlight> is a positively charged counterion, and each of E and E&prime; is a substituent which stabilizes the carbanion, e.g. an electron-withdrawing substituent selected from keto, carboxylic ester, cyano, and sulfonyl, or an aromatic or heteroaromatic group capable of stabilizing an &agr;-carbanion. Preferably, at least one of E and E&prime; is a carboxylic ester. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> In a preferred embodiment of the method, the catalyst is formed in situ by ligand exchange of a soluble molybdenum(0) complex with ligand L<highlight><superscript>1</superscript></highlight>. The complex, as described above, comprises ligands which are effective to form a stable complex with Mo(0) and which are displaceable by ligand L<highlight><superscript>1 </superscript></highlight>under the conditions of the ligand exchange. Preferred ligands include cycloheptatriene, CO, lower alkyl nitrile, and lower alkyl isonitrile. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> These and other objects and features of the invention will become more fully apparent when the following detailed description of the invention is read in conjunction with the accompanying drawings. </paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> shows the generally favored regioselectivity of allylic alkylation using palladium catalysts (a) and using molybdenum and tungsten catalysts (b); </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> FIGS. <highlight><bold>2</bold></highlight>A-<highlight><bold>2</bold></highlight>D show the preparation of several representative chiral ligands which may be employed in the chiral molybdenum catalyst of the invention; </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference>A-C show additional examples of chiral ligands; </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> shows the reaction of an allylic substrate with an alkylating agent, and the two possible products, formed by alkylation at the different termini of the allyl group; and </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> illustrates the intramolecular Diels-Alder reaction of the product of reaction <highlight><bold>14</bold></highlight>, Table 1, which was prepared according to the method of the invention.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0045" lvl="7"><number>&lsqb;0045&rsqb;</number> I. Definitions </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> The terms below have the following meanings unless indicated otherwise. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> &ldquo;Enantiomeric excess&rdquo; or &ldquo;e.e.&rdquo; refers to the quantity E1-E2, where E1 is the fraction of a compound having one enantiomeric configuration, and E2 is the fraction having the mirror image configuration. </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> In an allyl group, that is, a three-carbon moiety having a double bond between carbons <highlight><bold>1</bold></highlight> and <highlight><bold>2</bold></highlight> and a single bond between carbons <highlight><bold>2</bold></highlight> and <highlight><bold>3</bold></highlight>, the &ldquo;allylic position&rdquo; is the 3 position, and the &ldquo;termini&rdquo; are the 1 and 3 positions. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> An &ldquo;asymmetric&rdquo; or &ldquo;enantioselective&rdquo; alkylation refers to an alkylation reaction which produces one possible enantiomer of an alkylated center in a product in excess over the other enantiomer. A &ldquo;regioselective&rdquo; alkylation is one in which, when the allyl group is nonsymmetrically substituted at its termini, alkylation occurs at one terminus in excess over the other. The term &ldquo;stereoselectivity&rdquo;, as used herein, encompasses enantioselectivity and/or regioselectivity. </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> A &ldquo;chiral component&rdquo;, as used herein in reference to chiral ligands used in the catalysts of the invention, refers to a chiral diamine moiety which forms a chiral scaffold to which two binding groups, as defined herein, are linked. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> &ldquo;Alkyl&rdquo; refers to a fully saturated acyclic monovalent radical containing carbon and hydrogen, which may be branched or a straight chain. Examples of alkyl groups are methyl, ethyl, n-butyl, t-butyl, n-heptyl, and isopropyl. &ldquo;Cycloalkyl&rdquo; refers to a fully saturated cyclic monovalent radical containing carbon and hydrogen, which may be further substituted with alkyl. Examples of cycloalkyl groups are cyclopropyl, methyl cyclo-propyl, cyclobutyl, cyclopentyl, ethylcyclopentyl, and cyclohexyl. As used herein, the term generally refers to alkyl groups having 1 to 12, preferably 2 to 6, carbon atoms, or 5 to 7 ring carbons in the case of cycloalkyl. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> A &ldquo;heterocycle&rdquo; refers to a non-aromatic ring, preferably a 5- to 7-membered ring, whose ring atoms are selected from the group consisting of carbon, nitrogen, oxygen and sulfur and include at least one non-carbon atom (heteroatom). Preferably, the ring atoms include 1 to 3, preferably 1 to 2, heteroatoms and the remainder carbon atoms. Such heterocycles include, for example, pyrrolidine, piperidine, piperazine, and morpholine. An &ldquo;N-heterocycle&rdquo; is such a ring containing at least one ring nitrogen atom. </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> &ldquo;Aryl&rdquo; refers to a substituted or unsubstituted monovalent aromatic radical, preferably having a single ring (e.g., phenyl) or two condensed rings (e.g., naphthyl). The term &ldquo;aryl&rdquo; includes heteroaryl; that is, aryl groups having one or more nitrogen, oxygen, or sulfur atoms in the ring, such as furan, pyrrole, pyridine, pyrimidine, and indole. &ldquo;N-heteroaryl&rdquo; indicates that the group contains at least one ring nitrogen atom. An aryl group may be substituted with one or more substituents, preferably selected from alkyl, alkenyl, aryl, aralkyl, alkoxy, aryloxy, acyl, acyloxy, amide, tertiary amine, nitro, and halogen. </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> &ldquo;Aralkyl&rdquo; refers to an alkyl, preferably lower alkyl (C<highlight><subscript>1 </subscript></highlight>to C<highlight><subscript>4</subscript></highlight>), substituent which is further substituted with an aryl group. </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> &ldquo;Acyl&rdquo; and &ldquo;acyloxy&rdquo; refer to groups having the form &mdash;C(O)R or &mdash;OC(O)R, respectively, where R is an alkyl, aryl, or aralkyl group. </paragraph>
<paragraph id="P-0056" lvl="7"><number>&lsqb;0056&rsqb;</number> II. Catalysts for Asymmetric Alkylation </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> The asymmetric catalysts of the invention are complexes of molybdenum, tungsten, or chromium with a chiral ligand as described below. Complexes of molybdenum or tungsten are preferred, with molybdenum being most preferred. In accordance with the invention, such catalysts are effective to catalyze the alkylation of allylic substrates, giving a product which is enriched in one of the possible isomeric products of such alkylation. Specifically, use of the catalysts provides high enantioselectivity and high regioselectivity, as demonstrated below. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> A. The Chiral Ligand </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> The chiral ligand, designated L<highlight><superscript>1</superscript></highlight>, can be described in terms of structural components, which include a chiral component, or &ldquo;scaffold&rdquo;, and binding components. Exemplary ligands include those designated I-XV herein. A linearized structure of a representative ligand, according to one embodiment of the invention, is given below. </paragraph>
<paragraph lvl="0"><in-line-formula>B&mdash;(C&boxH;O)&mdash;NH&mdash;CR<highlight><superscript>1</superscript></highlight>R<highlight><superscript>3</superscript></highlight>&mdash;CR<highlight><superscript>2</superscript></highlight>R<highlight><superscript>4</superscript></highlight>&mdash;NH&mdash;(C&boxH;O)&mdash;B </in-line-formula></paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> The chiral component, represented by the central portion of the structure, is derived from a chiral diamine. The nitrogen atoms of the diamine are linked to first and second carbon atoms as shown, of which at least one is chiral. Groups B, described further below, are linked to the scaffold via amide linkages containing these nitrogen atoms. </paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> The moieties &mdash;NH&mdash;(C&boxH;O)&mdash;B are referred to herein as binding groups. Each group B is independently selected from alkyl, cycloalkyl, heterocycle, aryl, including heteroaryl, and aralkyl, as defined above. </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> In one embodiment, B is a N-heterocyclic or N-heteroaryl group, represented herein by CyN. The group CyN has an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen, and is preferably linked to the carbonyl group (C&boxH;O) via a ring carbon atom which is &agr; to (adjacent) this ring nitrogen. Such a group is referred to herein as &ldquo;&agr;-linked&rdquo;. Examples of such heterocyclic and heteroaryl groups which are &agr;-linked include 2-pyridine, 2- or 4-pyrimidine, 2-pyrazine, 2-triazine, 3- or 5-triazole, 3- or 5-pyrazole, 2-2-pyrazine, 2-4-imidazole, 2- or 5-oxazole, 2- or 5-thiazole, 2-oxazoline, and the like, and multiring structures such as 2-benzoxazole, 2-benzimidazole, 2-quinoline, and 1- or 3-isoquinoline. Also included are dihydro derivatives of these groups, e.g. dihydropyridines, as long as the ring includes an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen. (Linking of some dihydro derivatives will create a further chiral center, whose stereochemistry must be controlled during synthesis or purification of the ligand.) </paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> Non-&agr;-linked CyN groups (e.g. &bgr;-linked groups, which would include, for example, 3-pyridyl, 3-quinolinyl, 4-isoquinolyl, 4-pyrazolyl, 3-oxazinyl, 4-oxazolyl, 4-thiazolyl, and dihydro derivatives of the above) and carbocyclic aryl groups (e.g. phenyl) are additional embodiments of B. </paragraph>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> Each group B, particularly cyclic groups, may be substituted with one or more groups selected from alkyl, alkenyl, aryl, aralkyl, alkoxy, aryloxy, acyl, acyloxy, ester, amide, tertiary amine, nitro, or halogen. Cyclic groups may be fused to one or more additional rings, preferably no more than one. Preferably, substituents on the ligand do not include active (acidic) hydrogens, e.g. phenolic groups or primary or secondary amines. </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> At least one of the carbon atoms of the diamine (chiral scaffold) is a chiral carbon atom and bears a substituent (e.g., R<highlight><superscript>1 </superscript></highlight>in the linearized structure above) which is effective to create a conformationally biased system (i.e., having a conformation which is energetically favored and influenced by the presence of the substituent) containing the two carbon atoms and the binding groups. The extent of conformational bias is such that the chiral ligand is effective in catalyzing the stereoselective (i.e. enantioselective and/or regioselective) alkylation reactions described herein. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> Such a substituent (e.g. R<highlight><superscript>1</superscript></highlight>) is preferably selected from aryl, heteroaryl, aralkyl, cycloalkyl, heterocyclyl, and secondary or tertiary alkyl having 3 or more, preferably 4 or more, carbon atoms. Cycloalkyl is preferably cyclopentyl to cycloheptyl, and heterocyclyl is preferably or a 5- to 7-membered heterocyclic ring having 2-3 ring atoms selected from oxygen and nitrogen and the remaining ring atoms carbon. Preferably, such a heterocyclic ring contains one or two heteroatoms. Examples of suitable substituents on the chiral carbon atoms include, but are not limited to, phenyl, pyridyl, benzyl, naphthyl, cyclohexyl, furanyl, pyranyl, isopropyl, t-butyl, and 1-methyl butyl (sec-pentyl). Aryl substituents are preferred, particularly when the ligand includes only one chiral carbon. The substituents themselves, particularly the cyclic substituents, may be further substituted with alkyl, alkenyl, aryl, aralkyl, alkoxy, aryloxy, acyl, acyloxy, amide, tertiary amine, nitro, or halogen. The chiral carbon(s) may be disubstituted, as long as chirality is maintained, but are preferably monosubstituted. </paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> Ligands in which each carbon atom is chiral and bears such a substituent include those in which the chiral carbons are adjacent and their substituents together form a carbocyclic or heterocyclic ring. Preferably, such a ring is a 5- to 7-membered carbocyclic ring, or a 5- to 7-membered heterocyclic ring having 2-3 ring atoms selected from oxygen and nitrogen and the remaining ring atoms carbon. Preferably, such a heterocyclic ring contains one or two heteroatoms. Examples include, but are not limited to, cyclohexane, piperidine, piperazine, pyrrolidine, morpholine, di- or tetrahydrofuran, and di- or tetrahydropyran. R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>2</superscript></highlight>, or the ring formed thereby, may be further substituted with one or more groups selected from alkyl alkenyl, aryl, aralkyl, alkoxy, aryloxy, acyl, acyloxy, amide, tertiary amine, nitro, or halogen. R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>2</superscript></highlight>, or the ring formed thereby, may also be fused to one or more additional rings, preferably no more than two, and more preferably one or none. Although the remaining groups on the carbon atoms (R<highlight><superscript>3 </superscript></highlight>and R<highlight><superscript>4</superscript></highlight>) are typically hydrogen, the carbon atoms may also be tetrasubstituted, as long as they remain chiral. </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> An exemplary chiral diamine for use in preparing ligands of this class is 1R,2R-trans-diaminocyclohexane (see <cross-reference target="DRAWINGS">FIG. 2A</cross-reference>) or its enantiomer, 1S,2S-trans-diaminocyclohexane, both of which are commercially available. FIGS. <highlight><bold>2</bold></highlight>-<highlight><bold>3</bold></highlight> show additional chiral ligands based on 5- and 7-membered rings. See, for example, ligands XIV and XV, where the chiral scaffold is based on cyclohexanediamine, one group B is 2-pyridyl, and the second group B is phenyl or 3-pyridyl, respectively. Also preferred are diamines having bulky substituents, such as trans-1,2-diamino-1,2-diphenylethane (see e.g. ligand II). </paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> An example of a ligand in which only one of the carbon atoms is chiral (e.g., where R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>4 </superscript></highlight>are both hydrogen) is ligand XIII, where R<highlight><superscript>1 </superscript></highlight>is phenyl, R<highlight><superscript>2</superscript></highlight>-R<highlight><superscript>4 </superscript></highlight>are hydrogen, and each group B is 2-pyridyl. </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> In preferred embodiments, the carbon atoms bearing the binding groups are connected by a direct bond, as in the linearized structure above; that is, the diamine is a 1,2 system. However, chiral components having intervening bonds between these carbon atoms, e.g. 1,3-, 1,4-, or 1,5-systems, can also be effective. In such cases, the carbon atoms are connected by a chain of one to three atoms comprising linkages selected from alkyl (carbon-carbon) alkyl ether (carbon-oxygen), alkyl amino (carbon-nitrogen), or a combination thereof. In such ligands, each group B is preferably an &agr;-linked CyN as described above. </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> A distinctive type of chiral ligand is that in which R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>2 </superscript></highlight>are naphthyl groups which are linked to form a 1,1&prime;-binaphthyl system (or analogous multinuclear systems). In such cases, for use in the present catalysts, the amine and/or alcohol groups of the chiral component are at the 2 and 2&prime;-positions. Although these positions are not chiral centers in the conventional sense (i.e. they do not have four different substituents), the naphthyl groups form a helical system possessing what is termed axial chirality. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> B. Preparation of the Chiral Ligand </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> Many chiral diamines are commercially available. Such compounds can also be prepared from naturally occurring chiral precursors, e.g. amino acids, saccharides, tartrates, etc., using established synthetic procedures. Chiral compounds may also be prepared from achiral or racemic precursors using known synthetic methods having high stereoselectivity. The development of such methods has been an active field of research for many years and is the subject of many articles, books and treatises. In many cases, particularly for compounds which can form crystalline salts, e.g. many amines, optical resolution can provide compounds of high optical purity. For example, optical resolution of racemic 1,2-diphenylethanediamine gave the (&plus;) and (&minus;) enantiomers in over 99% and 97% optical purity, respectively (Saigo et al., 1986), and racemic trans-1,2-diaminocyclohexane was resolved to &gt;99% optical purity via the lactic acid salt (Imaoka, 1995). Chromatography of racemic compounds on chiral supports has also been found useful. </paragraph>
<paragraph id="P-0074" lvl="0"><number>&lsqb;0074&rsqb;</number> Chiral ligands as described above can be conveniently prepared by condensation reaction of the chiral diamine with a suitable carboxylic acid derivative of the component or components represented by B. As shown in the preparation of ligands XIV and XV described in the Examples, ligands having two different binding groups can be prepared by using differentially activated or protected precursors (Example 24) or simply by separating the desired compound from the side product symmetrical compounds (Example 23). </paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> C. Preparation of Catalysts </paragraph>
<paragraph id="P-0076" lvl="0"><number>&lsqb;0076&rsqb;</number> The chiral catalyst is readily generated by ligand exchange of the ligand L<highlight><superscript>1 </superscript></highlight>with a soluble complex of Mo(0), W(0), or Cr(0), where the molybdenum and tungsten complexes are preferred, and molybdenum particularly preferred. Suitable starting complexes are those having ligands which stabilize the starting complex, but are displacable by the chiral ligand L<highlight><superscript>1 </superscript></highlight>under mild conditions. Such ligands include, for example, cycloheptatriene, carbon monoxide, lower alkyl nitrites or isonitriles, or combinations thereof. Particularly preferred starting complexes are cycloheptatriene molybdenum tricarbonyl (Mo(h3-C<highlight><subscript>7</subscript></highlight>H<highlight><subscript>8</subscript></highlight>)(CO)<highlight><subscript>3</subscript></highlight>), molybdenum hexacarbonyl (Mo(CO)<highlight><subscript>6</subscript></highlight>) and molybdenum tris(propionitrile) triscarbonyl (CH<highlight><subscript>3</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>CN)<highlight><subscript>3</subscript></highlight>Mo(CO)<highlight><subscript>3</subscript></highlight>. </paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> The ligand L<highlight><superscript>1 </superscript></highlight>and starting complex are stirred in an inert, nonprotic and noncomplexing solvent, in an inert atmosphere, e.g. dry nitrogen or argon, preferably in a molar ratio of about 1:1 to about 1:2, more preferably in the range of about 1:1.1 to about 1:1.5. In general, a larger scale preparation will call for a smaller excess of ligand L<highlight><superscript>1 </superscript></highlight>over starting metal complex. Suitable solvents include THF, diethyl ether, other hydrocarbon ethers such as dioxane; toluene, other hydrocarbon solvents such as benzene or petroleum ether; chlorinated solvents such as chloroform or dichloromethane, or mixtures thereof. Preferred solvents are hydrocarbons, hydrocarbon ethers, and mixtures thereof. </paragraph>
<paragraph id="P-0078" lvl="0"><number>&lsqb;0078&rsqb;</number> For the experiments described below, a 1:1.5 ratio of (CH<highlight><subscript>3</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>CN)<highlight><subscript>3</subscript></highlight>Mo(CO)<highlight><subscript>3 </subscript></highlight>to ligand L<highlight><superscript>1 </superscript></highlight>was typically used in preparing the catalyst, and the reaction was carried out at room temperature or in refluxing THF (about 65&deg; C.). The catalytic complexes may be thus generated and then used in situ for alkylation, as described in the Examples below. </paragraph>
<paragraph id="P-0079" lvl="7"><number>&lsqb;0079&rsqb;</number> III. Asynmmetric Allylic Alkylation Method </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> A. General Procedure </paragraph>
<paragraph id="P-0081" lvl="0"><number>&lsqb;0081&rsqb;</number> The asymmetric alkylation of the invention is carried out by contacting an allylic substrate and an alkylating agent with a solution containing a catalytic amount of a chiral catalyst as described above. In a preferred embodiment, the catalyst is generated in situ by reaction of a chiral ligand L<highlight><superscript>1 </superscript></highlight>with a soluble starting complex, as described above. Generation of the catalyst is followed by addition of the alkylating agent and the allylic substrate. In other embodiments of the method, the catalyst may be added to the substrate and alkylating agent. </paragraph>
<paragraph id="P-0082" lvl="0"><number>&lsqb;0082&rsqb;</number> All of these operations are carried out in a suitable aprotic and non-complexing solvent, such as, for example, THF, diethyl ether, other hydrocarbon ethers such as dioxane; toluene, other hydrocarbon solvents such as benzene or petroleum ether; chlorinated solvents such as chloroform or dichloromethane, or a mixture thereof, in an inert atmosphere, e.g. dry nitrogen or argon. Preferred solvents are hydrocarbons, hydrocarbon ethers, and mixtures thereof. The reaction proceeds well both at room temperature and in refluxing THF (65&deg; C.), with greater selectivities and longer reaction times typically resulting at lower temperatures, as shown, for example, in Table 1. A mixture of THF and toluene also gave excellent results. Optimum reaction time and temperature will vary based on factors such as the structure of the substrate, the level of catalyst, and the degree of selectivity desired, and can be determined by one of skill in the art using routine experimentation. </paragraph>
<paragraph id="P-0083" lvl="0"><number>&lsqb;0083&rsqb;</number> The catalyst is generally effective at levels of about 15 mole percent or less, with respect to the target allyl group. Preferred levels are in the range of about 0.5 to 15 mole percent, and more preferably 1 to 10 mole percent. Larger amounts of catalyst may be used for less reactive ligands and/or substrates. </paragraph>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> The alkylating agent (nucleophile) is a preferably a stabilized carbanion, such as a carbanion of the form EE&prime;RC<highlight><superscript>&minus;</superscript></highlight> M<highlight><superscript>&plus;</superscript></highlight>, where M<highlight><superscript>&plus;</superscript></highlight> is a positively charged counterion, and each of E and E&prime; is a substituent which stabilizes the carbanion, e.g. an electron-withdrawing substituent selected from keto, carboxylic ester, cyano, and sulfonyl, or an aromatic or heteroaromatic group capable of stabilizing an &agr;-carbanion. Preferably, at least one of E and E&prime; is a carboxylic ester. Preferred nucleophiles include malonates, &bgr;-keto esters and &bgr;-cyano esters. Alkylating agents containing alkyl and allylic substitution at the attacking carbon were found to be effective (Table 1, lines 8-14). Reaction with other nucleophilic species, such as oxygen- or nitrogen-based nucleophiles, is also contemplated. </paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> The substrate is a compound containing an allyl group which bears a leaving group at the allylic position. Alkylation of such a substrate according to the present method, using the catalytic complex described herein, is effective to produce an alkylated product which is enriched in one of the possible isomeric products of such alkylation. The benefits of the invention are most clearly seen with non-symmetrically substituted allyl groups. By &ldquo;non-symmetrically substituted&rdquo; is meant that the allyl group contains different groups (not considering the leaving group) at its termini, that is, at the 1 and 3 positions, where the 3 position is the allylic position. In such cases, both high regioselectivity and enantioselectivity are demonstrated, as discussed below. </paragraph>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> The catalytic compositions and methods are also useful for enantioselective alkylation of symmetrically substituted allyl groups, that is, where the 1 and 3 positions have identical substituents, with the exception of the leaving group. A simple example of such a substrate is cyclopentene having a leaving group at the 3 position. </paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> shows representative non-symmetrically substituted substrates <highlight><bold>1</bold></highlight> and <highlight><bold>2</bold></highlight>, where the leaving group is a carbonate or acetate. These can be represented more generally by structures R&prime;&mdash;CH&equals;CH&mdash;CR&ldquo;H&mdash;X (1) or R&apos;&mdash;CHX&mdash;CH&equals;CR&rdquo;H (2), where X is a leaving group, and R&apos; and R&rdquo; are substituents, such as, for example, alkyl, alkenyl, aryl, alkynyl, or heteroaryl. Preferred substrates are those in which the more highly substituted terminus is remote from the leaving group, i.e. <highlight><bold>1</bold></highlight> as opposed to <highlight><bold>2</bold></highlight>, although good results are also obtained with the latter type of substrate, as shown, for example, in Table I. Especially favorable substrates are those of structure 1 in which R&apos; is aryl, heteroaryl, or alkenyl, that is, in which R&apos; forms a conjugated system with the allylic double bond. R&Prime; is preferably hydrogen, although it may be a substituent. </paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> A very useful feature of the alkylation catalyst and method is the high regioselectivity favoring the more highly substituted terminus of the allyl group, as shown by the data presented herein. The reactions outlined in Table 1, for example, consistently gave regioselectivities of at least &tilde;83% (a 5:1 product ratio), and selectivities of about 97% (a 32:1 ratio), or greater, were common. </paragraph>
<paragraph id="P-0089" lvl="0"><number>&lsqb;0089&rsqb;</number> One general procedure for the reaction, using THF as solvent, is described in Example 1 below. This process was used, with variations in reaction time and temperature, in the alkylation of various substrates with a series of diethyl malonates, using chiral ligand I, to give the results shown in Table 1. All reactions were performed with 10 mol % (C<highlight><subscript>2</subscript></highlight>H<highlight><subscript>5</subscript></highlight>CN)<highlight><subscript>3</subscript></highlight>Mo(CO)<highlight><subscript>3</subscript></highlight>, 15 mol % I in THF at 0.1 M substrate. Values for e.e. were determined by chiral HPLC. In this Table, and others throughout this document, yields not in parenthesis are isolated yields; yields in parentheses are based upon recovered starting material. Typically, tatios of regioisomers were determined by <highlight><superscript>1</superscript></highlight>H NMR, and e.e. by chiral HPLC, or by comparison to literature values. </paragraph>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> In a typical reaction (entry 1), approximately 10 mol % of chiral molybdenum catalyst (based on the starting Mo complex) incorporating chiral ligand I was used in the alkylation of <highlight><bold>1</bold></highlight> (<cross-reference target="DRAWINGS">FIG. 4</cross-reference>) with dimethyl sodiomalonate (<highlight><bold>3</bold></highlight>, R&boxH;H). An 88% yield of a 97:3 ratio of <highlight><bold>4</bold></highlight>:<highlight><bold>5</bold></highlight> (Ar&boxH;Ph, R&boxH;H) was obtained, with <highlight><bold>4</bold></highlight> having an e.e. of 99%. When the reaction was carried out at room temperature (entry 2) rather than at reflux, a good yield was still obtained, with somewhat improved regioselectivity and a similarly high e.e.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="280PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 1</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Mo Catalyzed Asymmetric Allylic Alkylations</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="OFFSET" colwidth="21PT" align="left"/>
<colspec colname="1" colwidth="49PT" align="left"/>
<colspec colname="2" colwidth="49PT" align="left"/>
<colspec colname="3" colwidth="28PT" align="left"/>
<colspec colname="4" colwidth="35PT" align="center"/>
<colspec colname="5" colwidth="35PT" align="center"/>
<colspec colname="6" colwidth="35PT" align="center"/>
<colspec colname="7" colwidth="28PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>1 or 2 Ar</entry>
<entry>3 R</entry>
<entry>T, &deg; C.</entry>
<entry>Time, hrs</entry>
<entry>Yield, %</entry>
<entry>Ratio 4:5</entry>
<entry>ee of 4</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="7" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="21PT" align="center"/>
<colspec colname="2" colwidth="49PT" align="left"/>
<colspec colname="3" colwidth="49PT" align="left"/>
<colspec colname="4" colwidth="28PT" align="left"/>
<colspec colname="5" colwidth="35PT" align="center"/>
<colspec colname="6" colwidth="35PT" align="center"/>
<colspec colname="7" colwidth="35PT" align="center"/>
<colspec colname="8" colwidth="28PT" align="center"/>
<tbody valign="top">
<row>
<entry>1</entry>
<entry>1, Ph</entry>
<entry>H</entry>
<entry>reflux</entry>
<entry>3</entry>
<entry>88</entry>
<entry>32:1</entry>
<entry>99</entry>
</row>
<row>
<entry>2</entry>
<entry>1, Ph</entry>
<entry>H</entry>
<entry>r.t.</entry>
<entry>3</entry>
<entry>70 (90)</entry>
<entry>49:1</entry>
<entry>99</entry>
</row>
<row>
<entry>3</entry>
<entry>2a, Ph</entry>
<entry>H</entry>
<entry>reflux</entry>
<entry>3</entry>
<entry>70</entry>
<entry>13:1</entry>
<entry>92</entry>
</row>
<row>
<entry>4</entry>
<entry>2a, Ph</entry>
<entry>H</entry>
<entry>r.t.</entry>
<entry>3</entry>
<entry>61 (68)</entry>
<entry>32:1</entry>
<entry>97</entry>
</row>
<row>
<entry>5</entry>
<entry>2a, 2-thienyl</entry>
<entry>H</entry>
<entry>reflux</entry>
<entry>2</entry>
<entry>78</entry>
<entry>19:1</entry>
<entry>88</entry>
</row>
<row>
<entry>6</entry>
<entry>2a, 2-pyridyl</entry>
<entry>H</entry>
<entry>reflux</entry>
<entry>2</entry>
<entry>69 (82)</entry>
<entry>&ensp;8:1</entry>
<entry>96</entry>
</row>
<row>
<entry>7</entry>
<entry>2a, 1-naphthyl</entry>
<entry>H</entry>
<entry>reflux</entry>
<entry>2</entry>
<entry>82</entry>
<entry>99:1</entry>
<entry>87</entry>
</row>
<row>
<entry>8</entry>
<entry>1, Ph</entry>
<entry>CH<highlight><subscript>3</subscript></highlight></entry>
<entry>reflux</entry>
<entry>4</entry>
<entry>67</entry>
<entry>24:1</entry>
<entry>98</entry>
</row>
<row>
<entry>9</entry>
<entry>1, 2-furyl</entry>
<entry>CH<highlight><subscript>3</subscript></highlight></entry>
<entry>reflux</entry>
<entry>2</entry>
<entry>71</entry>
<entry>32:1</entry>
<entry>97</entry>
</row>
<row>
<entry>10&ensp;</entry>
<entry>2b, 2-furyl</entry>
<entry>CH<highlight><subscript>3</subscript></highlight></entry>
<entry>reflux</entry>
<entry>2</entry>
<entry>65</entry>
<entry>32:1</entry>
<entry>87</entry>
</row>
<row>
<entry>11&ensp;</entry>
<entry>2b, 2-furyl</entry>
<entry>CH<highlight><subscript>3</subscript></highlight></entry>
<entry>r.t.</entry>
<entry>18&ensp;</entry>
<entry>54</entry>
<entry>99:1</entry>
<entry>95</entry>
</row>
<row>
<entry>12&ensp;</entry>
<entry>2a, 2-pyridyl</entry>
<entry>CH<highlight><subscript>3</subscript></highlight></entry>
<entry>reflux</entry>
<entry>2</entry>
<entry>71</entry>
<entry>&ensp;5:1</entry>
<entry>94</entry>
</row>
<row>
<entry>13&ensp;</entry>
<entry>2a, 2-thienyl</entry>
<entry>CH<highlight><subscript>3</subscript></highlight></entry>
<entry>reflux</entry>
<entry>2</entry>
<entry>71</entry>
<entry>13:1</entry>
<entry>75</entry>
</row>
<row>
<entry>14&ensp;</entry>
<entry>2b, 2-furyl</entry>
<entry>CH<highlight><subscript>2</subscript></highlight>CH&boxH;CH<highlight><subscript>2</subscript></highlight></entry>
<entry>r.t.</entry>
<entry>12&ensp;</entry>
<entry>50</entry>
<entry>99:1</entry>
<entry>98</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> Entries 5-7 show corresponding results obtained upon variation of the aromatic ring in the substrate. An electron rich thiophene ring (entry 5), an electron deficient pyridine ring (entry 6), and a bulkier naphthalene substrate (entry 7) all gave good yields and selectivities. </paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> Increasing the steric bulk of the nucleophile by using alkylating agent <highlight><bold>3</bold></highlight><highlight><italic>b </italic></highlight>(<cross-reference target="DRAWINGS">FIG. 4</cross-reference>) gave similar excellent results with both carbocyclic and heterocyclic substrates (entries 8-12). Only in the case of the thiophene substrate was there some deterioration of the e.e. (75%) for the product (entry 13), although no attempt was made to optimize this reaction. The regioselectivity was still good (about 93%, or a 13:1 product ratio). </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> When the steric bulk of the alkylating agent was increased further, by using the allylmalonate nucleophile <highlight><bold>3</bold></highlight><highlight><italic>c</italic></highlight>, the regio- and enantio-selectivities were still excellent (entry 14). For the furan substrate bearing the leaving group at the secondary carbon, the acetate <highlight><bold>2</bold></highlight><highlight><italic>b</italic></highlight>, rather than the carbonate <highlight><bold>2</bold></highlight><highlight><italic>a</italic></highlight>, was employed. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> The corresponding tungsten catalyst employing ligand I was also found to give high e.e.&apos;s, but gave lower yields and required higher concentrations to give regioselectivities comparable to the molybdenum catalyst. When the reaction in entry 1 was conducted with the tungsten catalyst, generated by stirring a 1:1.5 mixture of (C<highlight><subscript>2</subscript></highlight>H<highlight><subscript>5</subscript></highlight>CN)<highlight><subscript>3</subscript></highlight>W(CO)<highlight><subscript>3</subscript></highlight>: ligand I in THF at 60&deg; C., a modest yield of a 19:1 ratio of <highlight><bold>4</bold></highlight>:<highlight><bold>5</bold></highlight> (Ar&equals;Ph, R&equals;H), where <highlight><bold>4</bold></highlight> had an ee of 98%, was observed. Increasing the catalyst to 15 mol % increased the yield to 55% and the <highlight><bold>4</bold></highlight>:<highlight><bold>5</bold></highlight> ratio to 49:1, with <highlight><bold>4</bold></highlight> still having 98% ee. </paragraph>
<paragraph id="P-0095" lvl="0"><number>&lsqb;0095&rsqb;</number> B. Variation of Chiral Ligand </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> Table 2 shows the results of the Mo-catalyzed alkylation reaction of methyl cinnamyl carbonate using dimethylmalonate as the alkylating agent and catalysts prepared from ligands II and III (based on diphenylethane and pyrrolidine, respectively), shown in <cross-reference target="DRAWINGS">FIGS. 2B and 3A</cross-reference>. Both ligands gave good selectivity, as shown in the Table.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="left"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 2</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="51.597" wi="129.843" file="US20020198383A1-20021226-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20020198383A1-20021226-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20020198383A1-20021226-C00001.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="34.8138" wi="101.52135" file="US20020198383A1-20021226-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20020198383A1-20021226-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20020198383A1-20021226-C00002.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="70.0812" wi="78.246" file="US20020198383A1-20021226-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20020198383A1-20021226-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20020198383A1-20021226-C00003.MOL"/>
</chemistry-cwu>
</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00004">
<number>4</number>
<image id="EMI-C00004" he="45.84195" wi="117.1422" file="US20020198383A1-20021226-C00004.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00004" file="US20020198383A1-20021226-C00004.CDX"/>
<chemistry-mol-file id="CHEMMOL-00004" file="US20020198383A1-20021226-C00004.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>Alkylation of Me cinnamyl carbonate with ligands II-III</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="21PT" align="center"/>
<colspec colname="2" colwidth="28PT" align="left"/>
<colspec colname="3" colwidth="42PT" align="left"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="center"/>
<colspec colname="6" colwidth="28PT" align="left"/>
<colspec colname="7" colwidth="21PT" align="left"/>
<colspec colname="8" colwidth="28PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>temp.</entry>
<entry>time</entry>
<entry>yield</entry>
<entry>ratio</entry>
<entry></entry>
</row>
<row>
<entry>Entry</entry>
<entry>ligand</entry>
<entry>solvent</entry>
<entry>&lsqb;&deg; C.&rsqb;</entry>
<entry>&lsqb;h&rsqb;</entry>
<entry>(a &plus; b)</entry>
<entry>(a:b)</entry>
<entry>ee &lsqb;%&rsqb;</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
<row>
<entry>1</entry>
<entry>III</entry>
<entry>THE</entry>
<entry>70</entry>
<entry>18&ensp;</entry>
<entry>40 (55)</entry>
<entry>82:18</entry>
<entry>94</entry>
</row>
<row>
<entry>2</entry>
<entry>II</entry>
<entry>THF</entry>
<entry>70</entry>
<entry>8</entry>
<entry>74 (89)</entry>
<entry>92:8</entry>
<entry>98</entry>
</row>
<row>
<entry>3</entry>
<entry>III</entry>
<entry>toluene/THF</entry>
<entry>90</entry>
<entry>8</entry>
<entry>76 (98)</entry>
<entry>89:11</entry>
<entry>94</entry>
</row>
<row>
<entry>4</entry>
<entry>II</entry>
<entry>toluene/THF</entry>
<entry>90</entry>
<entry>3</entry>
<entry>95</entry>
<entry>95:5</entry>
<entry>99</entry>
</row>
<row>
<entry>5</entry>
<entry>II</entry>
<entry>toluene/THF</entry>
<entry>90</entry>
<entry>20&ensp;</entry>
<entry>46</entry>
<entry>70:30</entry>
<entry>86</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> All reactions were performed in the presence of 0.1 eq Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3</subscript></highlight>, 0.15 eq ligand, 1.0 eq carbonate, 2.2 eq dimethylmalonate and 2.0 eq NaH (&ap;0.1 molar), with the exception of entry 5, where only 5 mol % (EtCN)<highlight><subscript>3</subscript></highlight>Mo(CO)<highlight><subscript>3 </subscript></highlight>was used. Regioselectivity was determined by <highlight><superscript>1</superscript></highlight>H NMR spectroscopy, and e.e. was determined by enantioselective HPLC. Assignment of the absolute stereochemistry of the major enantiomer as S is based upon comparison of the optical rotation with literature values. </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> The use of toluene/THF 1:1 as solvent was found to give excellent results. In the case of the pyrrolidine ligand III, the yield and regioselectivity improved and enantioselectivity was still high (entry 3). With the diphenyl ligand II, the reaction was complete after 3 hours, and the product was isolated in 95% yield with excellent regio-(95:5) and enantioselectivity (99% ee) (entry 4). In using this solvent system, the catalyst generally is prepared in toluene (60&deg; C., 1 h), and the substrate and alkylating agent added as a solution in THF (see Example 2). </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> Table 3 shows the reaction of several substrates with malonate using catalysts formed from ligands IV-VIII, shown in FIGS. <highlight><bold>2</bold></highlight>C-D and <highlight><bold>3</bold></highlight><highlight><italic>A</italic></highlight>. Thiophene and naphthalene derivatives were chosen as substrates since they were known to give less than optimum selectivity with the cyclohexyl ligand I.  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 3</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Alkylations employing chiral ligands IV-VIII</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00005">
<number>5</number>
<image id="EMI-C00005" he="56.4165" wi="75.38265" file="US20020198383A1-20021226-C00005.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00005" file="US20020198383A1-20021226-C00005.CDX"/>
<chemistry-mol-file id="CHEMMOL-00005" file="US20020198383A1-20021226-C00005.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00006">
<number>6</number>
<image id="EMI-C00006" he="35.0406" wi="127.94355" file="US20020198383A1-20021226-C00006.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00006" file="US20020198383A1-20021226-C00006.CDX"/>
<chemistry-mol-file id="CHEMMOL-00006" file="US20020198383A1-20021226-C00006.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00007">
<number>7</number>
<image id="EMI-C00007" he="47.76975" wi="73.45485" file="US20020198383A1-20021226-C00007.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00007" file="US20020198383A1-20021226-C00007.CDX"/>
<chemistry-mol-file id="CHEMMOL-00007" file="US20020198383A1-20021226-C00007.MOL"/>
</chemistry-cwu>
</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00008">
<number>8</number>
<image id="EMI-C00008" he="41.53275" wi="94.32045" file="US20020198383A1-20021226-C00008.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00008" file="US20020198383A1-20021226-C00008.CDX"/>
<chemistry-mol-file id="CHEMMOL-00008" file="US20020198383A1-20021226-C00008.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="56PT" align="left"/>
<colspec colname="2" colwidth="28PT" align="left"/>
<colspec colname="3" colwidth="28PT" align="left"/>
<colspec colname="4" colwidth="35PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="center"/>
<colspec colname="6" colwidth="35PT" align="center"/>
<colspec colname="7" colwidth="28PT" align="left"/>
<colspec colname="8" colwidth="28PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Temp,</entry>
<entry>Time,</entry>
<entry>Yield,</entry>
<entry></entry>
<entry>e.e. of</entry>
</row>
<row>
<entry>Substrate</entry>
<entry>Ligand</entry>
<entry>Solvent</entry>
<entry>&deg; C.</entry>
<entry>h</entry>
<entry>%</entry>
<entry>A/B</entry>
<entry>A, %</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="56PT" align="left"/>
<colspec colname="2" colwidth="28PT" align="left"/>
<colspec colname="3" colwidth="28PT" align="left"/>
<colspec colname="4" colwidth="35PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="char" char="."/>
<colspec colname="6" colwidth="35PT" align="center"/>
<colspec colname="7" colwidth="28PT" align="left"/>
<colspec colname="8" colwidth="28PT" align="center"/>
<tbody valign="top">
<row>
<entry>R &equals; Ph</entry>
<entry>IV</entry>
<entry>THF</entry>
<entry>65</entry>
<entry>8</entry>
<entry>74</entry>
<entry>34/1</entry>
<entry>99</entry>
</row>
<row>
<entry>(upper structure)</entry>
<entry>V</entry>
<entry>THF</entry>
<entry>65</entry>
<entry>18</entry>
<entry>63</entry>
<entry>4.6/1</entry>
<entry>87</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>(66)</entry>
</row>
<row>
<entry>R &equals; 2-thiophenyl</entry>
<entry>IV</entry>
<entry>THF</entry>
<entry>65</entry>
<entry>4.5</entry>
<entry>78</entry>
<entry>16/1</entry>
<entry>92</entry>
</row>
<row>
<entry>(lower structure)</entry>
<entry>IV</entry>
<entry>THF/</entry>
<entry>90</entry>
<entry>1.5</entry>
<entry>87</entry>
<entry>9.5/1</entry>
<entry>82</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>toluene</entry>
</row>
<row>
<entry></entry>
<entry>VI</entry>
<entry>THF</entry>
<entry>65</entry>
<entry>18</entry>
<entry>73</entry>
<entry>6.4/1</entry>
<entry>77</entry>
</row>
<row>
<entry></entry>
<entry>VII</entry>
<entry>THF</entry>
<entry>RT</entry>
<entry>47</entry>
<entry>29</entry>
<entry>4.4/1</entry>
<entry>68</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>(34)</entry>
</row>
<row>
<entry></entry>
<entry>VIII</entry>
<entry>THF</entry>
<entry>65</entry>
<entry>3</entry>
<entry>83</entry>
<entry>12.7/1</entry>
<entry>84</entry>
</row>
<row>
<entry>R &equals; 1-naphthyl</entry>
<entry>IV</entry>
<entry>THF</entry>
<entry>65</entry>
<entry>5</entry>
<entry>78</entry>
<entry>28.5/1</entry>
<entry>85</entry>
</row>
<row>
<entry>(lower structure)</entry>
<entry>VI</entry>
<entry>THF</entry>
<entry>65</entry>
<entry>9</entry>
<entry>55</entry>
<entry>12.5/1</entry>
<entry>79</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>(72)</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> Cycloheptyl ligand IV gave similar selectivity to that of the cyclohexyl ligand I, although reaction times were generally longer. Of the remaining ligands in this group, cyclohexyl ligand VIII, having methoxy-substituted pyridyl binding groups, gave the best selectivity and the shortest reaction times. </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> A molybdenum catalyst prepared as described above and having a 2-quinolinyl group in place of one of the 2-pyridyl groups of ligand I (not pictured) was found to give enantioselectivities similar to those obtained with ligand I, although reaction rates were generally slower. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> Results are shown below for ligands in which group B, as described above, is selected from a variety of other &agr;-linked CyN type binding groups, including 5-membered rings, as shown in <cross-reference target="DRAWINGS">FIG. 3B</cross-reference>. In ligand IX, the pyridine rings of ligand I are replaced by 4-pyrimidine rings. Reactions employing this ligand, in accordance with the general procedure, are shown in Table 4.  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="left"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 4</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00009">
<number>9</number>
<image id="EMI-C00009" he="56.4165" wi="75.38265" file="US20020198383A1-20021226-C00009.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00009" file="US20020198383A1-20021226-C00009.CDX"/>
<chemistry-mol-file id="CHEMMOL-00009" file="US20020198383A1-20021226-C00009.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00010">
<number>10</number>
<image id="EMI-C00010" he="34.8138" wi="115.69635" file="US20020198383A1-20021226-C00010.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00010" file="US20020198383A1-20021226-C00010.CDX"/>
<chemistry-mol-file id="CHEMMOL-00010" file="US20020198383A1-20021226-C00010.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00011">
<number>11</number>
<image id="EMI-C00011" he="47.76975" wi="73.45485" file="US20020198383A1-20021226-C00011.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00011" file="US20020198383A1-20021226-C00011.CDX"/>
<chemistry-mol-file id="CHEMMOL-00011" file="US20020198383A1-20021226-C00011.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00012">
<number>12</number>
<image id="EMI-C00012" he="41.53275" wi="90.97515" file="US20020198383A1-20021226-C00012.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00012" file="US20020198383A1-20021226-C00012.CDX"/>
<chemistry-mol-file id="CHEMMOL-00012" file="US20020198383A1-20021226-C00012.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<tbody valign="top">
<row>
<entry>Alkylation reactions employing ligand IX</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="133PT" align="center"/>
<colspec colname="2" colwidth="21PT" align="center"/>
<colspec colname="3" colwidth="21PT" align="center"/>
<colspec colname="4" colwidth="21PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>temp</entry>
<entry>yield</entry>
<entry>ratio</entry>
<entry>ee</entry>
</row>
<row>
<entry>substrate</entry>
<entry>(&deg; C.)</entry>
<entry>(%)</entry>
<entry>(b/n)</entry>
<entry>(%)</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="133PT" align="center"/>
<colspec colname="2" colwidth="21PT" align="center"/>
<colspec colname="3" colwidth="21PT" align="char" char="."/>
<colspec colname="4" colwidth="21PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00013">
<number>13</number>
<image id="EMI-C00013" he="37.45035" wi="132.98985" file="US20020198383A1-20021226-C00013.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00013" file="US20020198383A1-20021226-C00013.CDX"/>
<chemistry-mol-file id="CHEMMOL-00013" file="US20020198383A1-20021226-C00013.MOL"/>
</chemistry-cwu>
</entry>
<entry>85</entry>
<entry>81.5</entry>
<entry>92/8</entry>
<entry>99</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00014">
<number>14</number>
<image id="EMI-C00014" he="35.0406" wi="94.09365" file="US20020198383A1-20021226-C00014.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00014" file="US20020198383A1-20021226-C00014.CDX"/>
<chemistry-mol-file id="CHEMMOL-00014" file="US20020198383A1-20021226-C00014.MOL"/>
</chemistry-cwu>
</entry>
<entry>90</entry>
<entry>94</entry>
<entry>94/6</entry>
<entry>91</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00015">
<number>15</number>
<image id="EMI-C00015" he="48.4785" wi="67.9266" file="US20020198383A1-20021226-C00015.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00015" file="US20020198383A1-20021226-C00015.CDX"/>
<chemistry-mol-file id="CHEMMOL-00015" file="US20020198383A1-20021226-C00015.MOL"/>
</chemistry-cwu>
</entry>
<entry>90</entry>
<entry>88</entry>
<entry>93/7</entry>
<entry>86</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> Ligands having various 5-membered heterocyclic rings as groups B were also prepared. In ligands X-XII (<cross-reference target="DRAWINGS">FIG. 3B</cross-reference>), the 2-pyridyl groups of ligand I are replaced by 2,5-dimethyl-4-oxazole, 4-oxazole, and 2,5-dimethyl-4-thiazole, respectively. Reactions were run in THF using the standard procedure, employing 0.05 mmol Mo complex C<highlight><subscript>7</subscript></highlight>H<highlight><subscript>8</subscript></highlight>Mo(CO)<highlight><subscript>3, </subscript></highlight>0.075 mmol ligand, 1.0 mmol sodiomalonate and 0.5 mmol substrate (methyl cinnamyl carbonate). The reactions were carried out at 25-60&deg; C. for 16 hrs. Results are shown in Table 5. Yields, which were not optimized, were modest (possibly due to contamination and deactivation of the catalyst), but enantioselectivity and regioselectivity (as determined by <highlight><superscript>1</superscript></highlight>H NMR) were excellent.  
<table-cwu id="TABLE-US-00005">
<number>5</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 5</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Alkylation of methyl cinnamyl carbonate employing ligands X-XII</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="42PT" align="left"/>
<colspec colname="2" colwidth="21PT" align="center"/>
<colspec colname="3" colwidth="63PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="49PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry>temp</entry>
<entry></entry>
<entry>ratio</entry>
<entry>ee</entry>
</row>
<row>
<entry></entry>
<entry>ligand</entry>
<entry>(&deg; C.)</entry>
<entry>yield</entry>
<entry>(br/lin)</entry>
<entry>(%)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>X</entry>
<entry>25</entry>
<entry>55</entry>
<entry>33:1</entry>
<entry>99</entry>
</row>
<row>
<entry></entry>
<entry>X</entry>
<entry>40</entry>
<entry>60</entry>
<entry>34:1</entry>
<entry>99</entry>
</row>
<row>
<entry></entry>
<entry>XI</entry>
<entry>60</entry>
<entry>23(36)</entry>
<entry>21:1</entry>
<entry>99</entry>
</row>
<row>
<entry></entry>
<entry>XII</entry>
<entry>25</entry>
<entry>20(30)</entry>
<entry>100:1&ensp;</entry>
<entry>99</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> The reaction scheme below illustrates the effectiveness of a catalyst employing the ligand XIV (<cross-reference target="DRAWINGS">Fig.3C</cross-reference>), which has one 2-picolinamide and one benzamide binding group (i.e. one group B is 2-pyridyl and one is phenyl).  
<chemistry-cwu id="CHEM-US-00016">
<number>16</number>
<image id="EMI-C00016" he="209.30805" wi="216.027" file="US20020198383A1-20021226-C00016.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00016" file="US20020198383A1-20021226-C00016.CDX"/>
<chemistry-mol-file id="CHEMMOL-00016" file="US20020198383A1-20021226-C00016.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> A similar reaction employing ligand XV, which has one 2-picolinamide (B&equals;2-pyridyl) and one 3-picolinamide (B&equals;3-pyridyl) binding group, was also successful, giving a 46:1 ratio of branched to linear product in 6 hrs. The branched product had a very high e.e. of 99%.  
<chemistry-cwu id="CHEM-US-00017">
<number>17</number>
<image id="EMI-C00017" he="133.44345" wi="216.027" file="US20020198383A1-20021226-C00017.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00017" file="US20020198383A1-20021226-C00017.CDX"/>
<chemistry-mol-file id="CHEMMOL-00017" file="US20020198383A1-20021226-C00017.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> A similar reaction was conducted employing ligand XIII, also shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>C, which has two 2-picolinamide binding groups (B&equals;2-pyridyl) on a chiral scaffold having only one chiral carbon, substituted with phenyl. This reaction, shown in the scheme below, where Ar&equals;3,4-dimethoxyphenyl (2 eq substrate), gave a 90% yield of alkylation product, in an 89/11 ratio of branched to linear product (a/b), after 2 hrs at reflux. The branched product a had an e.e. of 90%.  
<chemistry-cwu id="CHEM-US-00018">
<number>18</number>
<image id="EMI-C00018" he="129.13425" wi="215.54505" file="US20020198383A1-20021226-C00018.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00018" file="US20020198383A1-20021226-C00018.CDX"/>
<chemistry-mol-file id="CHEMMOL-00018" file="US20020198383A1-20021226-C00018.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> C. Substrate </paragraph>
<paragraph id="P-0108" lvl="0"><number>&lsqb;0108&rsqb;</number> C1. Aromatic Polyenes </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> The alkylation of a variety of carbonate substrates using the diphenyl ligand II in toluene/THF 1:1 is shown in Table 6. All reactions were performed in the presence of 0.1 equiv Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3</subscript></highlight>, 0.15 equiv ligand II, 2.2 equiv dimethylmalonate and 2.0 equiv sodium hydride in toluene/THF 1:1, according to the general procedure of Example 2. </paragraph>
<paragraph id="P-0110" lvl="0"><number>&lsqb;0110&rsqb;</number> The 2-furyl derivative <highlight><bold>6</bold></highlight> was alkylated in 71% yield with excellent regio-(95:5) and enantioselectivity (98%) (entry 1). Of this group, the best regioselectivity (98:2) was obtained with the 1-naphthyl carbonate <highlight><bold>7</bold></highlight>, which was alkylated obtained in 91% yield, giving an enantiomeric excess of 87% (entry 2). </paragraph>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> The diene system <highlight><bold>8</bold></highlight> (entry 3) also gave good results, proceeding in 3 hours to give excellent (95%) yield with good regioselectivity (<highlight><bold>12</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>12</bold></highlight><highlight><italic>b </italic></highlight>86:14) and excellent enantioselectivity (98% ee). The <highlight><superscript>1</superscript></highlight>H NMR spectra of the isolated product showed no traces of the product derived from alkylation at C5. </paragraph>
<paragraph id="P-0112" lvl="0"><number>&lsqb;0112&rsqb;</number> The aromatic triene substrate <highlight><bold>9</bold></highlight> (entry 4) was also converted with high enantio-selectivity (97% ee), although the turnover was somewhat lower. As in the case of substrate <highlight><bold>8</bold></highlight>, this reaction proceeded with high regioselectivity, in the sense that no other alkylation products (i.e. derived from alkylation at C5 or C7), nor the corresponding cis isomer, were detected by <highlight><superscript>1</superscript></highlight>H NMR. Furthermore, the linear product <highlight><bold>13</bold></highlight><highlight><italic>b </italic></highlight>was formed almost exclusively as the all-trans isomer.  
<table-cwu id="TABLE-US-00006">
<number>6</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="441PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 6</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Asymmetric Mo-catalyzed alkylation with diphenyl ligand II</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00019">
<number>19</number>
<image id="EMI-C00019" he="68.63535" wi="313.01235" file="US20020198383A1-20021226-C00019.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00019" file="US20020198383A1-20021226-C00019.CDX"/>
<chemistry-mol-file id="CHEMMOL-00019" file="US20020198383A1-20021226-C00019.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="28PT" align="center"/>
<colspec colname="2" colwidth="189PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="center"/>
<colspec colname="4" colwidth="119PT" align="center"/>
<colspec colname="5" colwidth="28PT" align="left"/>
<colspec colname="6" colwidth="21PT" align="left"/>
<colspec colname="7" colwidth="28PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry>time</entry>
<entry></entry>
<entry>yield</entry>
<entry>ratio</entry>
<entry>ee</entry>
</row>
<row>
<entry>entry</entry>
<entry>substrate</entry>
<entry>&lsqb;h&rsqb;</entry>
<entry>R &equals;</entry>
<entry>(a &plus; b)</entry>
<entry>(a:b)</entry>
<entry>&lsqb;%&rsqb;</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>1</entry>
<entry>
<chemistry-cwu id="CHEM-US-00020">
<number>20</number>
<image id="EMI-C00020" he="59.05305" wi="120.4875" file="US20020198383A1-20021226-C00020.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00020" file="US20020198383A1-20021226-C00020.CDX"/>
<chemistry-mol-file id="CHEMMOL-00020" file="US20020198383A1-20021226-C00020.MOL"/>
</chemistry-cwu>
</entry>
<entry>10&ensp;</entry>
<entry>
<chemistry-cwu id="CHEM-US-00021">
<number>21</number>
<image id="EMI-C00021" he="54.00675" wi="54.00675" file="US20020198383A1-20021226-C00021.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00021" file="US20020198383A1-20021226-C00021.CDX"/>
<chemistry-mol-file id="CHEMMOL-00021" file="US20020198383A1-20021226-C00021.MOL"/>
</chemistry-cwu>
</entry>
<entry>71 (89)</entry>
<entry>95:5</entry>
<entry>98</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>2</entry>
<entry>
<chemistry-cwu id="CHEM-US-00022">
<number>22</number>
<image id="EMI-C00022" he="109.68615" wi="84.73815" file="US20020198383A1-20021226-C00022.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00022" file="US20020198383A1-20021226-C00022.CDX"/>
<chemistry-mol-file id="CHEMMOL-00022" file="US20020198383A1-20021226-C00022.MOL"/>
</chemistry-cwu>
</entry>
<entry>8</entry>
<entry>
<chemistry-cwu id="CHEM-US-00023">
<number>23</number>
<image id="EMI-C00023" he="81.1377" wi="57.12525" file="US20020198383A1-20021226-C00023.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00023" file="US20020198383A1-20021226-C00023.CDX"/>
<chemistry-mol-file id="CHEMMOL-00023" file="US20020198383A1-20021226-C00023.MOL"/>
</chemistry-cwu>
</entry>
<entry>91</entry>
<entry>98:2</entry>
<entry>87</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>3</entry>
<entry>
<chemistry-cwu id="CHEM-US-00024">
<number>24</number>
<image id="EMI-C00024" he="61.9164" wi="154.1106" file="US20020198383A1-20021226-C00024.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00024" file="US20020198383A1-20021226-C00024.CDX"/>
<chemistry-mol-file id="CHEMMOL-00024" file="US20020198383A1-20021226-C00024.MOL"/>
</chemistry-cwu>
</entry>
<entry>3</entry>
<entry>
<chemistry-cwu id="CHEM-US-00025">
<number>25</number>
<image id="EMI-C00025" he="57.12525" wi="84.73815" file="US20020198383A1-20021226-C00025.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00025" file="US20020198383A1-20021226-C00025.CDX"/>
<chemistry-mol-file id="CHEMMOL-00025" file="US20020198383A1-20021226-C00025.MOL"/>
</chemistry-cwu>
</entry>
<entry>95</entry>
<entry>86:14</entry>
<entry>98</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>4</entry>
<entry>
<chemistry-cwu id="CHEM-US-00026">
<number>26</number>
<image id="EMI-C00026" he="61.9164" wi="181.69515" file="US20020198383A1-20021226-C00026.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00026" file="US20020198383A1-20021226-C00026.CDX"/>
<chemistry-mol-file id="CHEMMOL-00026" file="US20020198383A1-20021226-C00026.MOL"/>
</chemistry-cwu>
</entry>
<entry>4</entry>
<entry>
<chemistry-cwu id="CHEM-US-00027">
<number>27</number>
<image id="EMI-C00027" he="56.4165" wi="112.3227" file="US20020198383A1-20021226-C00027.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00027" file="US20020198383A1-20021226-C00027.CDX"/>
<chemistry-mol-file id="CHEMMOL-00027" file="US20020198383A1-20021226-C00027.MOL"/>
</chemistry-cwu>
</entry>
<entry>58 (92)</entry>
<entry>84:16</entry>
<entry>97</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0113" lvl="0"><number>&lsqb;0113&rsqb;</number> C2. Non-aromatic substrates </paragraph>
<paragraph id="P-0114" lvl="0"><number>&lsqb;0114&rsqb;</number> Reactions with conjugated polyenes and enynes as substrates were very successful. Reaction of several diene substrates is shown in Table 7. </paragraph>
<paragraph id="P-0115" lvl="0"><number>&lsqb;0115&rsqb;</number> All reactions were performed in the presence of 0.1 eq.catalyst, 0.15 eq. ligand, 1.0 substrate, 2.2 eq. dimethylmalonate and 2.0 eq. NaH ( 0.1 M), with the exception of entry 7, where 20 mol % catalyst and 30 mol % ligand I were used.  
<table-cwu id="TABLE-US-00007">
<number>7</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="301PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 7</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Asymmetric Mo-catalyzed alkylation of non-aromatic diene substrates.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="301PT" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00028">
<number>28</number>
<image id="EMI-C00028" he="17.2935" wi="30.7314" file="US20020198383A1-20021226-C00028.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00028" file="US20020198383A1-20021226-C00028.CDX"/>
<chemistry-mol-file id="CHEMMOL-00028" file="US20020198383A1-20021226-C00028.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="301PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00029">
<number>29</number>
<image id="EMI-C00029" he="34.55865" wi="102.0033" file="US20020198383A1-20021226-C00029.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00029" file="US20020198383A1-20021226-C00029.CDX"/>
<chemistry-mol-file id="CHEMMOL-00029" file="US20020198383A1-20021226-C00029.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00030">
<number>30</number>
<image id="EMI-C00030" he="47.5146" wi="73.1997" file="US20020198383A1-20021226-C00030.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00030" file="US20020198383A1-20021226-C00030.CDX"/>
<chemistry-mol-file id="CHEMMOL-00030" file="US20020198383A1-20021226-C00030.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="301PT" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00031">
<number>31</number>
<image id="EMI-C00031" he="41.53275" wi="90.97515" file="US20020198383A1-20021226-C00031.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00031" file="US20020198383A1-20021226-C00031.CDX"/>
<chemistry-mol-file id="CHEMMOL-00031" file="US20020198383A1-20021226-C00031.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="21PT" align="left"/>
<colspec colname="2" colwidth="126PT" align="center"/>
<colspec colname="3" colwidth="21PT" align="center"/>
<colspec colname="4" colwidth="63PT" align="center"/>
<colspec colname="5" colwidth="28PT" align="left"/>
<colspec colname="6" colwidth="21PT" align="left"/>
<colspec colname="7" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry>time</entry>
<entry></entry>
<entry>yield</entry>
<entry>ratio</entry>
<entry>ee</entry>
</row>
<row>
<entry>entry</entry>
<entry>substrate</entry>
<entry>&lsqb;h&rsqb;</entry>
<entry>R &equals;</entry>
<entry>(a &plus; b)</entry>
<entry>(a:b)</entry>
<entry>&lsqb;%&rsqb;</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>1</entry>
<entry>
<chemistry-cwu id="CHEM-US-00032">
<number>32</number>
<image id="EMI-C00032" he="61.9164" wi="123.606" file="US20020198383A1-20021226-C00032.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00032" file="US20020198383A1-20021226-C00032.CDX"/>
<chemistry-mol-file id="CHEMMOL-00032" file="US20020198383A1-20021226-C00032.MOL"/>
</chemistry-cwu>
</entry>
<entry>3</entry>
<entry>
<chemistry-cwu id="CHEM-US-00033">
<number>33</number>
<image id="EMI-C00033" he="57.12525" wi="57.12525" file="US20020198383A1-20021226-C00033.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00033" file="US20020198383A1-20021226-C00033.CDX"/>
<chemistry-mol-file id="CHEMMOL-00033" file="US20020198383A1-20021226-C00033.MOL"/>
</chemistry-cwu>
</entry>
<entry>91</entry>
<entry>92:8</entry>
<entry>94</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>2 3</entry>
<entry>
<chemistry-cwu id="CHEM-US-00034">
<number>34</number>
<image id="EMI-C00034" he="61.9164" wi="109.68615" file="US20020198383A1-20021226-C00034.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00034" file="US20020198383A1-20021226-C00034.CDX"/>
<chemistry-mol-file id="CHEMMOL-00034" file="US20020198383A1-20021226-C00034.MOL"/>
</chemistry-cwu>
</entry>
<entry>3 6</entry>
<entry>
<chemistry-cwu id="CHEM-US-00035">
<number>35</number>
<image id="EMI-C00035" he="57.12525" wi="42.9786" file="US20020198383A1-20021226-C00035.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00035" file="US20020198383A1-20021226-C00035.CDX"/>
<chemistry-mol-file id="CHEMMOL-00035" file="US20020198383A1-20021226-C00035.MOL"/>
</chemistry-cwu>
</entry>
<entry>89 (94) 87 (95)</entry>
<entry>98:2 94:6</entry>
<entry>98 97</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>4</entry>
<entry>
<chemistry-cwu id="CHEM-US-00036">
<number>36</number>
<image id="EMI-C00036" he="54.00675" wi="109.68615" file="US20020198383A1-20021226-C00036.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00036" file="US20020198383A1-20021226-C00036.CDX"/>
<chemistry-mol-file id="CHEMMOL-00036" file="US20020198383A1-20021226-C00036.MOL"/>
</chemistry-cwu>
</entry>
<entry>3</entry>
<entry>
<chemistry-cwu id="CHEM-US-00037">
<number>37</number>
<image id="EMI-C00037" he="49.2156" wi="42.9786" file="US20020198383A1-20021226-C00037.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00037" file="US20020198383A1-20021226-C00037.CDX"/>
<chemistry-mol-file id="CHEMMOL-00037" file="US20020198383A1-20021226-C00037.MOL"/>
</chemistry-cwu>
</entry>
<entry>81 (89)</entry>
<entry>89:11</entry>
<entry>&ap;80&ensp;</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>5</entry>
<entry>
<chemistry-cwu id="CHEM-US-00038">
<number>38</number>
<image id="EMI-C00038" he="82.81035" wi="78.9831" file="US20020198383A1-20021226-C00038.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00038" file="US20020198383A1-20021226-C00038.CDX"/>
<chemistry-mol-file id="CHEMMOL-00038" file="US20020198383A1-20021226-C00038.MOL"/>
</chemistry-cwu>
</entry>
<entry>2</entry>
<entry>
<chemistry-cwu id="CHEM-US-00039">
<number>39</number>
<image id="EMI-C00039" he="54.00675" wi="54.00675" file="US20020198383A1-20021226-C00039.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00039" file="US20020198383A1-20021226-C00039.CDX"/>
<chemistry-mol-file id="CHEMMOL-00039" file="US20020198383A1-20021226-C00039.MOL"/>
</chemistry-cwu>
</entry>
<entry>94</entry>
<entry>92:8</entry>
<entry>87</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>6</entry>
<entry>
<chemistry-cwu id="CHEM-US-00040">
<number>40</number>
<image id="EMI-C00040" he="60.98085" wi="109.68615" file="US20020198383A1-20021226-C00040.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00040" file="US20020198383A1-20021226-C00040.CDX"/>
<chemistry-mol-file id="CHEMMOL-00040" file="US20020198383A1-20021226-C00040.MOL"/>
</chemistry-cwu>
</entry>
<entry>2</entry>
<entry>
<chemistry-cwu id="CHEM-US-00041">
<number>41</number>
<image id="EMI-C00041" he="57.834" wi="42.9786" file="US20020198383A1-20021226-C00041.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00041" file="US20020198383A1-20021226-C00041.CDX"/>
<chemistry-mol-file id="CHEMMOL-00041" file="US20020198383A1-20021226-C00041.MOL"/>
</chemistry-cwu>
</entry>
<entry>96</entry>
<entry>94:6</entry>
<entry>86</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>7<highlight><superscript>f)</superscript></highlight></entry>
<entry>
<chemistry-cwu id="CHEM-US-00042">
<number>42</number>
<image id="EMI-C00042" he="61.9164" wi="123.606" file="US20020198383A1-20021226-C00042.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00042" file="US20020198383A1-20021226-C00042.CDX"/>
<chemistry-mol-file id="CHEMMOL-00042" file="US20020198383A1-20021226-C00042.MOL"/>
</chemistry-cwu>
</entry>
<entry>1.5</entry>
<entry>
<chemistry-cwu id="CHEM-US-00043">
<number>43</number>
<image id="EMI-C00043" he="57.12525" wi="57.12525" file="US20020198383A1-20021226-C00043.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00043" file="US20020198383A1-20021226-C00043.CDX"/>
<chemistry-mol-file id="CHEMMOL-00043" file="US20020198383A1-20021226-C00043.MOL"/>
</chemistry-cwu>
</entry>
<entry>93</entry>
<entry>93:7</entry>
<entry>96</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0116" lvl="0"><number>&lsqb;0116&rsqb;</number> Excellent results were obtained with the diene substrates <highlight><bold>14</bold></highlight> and <highlight><bold>15</bold></highlight>, using either the cyclohexyl ligand I (entries 1-2) or the diphenyl ligand IV (entry 3). Substrates <highlight><bold>16</bold></highlight>-<highlight><bold>18</bold></highlight> (entries 4-6) were also alkylated in high yields and with good regioselectivities (&gt;9:1), although the enantiomeric excesses were somewhat lower. Alkylation of the heterocyclic non-aromatic dihydropyran carbonate <highlight><bold>19</bold></highlight> was also successful (entry 7), although a larger amount of catalyst (20 mol %) was required for the reaction to proceed at an acceptable rate. </paragraph>
<paragraph id="P-0117" lvl="0"><number>&lsqb;0117&rsqb;</number> Substrate <highlight><bold>18</bold></highlight> was alkylated using the present method within 2 h in 96% yield, with very good regioselectivity (94:6) and with an enantiomeric excess of 86%. In comparison, using the Pd catalyzed method of Pr&eacute;tot et al. (1998), the allylic regioisomer of the same carbonate <highlight><bold>18</bold></highlight> was alkylated in 75% yield, with much lower regio- and enantioselectivity (75:25 and 51% ee, respectively). </paragraph>
<paragraph id="P-0118" lvl="0"><number>&lsqb;0118&rsqb;</number> Triene systems such as carbonates <highlight><bold>26</bold></highlight> or <highlight><bold>27</bold></highlight> were alkylated in good yields and excellent regio- and enantioselectivities (Table 8). In each case, only 10 mol % catalyst was required, and only one branched isomer (<highlight><bold>28</bold></highlight><highlight><italic>a </italic></highlight>and <highlight><bold>29</bold></highlight><highlight><italic>a</italic></highlight>) was obtained. As in the case of the aromatic triene substrate <highlight><bold>13</bold></highlight>, alkylation at C5 or C7 was not observed by <highlight><superscript>1</superscript></highlight>H NMR spectroscopy.  
<table-cwu id="TABLE-US-00008">
<number>8</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="357PT" align="left"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 8</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00044">
<number>44</number>
<image id="EMI-C00044" he="17.2935" wi="30.7314" file="US20020198383A1-20021226-C00044.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00044" file="US20020198383A1-20021226-C00044.CDX"/>
<chemistry-mol-file id="CHEMMOL-00044" file="US20020198383A1-20021226-C00044.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="357PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00045">
<number>45</number>
<image id="EMI-C00045" he="34.8138" wi="100.10385" file="US20020198383A1-20021226-C00045.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00045" file="US20020198383A1-20021226-C00045.CDX"/>
<chemistry-mol-file id="CHEMMOL-00045" file="US20020198383A1-20021226-C00045.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00046">
<number>46</number>
<image id="EMI-C00046" he="47.5146" wi="65.9988" file="US20020198383A1-20021226-C00046.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00046" file="US20020198383A1-20021226-C00046.CDX"/>
<chemistry-mol-file id="CHEMMOL-00046" file="US20020198383A1-20021226-C00046.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="357PT" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00047">
<number>47</number>
<image id="EMI-C00047" he="41.2776" wi="90.97515" file="US20020198383A1-20021226-C00047.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00047" file="US20020198383A1-20021226-C00047.CDX"/>
<chemistry-mol-file id="CHEMMOL-00047" file="US20020198383A1-20021226-C00047.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="357PT" align="center"/>
<tbody valign="top">
<row>
<entry>Asymmetric Mo-catalyzed alkylation of non-aromatic triene substrates.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="21PT" align="center"/>
<colspec colname="2" colwidth="154PT" align="center"/>
<colspec colname="3" colwidth="21PT" align="center"/>
<colspec colname="4" colwidth="91PT" align="center"/>
<colspec colname="5" colwidth="28PT" align="center"/>
<colspec colname="6" colwidth="21PT" align="center"/>
<colspec colname="7" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry>time</entry>
<entry></entry>
<entry>yield</entry>
<entry>ratio</entry>
<entry>ee</entry>
</row>
<row>
<entry>entry</entry>
<entry>substrate</entry>
<entry>&lsqb;h&rsqb;</entry>
<entry>R &equals;</entry>
<entry>(a &plus; b)</entry>
<entry>(a:b)</entry>
<entry>&lsqb;%&rsqb;</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>1</entry>
<entry>
<chemistry-cwu id="CHEM-US-00048">
<number>48</number>
<image id="EMI-C00048" he="61.9164" wi="151.2189" file="US20020198383A1-20021226-C00048.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00048" file="US20020198383A1-20021226-C00048.CDX"/>
<chemistry-mol-file id="CHEMMOL-00048" file="US20020198383A1-20021226-C00048.MOL"/>
</chemistry-cwu>
</entry>
<entry>2</entry>
<entry>
<chemistry-cwu id="CHEM-US-00049">
<number>49</number>
<image id="EMI-C00049" he="57.12525" wi="84.73815" file="US20020198383A1-20021226-C00049.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00049" file="US20020198383A1-20021226-C00049.CDX"/>
<chemistry-mol-file id="CHEMMOL-00049" file="US20020198383A1-20021226-C00049.MOL"/>
</chemistry-cwu>
</entry>
<entry>70 (79)</entry>
<entry>92:8</entry>
<entry>97</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>2</entry>
<entry>
<chemistry-cwu id="CHEM-US-00050">
<number>50</number>
<image id="EMI-C00050" he="39.60495" wi="151.2189" file="US20020198383A1-20021226-C00050.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00050" file="US20020198383A1-20021226-C00050.CDX"/>
<chemistry-mol-file id="CHEMMOL-00050" file="US20020198383A1-20021226-C00050.MOL"/>
</chemistry-cwu>
</entry>
<entry>3</entry>
<entry>
<chemistry-cwu id="CHEM-US-00051">
<number>51</number>
<image id="EMI-C00051" he="38.8962" wi="84.483" file="US20020198383A1-20021226-C00051.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00051" file="US20020198383A1-20021226-C00051.CDX"/>
<chemistry-mol-file id="CHEMMOL-00051" file="US20020198383A1-20021226-C00051.MOL"/>
</chemistry-cwu>
</entry>
<entry>81 (85)</entry>
<entry>91:9</entry>
<entry>98</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0119" lvl="0"><number>&lsqb;0119&rsqb;</number> The aromatic alkyne substrate <highlight><bold>30</bold></highlight>, below, was alkylated with 10 mol % catalyst in high yield and with good regio-(84:16) and excellent enantioselectivity (99% ee). In contrast to these results, Pd-catalyzed reactions of such substrates were in many cases poorly stereoselective and produced cis/trans mixtures. For example, Pd(0)-catalyzed alkylation of carbonate <highlight><bold>30</bold></highlight> with malonate (5 mol % Pd<highlight><subscript>2</subscript></highlight>(dba)<highlight><subscript>3 </subscript></highlight>CHCl<highlight><subscript>3</subscript></highlight>, 25 mol % PPh<highlight><subscript>3</subscript></highlight>, THF, rt, 2h) afforded a mixture of <highlight><bold>31</bold></highlight><highlight><italic>b </italic></highlight>and <highlight><bold>31</bold></highlight><highlight><italic>c </italic></highlight>in a ratio of 58:42.  
<chemistry-cwu id="CHEM-US-00052">
<number>52</number>
<image id="EMI-C00052" he="214.8363" wi="216.027" file="US20020198383A1-20021226-C00052.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00052" file="US20020198383A1-20021226-C00052.CDX"/>
<chemistry-mol-file id="CHEMMOL-00052" file="US20020198383A1-20021226-C00052.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0120" lvl="0"><number>&lsqb;0120&rsqb;</number> With the non-aromatic alkyne <highlight><bold>32</bold></highlight>, the turnover was somewhat lower (Table 9, entry 1) Increasing the amount of catalyst to 20 mol%, however, gave a much better yield 1) with good regio-(88:12) and excellent enantioselectivity (99% ee). With a phosphate leaving group, the alkylation product was obtained in good yield (82%) and enantioselectivity (96% ee) with less catalyst (10 mol %), although the regioselectivity much lower (entry 4). </paragraph>
<paragraph id="P-0121" lvl="0"><number>&lsqb;0121&rsqb;</number> For entry 3, 10 mol % DMSO was added to the preformed catalyst (60&deg; C., 1 h) re the substrate and malonate were added.  
<table-cwu id="TABLE-US-00009">
<number>9</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="left"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 9</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00053">
<number>53</number>
<image id="EMI-C00053" he="68.40855" wi="183.84975" file="US20020198383A1-20021226-C00053.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00053" file="US20020198383A1-20021226-C00053.CDX"/>
<chemistry-mol-file id="CHEMMOL-00053" file="US20020198383A1-20021226-C00053.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00054">
<number>54</number>
<image id="EMI-C00054" he="85.92885" wi="109.68615" file="US20020198383A1-20021226-C00054.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00054" file="US20020198383A1-20021226-C00054.CDX"/>
<chemistry-mol-file id="CHEMMOL-00054" file="US20020198383A1-20021226-C00054.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00055">
<number>55</number>
<image id="EMI-C00055" he="61.20765" wi="144.72675" file="US20020198383A1-20021226-C00055.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00055" file="US20020198383A1-20021226-C00055.CDX"/>
<chemistry-mol-file id="CHEMMOL-00055" file="US20020198383A1-20021226-C00055.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<tbody valign="top">
<row>
<entry>Alkylation of non-aromatic alkyne substrates.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="28PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="center"/>
<colspec colname="6" colwidth="56PT" align="left"/>
<colspec colname="7" colwidth="35PT" align="left"/>
<colspec colname="8" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry>catalyst</entry>
<entry></entry>
<entry>time</entry>
<entry>yield, %</entry>
<entry>ratio</entry>
<entry>ee</entry>
</row>
<row>
<entry>entry</entry>
<entry>substrate</entry>
<entry>&lsqb;mol %&rsqb;</entry>
<entry>additive</entry>
<entry>&lsqb;h&rsqb;</entry>
<entry>(34a &plus; 34b)</entry>
<entry>(34a:34b)</entry>
<entry>&lsqb;%&rsqb;</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="28PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="char" char="."/>
<colspec colname="6" colwidth="56PT" align="left"/>
<colspec colname="7" colwidth="35PT" align="left"/>
<colspec colname="8" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry>1</entry>
<entry>32</entry>
<entry>10</entry>
<entry>&mdash;</entry>
<entry>3.5</entry>
<entry>36</entry>
<entry>79:21<highlight><superscript>e)</superscript></highlight></entry>
<entry>97</entry>
</row>
<row>
<entry>2</entry>
<entry>32</entry>
<entry>20</entry>
<entry>&mdash;</entry>
<entry>4</entry>
<entry>81 (97)</entry>
<entry>88:12</entry>
<entry>99</entry>
</row>
<row>
<entry>3</entry>
<entry>32</entry>
<entry>10</entry>
<entry>DMSO</entry>
<entry>3.5</entry>
<entry>37% conversion</entry>
<entry>77:23<highlight><superscript>g)</superscript></highlight></entry>
<entry>ND</entry>
</row>
<row>
<entry>4</entry>
<entry>33</entry>
<entry>10</entry>
<entry>&mdash;</entry>
<entry>2</entry>
<entry>82 (95)</entry>
<entry>66:34</entry>
<entry>96</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0122" lvl="0"><number>&lsqb;0122&rsqb;</number> It was also observed that formation of the minor linear product in the present reactions was stereoselective. The linear product was always obtained with very high trans selectivity, generally only traces of the cis isomer were detected. This stereoselectivity was observed not only for linear carbonates but for the branched substrates as well. </paragraph>
<paragraph id="P-0123" lvl="0"><number>&lsqb;0123&rsqb;</number> As described below under the discussion of leaving groups (Section D), the present reaction can also be successfully carried out on substituents having simple alkyl substitution at the allyl terminus (e.g. crotyl chloride). </paragraph>
<paragraph id="P-0124" lvl="0"><number>&lsqb;0124&rsqb;</number> C3. Halogenated Substrates </paragraph>
<paragraph id="P-0125" lvl="0"><number>&lsqb;0125&rsqb;</number> The bromo-substituted aryl carbonate <highlight><bold>35</bold></highlight> was converted in 83% yield with good regio-(95:5) and enantioselectivitiy (90% ee) (Table 10). All reactions were performed in the presence of 0.1 eq Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3</subscript></highlight>, 0.15 eq ligand, 1.0 eq substrate, 2.2 eq dimethylmalonate and 2.0 eq NaH.  
<table-cwu id="TABLE-US-00010">
<number>10</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="left"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 10</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00056">
<number>56</number>
<image id="EMI-C00056" he="85.92885" wi="89.3025" file="US20020198383A1-20021226-C00056.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00056" file="US20020198383A1-20021226-C00056.CDX"/>
<chemistry-mol-file id="CHEMMOL-00056" file="US20020198383A1-20021226-C00056.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00057">
<number>57</number>
<image id="EMI-C00057" he="34.55865" wi="101.0394" file="US20020198383A1-20021226-C00057.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00057" file="US20020198383A1-20021226-C00057.CDX"/>
<chemistry-mol-file id="CHEMMOL-00057" file="US20020198383A1-20021226-C00057.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00058">
<number>58</number>
<image id="EMI-C00058" he="69.1173" wi="81.84645" file="US20020198383A1-20021226-C00058.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00058" file="US20020198383A1-20021226-C00058.CDX"/>
<chemistry-mol-file id="CHEMMOL-00058" file="US20020198383A1-20021226-C00058.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00059">
<number>59</number>
<image id="EMI-C00059" he="61.20765" wi="117.1422" file="US20020198383A1-20021226-C00059.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00059" file="US20020198383A1-20021226-C00059.CDX"/>
<chemistry-mol-file id="CHEMMOL-00059" file="US20020198383A1-20021226-C00059.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<tbody valign="top">
<row>
<entry>Asymmetric Mo-catalyzed alkylation of the carbonate 35.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="28PT" align="center"/>
<colspec colname="2" colwidth="28PT" align="left"/>
<colspec colname="3" colwidth="42PT" align="left"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="28PT" align="center"/>
<colspec colname="6" colwidth="42PT" align="left"/>
<colspec colname="7" colwidth="42PT" align="center"/>
<colspec colname="8" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>temp.</entry>
<entry>time</entry>
<entry>yield</entry>
<entry>Ratio</entry>
<entry>ee</entry>
</row>
<row>
<entry>entry</entry>
<entry>ligand</entry>
<entry>solvent</entry>
<entry>&lsqb;&deg; C.&rsqb;</entry>
<entry>&lsqb;h&rsqb;</entry>
<entry>(36a &plus; 36b)</entry>
<entry>(36a:36b)</entry>
<entry>&lsqb;%&rsqb;</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
<row>
<entry>1</entry>
<entry>(&plusmn;)-I</entry>
<entry>THF</entry>
<entry>70</entry>
<entry>4</entry>
<entry>63 (94)</entry>
<entry>94:6</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>2</entry>
<entry>(S,S)-I</entry>
<entry>toluene/THF</entry>
<entry>90</entry>
<entry>3</entry>
<entry>96</entry>
<entry>96:4</entry>
<entry>91</entry>
</row>
<row>
<entry>3</entry>
<entry>III</entry>
<entry>toluene/THF</entry>
<entry>90</entry>
<entry>14&ensp;</entry>
<entry>85</entry>
<entry>91:9</entry>
<entry>88</entry>
</row>
<row>
<entry>4</entry>
<entry>II</entry>
<entry>toluene/THF</entry>
<entry>90</entry>
<entry>5</entry>
<entry>83 (95)</entry>
<entry>95:5</entry>
<entry>90</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0126" lvl="0"><number>&lsqb;0126&rsqb;</number> As can be seen from Table 10, similar enantioselectivities were achieved with all ligands employed, although the regioselectivity was somewhat lower in the case of the pyrrolidine ligand III (entry 2-4). Use of toluene/THF as solvent gave higher turnover and better regioselectivity for ligand I (entries 1-2). </paragraph>
<paragraph id="P-0127" lvl="0"><number>&lsqb;0127&rsqb;</number> The use of dialkyl phosphate leaving groups, described further below, allows the reaction to be extended to simple aliphatic substrates, e.g. crotyl diisopropyl phosphate. This reaction (carried out substantially as described above) gave reasonable regioselectivity (about 5:1 branched/linear) and good enantioselectivity (about 93%). </paragraph>
<paragraph id="P-0128" lvl="0"><number>&lsqb;0128&rsqb;</number> It should be appreciated that, although the structures of the present examples illustrate the utility and selectivity of the reaction, the allylic substrate may also form part of a more complex molecule, as in the synthesis of pharmaceutically useful chiral compounds. </paragraph>
<paragraph id="P-0129" lvl="0"><number>&lsqb;0129&rsqb;</number> D. Leaving Group </paragraph>
<paragraph id="P-0130" lvl="0"><number>&lsqb;0130&rsqb;</number> Preferred leaving groups are those which are displacable by a nucleophilic species under the conditions of the reaction, but which do not tend to dissociate without the participation of the nucleophile. These include, for example, the above described leaving groups (lower alkyl esters or carbonates) or chloride. Table 11 shows the effect on the reaction of variation of the leaving group. All reactions were performed in the presence of 0.1 eq. Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3</subscript></highlight>, 0.15 eq. ligand, 1.0 eq. substrate, 2.2 eq. dimethylmalonate and 2.0 eq. NaH.  
<table-cwu id="TABLE-US-00011">
<number>11</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 11</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00060">
<number>60</number>
<image id="EMI-C00060" he="78.50115" wi="121.2246" file="US20020198383A1-20021226-C00060.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00060" file="US20020198383A1-20021226-C00060.CDX"/>
<chemistry-mol-file id="CHEMMOL-00060" file="US20020198383A1-20021226-C00060.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00061">
<number>61</number>
<image id="EMI-C00061" he="34.55865" wi="101.29455" file="US20020198383A1-20021226-C00061.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00061" file="US20020198383A1-20021226-C00061.CDX"/>
<chemistry-mol-file id="CHEMMOL-00061" file="US20020198383A1-20021226-C00061.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00062">
<number>62</number>
<image id="EMI-C00062" he="69.1173" wi="81.84645" file="US20020198383A1-20021226-C00062.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00062" file="US20020198383A1-20021226-C00062.CDX"/>
<chemistry-mol-file id="CHEMMOL-00062" file="US20020198383A1-20021226-C00062.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00063">
<number>63</number>
<image id="EMI-C00063" he="45.1332" wi="117.1422" file="US20020198383A1-20021226-C00063.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00063" file="US20020198383A1-20021226-C00063.CDX"/>
<chemistry-mol-file id="CHEMMOL-00063" file="US20020198383A1-20021226-C00063.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<tbody valign="top">
<row>
<entry>Variation of the leaving group</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="28PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="42PT" align="left"/>
<colspec colname="4" colwidth="21PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="center"/>
<colspec colname="6" colwidth="28PT" align="left"/>
<colspec colname="7" colwidth="21PT" align="center"/>
<colspec colname="8" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>temp.</entry>
<entry>time</entry>
<entry>yield</entry>
<entry>ratio</entry>
<entry>ee</entry>
</row>
<row>
<entry>entry</entry>
<entry>substrate</entry>
<entry>solvent</entry>
<entry>&lsqb;&deg; C.&rsqb;</entry>
<entry>&lsqb;h&rsqb;</entry>
<entry>(a &plus; b)</entry>
<entry>(a:b)</entry>
<entry>&lsqb;%&rsqb;</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
<row>
<entry>1</entry>
<entry>37</entry>
<entry>THF</entry>
<entry>70</entry>
<entry>3</entry>
<entry>88</entry>
<entry>97:3</entry>
<entry>99</entry>
</row>
<row>
<entry>2</entry>
<entry>37</entry>
<entry>THF/toluene</entry>
<entry>90</entry>
<entry>2</entry>
<entry>96</entry>
<entry>96:4</entry>
<entry>99</entry>
</row>
<row>
<entry>3</entry>
<entry>38</entry>
<entry>THF/toluene</entry>
<entry>90</entry>
<entry>12&ensp;</entry>
<entry>75 (91)</entry>
<entry>93:7</entry>
<entry>99</entry>
</row>
<row>
<entry>4</entry>
<entry>39</entry>
<entry>THF/toluene</entry>
<entry>90</entry>
<entry>4</entry>
<entry>94</entry>
<entry>93:7</entry>
<entry>99</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0131" lvl="0"><number>&lsqb;0131&rsqb;</number> It has been shown that carbamate and trifluoroacetate are generally useful leaving groups for Mo-catalyzed alkylation reactions (Dvorak et al., 1995). As can be seen from Table 11, these groups, particulary trifluoroacetate, are also useful in the present reaction. </paragraph>
<paragraph id="P-0132" lvl="0"><number>&lsqb;0132&rsqb;</number> Variation of the leaving group was also investigated with the much less reactive crotyl substrate, using catalyst prepared from 10 mol % Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>and 15 mol % ligand I (with the exception of entry 6, which used 20 and 30 mol %, respectively). The results are shown in Table 12.  
<table-cwu id="TABLE-US-00012">
<number>12</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="left"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 12</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00064">
<number>64</number>
<image id="EMI-C00064" he="12.95595" wi="65.0349" file="US20020198383A1-20021226-C00064.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00064" file="US20020198383A1-20021226-C00064.CDX"/>
<chemistry-mol-file id="CHEMMOL-00064" file="US20020198383A1-20021226-C00064.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00065">
<number>65</number>
<image id="EMI-C00065" he="34.55865" wi="106.34085" file="US20020198383A1-20021226-C00065.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00065" file="US20020198383A1-20021226-C00065.CDX"/>
<chemistry-mol-file id="CHEMMOL-00065" file="US20020198383A1-20021226-C00065.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00066">
<number>66</number>
<image id="EMI-C00066" he="45.84195" wi="72.49095" file="US20020198383A1-20021226-C00066.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00066" file="US20020198383A1-20021226-C00066.CDX"/>
<chemistry-mol-file id="CHEMMOL-00066" file="US20020198383A1-20021226-C00066.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00067">
<number>67</number>
<image id="EMI-C00067" he="55.19745" wi="175.45815" file="US20020198383A1-20021226-C00067.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00067" file="US20020198383A1-20021226-C00067.CDX"/>
<chemistry-mol-file id="CHEMMOL-00067" file="US20020198383A1-20021226-C00067.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<tbody valign="top">
<row>
<entry>Alkyl Substrate/Phosphate Leaving Groups</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="28PT" align="center"/>
<colspec colname="2" colwidth="56PT" align="left"/>
<colspec colname="3" colwidth="28PT" align="left"/>
<colspec colname="4" colwidth="35PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="center"/>
<colspec colname="6" colwidth="28PT" align="center"/>
<colspec colname="7" colwidth="35PT" align="left"/>
<colspec colname="8" colwidth="28PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Substrate</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Yield,</entry>
<entry></entry>
<entry>e.e. of</entry>
</row>
<row>
<entry>Entry</entry>
<entry>X &equals;</entry>
<entry>Solvent</entry>
<entry>Temp</entry>
<entry>Time</entry>
<entry>%</entry>
<entry>A/B/C</entry>
<entry>A, %</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
<row>
<entry>1</entry>
<entry>Cl</entry>
<entry>THF</entry>
<entry>60&deg; C.</entry>
<entry>2 h</entry>
<entry>76</entry>
<entry>2.1/1</entry>
<entry>82</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>(A/B &plus; C)</entry>
</row>
<row>
<entry>2</entry>
<entry>Cl</entry>
<entry>THF</entry>
<entry>RT</entry>
<entry>2 h</entry>
<entry>65</entry>
<entry>1.9/1</entry>
<entry>75</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>(A/B &plus; C)</entry>
</row>
<row>
<entry>3</entry>
<entry>Cl</entry>
<entry>THF/</entry>
<entry>60&deg; C.</entry>
<entry>5 h</entry>
<entry>79</entry>
<entry>2.6/1</entry>
<entry>79</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>toluene</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>(A/B &plus; C)</entry>
</row>
<row>
<entry>4</entry>
<entry>O(P&boxH;O)Ph<highlight><subscript>2</subscript></highlight></entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>4 h</entry>
<entry>70</entry>
<entry>2.5/1/0.13</entry>
<entry>85</entry>
</row>
<row>
<entry>5</entry>
<entry>O(P&boxH;O)(OEt)<highlight><subscript>2</subscript></highlight></entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>1 h</entry>
<entry>82</entry>
<entry>4.4/1/0.17</entry>
<entry>89</entry>
</row>
<row>
<entry>6</entry>
<entry>O(P&boxH;O)(OEt)<highlight><subscript>2</subscript></highlight></entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>1 h</entry>
<entry>71</entry>
<entry>5.1/1/0.26</entry>
<entry>89</entry>
</row>
<row>
<entry>7</entry>
<entry>O(P&boxH;O)(OPh)<highlight><subscript>2</subscript></highlight></entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>1 h</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>8</entry>
<entry>O(P&boxH;O)(OiPr)<highlight><subscript>2</subscript></highlight></entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>1 h</entry>
<entry>72</entry>
<entry>5.7/1/0.19</entry>
<entry>93</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0133" lvl="0"><number>&lsqb;0133&rsqb;</number> product C is generated by the competing uncatalyzed displacement reaction. Changing the leaving group from chloride to diphenyl phosphinate gave similar results, and the diphenyl phosphate substrate gave no reaction. Reaction of the diethyl phosphate, however, gave alkylated product with higher regioselectivity as well as good enantioselectivity. Use of a large amount of catalyst (20 mol %), or a bulkier leaving group, diisopropyl phosphate (last entry), reduced competition from the uncatalyzed S<highlight><subscript>N</subscript></highlight><highlight><bold>2</bold></highlight> reaction and gave still better results. </paragraph>
<paragraph id="P-0134" lvl="0"><number>&lsqb;0134&rsqb;</number> These results represent the most successful demonstration to date, in terms of regioselectivity and enantioselectivy, of allylic alkylation of an aliphatic allyl group. It should be noted that the reduction in regioselectivity in these reactions is believed to be primarily (if not exclusively) due to the competing uncatalalyzed reaction, which is nonselective. The catalyzed reaction is still highly stereoselective, as shown by the high e.e. of the addition products A. Reaction of substrates having bulkier substituents, and/or having the leaving group at the secondary position of the allyl group (i.e. the 1 terminus), is expected to give improved results. </paragraph>
<paragraph id="P-0135" lvl="0"><number>&lsqb;0135&rsqb;</number> E. Nucleophile (Alkylating Agent) </paragraph>
<paragraph id="P-0136" lvl="0"><number>&lsqb;0136&rsqb;</number> An ongoing challenge in molybdenum catalyzed allylic alkylations has been the limited range of effective nucleophiles. Historically, only malonates have given consistent results. In the present reaction, however, other nucleophiles have proven effective. Preferred nucleophiles may be represented as EE&prime;RC<highlight><superscript>&minus;</superscript></highlight> M<highlight><superscript>&plus;</superscript></highlight>, where M<highlight><superscript>&plus;</superscript></highlight> is a positively charged counterion, and each of E and E&prime; is a substituent which stabilizes the carbanion, e.g. an electron-withdrawing substituent selected from keto, carboxylic ester, cyano, and sulfonyl, or an aromatic or heteroaromatic group capable of stabilizing an &agr;-carbanion. Preferably, at least one of E and E&prime; is a carboxylic ester. Particularly preferred are malonates, including substituted malonates, as described below, acyclic &bgr;-ketoesters, and &bgr;-cyano esters. Nucleophiles in which E is a carboxylic ester and E&prime; is an aromatic group, such as phenyl or pyridyl, have also proven effective. In general, a wider range of nucleophiles will be effective when the substrate has an active leaving group, such as a dialkyl phosphate. Table 13 shows the results of alkylations using &bgr;-keto ester, methyl acetoacetate.  
<table-cwu id="TABLE-US-00013">
<number>13</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="441PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 13</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Alkylations with methyl acetoacetate (acac)</entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00068">
<number>68</number>
<image id="EMI-C00068" he="68.8905" wi="424.37115" file="US20020198383A1-20021226-C00068.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00068" file="US20020198383A1-20021226-C00068.CDX"/>
<chemistry-mol-file id="CHEMMOL-00068" file="US20020198383A1-20021226-C00068.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="10">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="49PT" align="left"/>
<colspec colname="3" colwidth="56PT" align="left"/>
<colspec colname="4" colwidth="56PT" align="left"/>
<colspec colname="5" colwidth="35PT" align="left"/>
<colspec colname="6" colwidth="35PT" align="left"/>
<colspec colname="7" colwidth="42PT" align="left"/>
<colspec colname="8" colwidth="35PT" align="left"/>
<colspec colname="9" colwidth="49PT" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Substrate; X &equals;</entry>
<entry>Mo mol %</entry>
<entry>Ligand mol %</entry>
<entry>Solvent</entry>
<entry>Temp</entry>
<entry>Time</entry>
<entry>Yield, %</entry>
<entry>A/B</entry>
<entry>ee of C, %</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="9" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>(a); OCO<highlight><subscript>2</subscript></highlight>Me</entry>
<entry>20</entry>
<entry>30</entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>18 h</entry>
<entry>25</entry>
<entry>&gt;40/1</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>(b); OCO<highlight><subscript>2</subscript></highlight>Me</entry>
<entry>10</entry>
<entry>15</entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>22 h</entry>
<entry>47 (61)</entry>
<entry>&gt;50/1</entry>
<entry>84</entry>
</row>
<row>
<entry></entry>
<entry>(b); OCO<highlight><subscript>2</subscript></highlight>Me</entry>
<entry>20</entry>
<entry>30</entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>&ensp;8 h</entry>
<entry>66 (72)</entry>
<entry>&ensp;53/1</entry>
<entry>92</entry>
</row>
<row>
<entry></entry>
<entry>(b); OCO<highlight><subscript>2</subscript></highlight>Me</entry>
<entry>10</entry>
<entry>15</entry>
<entry>THF/toluene</entry>
<entry>90&deg; C.</entry>
<entry>18 h</entry>
<entry>54 (68)</entry>
<entry>&ensp;15/1</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>(a); O(P&boxH;O)(OEt)<highlight><subscript>2</subscript></highlight></entry>
<entry>10</entry>
<entry>15</entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>20 h</entry>
<entry>72</entry>
<entry>&ensp;9.7/1</entry>
<entry>97</entry>
</row>
<row>
<entry></entry>
<entry>(a); O(P&boxH;O)(OEt)<highlight><subscript>2</subscript></highlight></entry>
<entry>20</entry>
<entry>30</entry>
<entry>THF</entry>
<entry>65&deg; C.</entry>
<entry>&ensp;4 h</entry>
<entry>85</entry>
<entry>&ensp;46/1</entry>
<entry>98</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="9" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0137" lvl="0"><number>&lsqb;0137&rsqb;</number> Substrates having a phosphate leaving group (e.g. cinnamyl phosphate) showed greater reactivity with this nucleophile, but also showed increased product from the uncatalyzed reaction. When increased catalyst (20 mol %) was used, the amount of competing product decreased, and regioselectivity was improved. </paragraph>
<paragraph id="P-0138" lvl="0"><number>&lsqb;0138&rsqb;</number> The &bgr;-ketoester methyl p-methoxy-benzoylacetate (below) reacted with cinnamyl phosphate to give a 1:1 diastereomeric mixture of allylic alkylation product in good regioselectivity. Enantioselectivity was determined, after decarboxylation of the compound, to be &gt;99%.  
<chemistry-cwu id="CHEM-US-00069">
<number>69</number>
<image id="EMI-C00069" he="309.8655" wi="216.027" file="US20020198383A1-20021226-C00069.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00069" file="US20020198383A1-20021226-C00069.CDX"/>
<chemistry-mol-file id="CHEMMOL-00069" file="US20020198383A1-20021226-C00069.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0139" lvl="0"><number>&lsqb;0139&rsqb;</number> Substituted malonates can also be used in the present reaction. For example, reaction of carbonate <highlight><bold>40</bold></highlight> with dimethyl sodio methylmalonate gave, after hydrolysis and decarboxylation, acid <highlight><bold>42</bold></highlight> (most probably as a diastereoisomeric mixture at position 2), the methyl ester of which is methyl mantolinate, a monoterpene constituent of <highlight><italic>Artemesia tridentada tridentada</italic></highlight>.  
<chemistry-cwu id="CHEM-US-00070">
<number>70</number>
<image id="EMI-C00070" he="252.2583" wi="215.54505" file="US20020198383A1-20021226-C00070.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00070" file="US20020198383A1-20021226-C00070.CDX"/>
<chemistry-mol-file id="CHEMMOL-00070" file="US20020198383A1-20021226-C00070.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0140" lvl="0"><number>&lsqb;0140&rsqb;</number> Good results were also obtained using malonates substituted at the nucleophilic carbon with protected alcohol or amine moieties (methoxymethyl ether and NH-Boc, respectively), and with &bgr;-cyano esters (e.g. t-butyl cyano acetate). Increasing the amount of catalyst to 20 mol % metal/30 mol % ligand was sometimes required. The reactions gave good regioselectivity and excellent enantioselectivity (generally &gt;98%). </paragraph>
<paragraph id="P-0141" lvl="7"><number>&lsqb;0141&rsqb;</number> IV. Intramolecular Diels-Alder reactions </paragraph>
<paragraph id="P-0142" lvl="0"><number>&lsqb;0142&rsqb;</number> The usefulness of the present stereo- and regioselective alkylation reaction was further demonstrated by subsequent Diels-Alder reaction, shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>, of the alkylation product of reaction 14, Table 1, predominantly <highlight><bold>4</bold></highlight><highlight><italic>c </italic></highlight>(R&equals;allyl). Heating the product at 80&deg; C. in 5:2 water:ethanol gave the diastereomeric Diels-Alder adducts <highlight><bold>43</bold></highlight> and <highlight><bold>44</bold></highlight> (<cross-reference target="DRAWINGS">FIG. 5</cross-reference>) in a 3:1 ratio, each of which had an e.e. of 98%. as determined by chiral HPLC. </paragraph>
<paragraph id="P-0143" lvl="0"><number>&lsqb;0143&rsqb;</number> In another example, Mo-catalyzed reaction of methyl cinnamyl carbonate with dimethyl (2E,4E)-hexadienyl malonate afforded the branched product <highlight><bold>45</bold></highlight> in 60% yield with very good enantioselectivity (&gt;94% ee) (see below). Heating the alkylation product <highlight><bold>45</bold></highlight> at 150&deg; C. in toluene (sealed tube) for 48 hours gave a 73% yield of a product tentatively identified as the Diels-Alder adducts <highlight><bold>46</bold></highlight>, as a mixture of three isomers in a 49:44:7 ratio, as determined by integration of the <highlight><superscript>1</superscript></highlight>H NMR methoxycarbonyl signals. (Apparently one of the four theoretically possible Diels-Alder adducts was not formed.)  
<chemistry-cwu id="CHEM-US-00071">
<number>71</number>
<image id="EMI-C00071" he="307.96605" wi="215.8002" file="US20020198383A1-20021226-C00071.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00071" file="US20020198383A1-20021226-C00071.CDX"/>
<chemistry-mol-file id="CHEMMOL-00071" file="US20020198383A1-20021226-C00071.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0144" lvl="0"><number>&lsqb;0144&rsqb;</number> As a further example, when substrate <highlight><bold>26</bold></highlight>, below, was reacted with dimethyl allylmalonate, a 5:1 mixture of two compounds was obtained (below). The branched isomer <highlight><bold>47</bold></highlight> was isolated in pure form in 71% yield. Heating <highlight><bold>47</bold></highlight> at 150&deg; C. in toluene (sealed tube) for 15 hours afforded a product tentatively identified as the Diels-Alder adducts <highlight><bold>48</bold></highlight>, as a mixture of four isomers in a 3:3:1:1 ratio, as determined by integration of the <highlight><superscript>1</superscript></highlight>H NMR methoxycarbonyl signals.  
<chemistry-cwu id="CHEM-US-00072">
<number>72</number>
<image id="EMI-C00072" he="282.28095" wi="215.8002" file="US20020198383A1-20021226-C00072.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00072" file="US20020198383A1-20021226-C00072.CDX"/>
<chemistry-mol-file id="CHEMMOL-00072" file="US20020198383A1-20021226-C00072.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0145" lvl="7"><number>&lsqb;0145&rsqb;</number> V. Advantages </paragraph>
<paragraph id="P-0146" lvl="0"><number>&lsqb;0146&rsqb;</number> The present reaction displays high selectivity over a wide temperature range, suggesting a fairly rigid chiral active site. The regioselectivity observed for attack at the more substituted terminus is generally significantly higher than with earlier achiral molybdenum catalysts. For example, as noted previously, previous molybdenum-catalyzed alkylations with dimethyl methylmalonate and cinnamyl substrates (Trost &amp; Lautens, 1982, 1987, Trost &amp; Merlic, 1990) normally led to attack at the less substituted allyl terminus. With the chiral ligands described herein, on the other hand, good selectivity for attack at the more substituted terminus is seen for a wide range of substrates. </paragraph>
<paragraph id="P-0147" lvl="0"><number>&lsqb;0147&rsqb;</number> The rate of reaction is also significantly improved compared to earlier molybdenum catalysts, where reaction typically required heating at reflux for 24 h or more (Trost &amp; Lautens, 1982, 1987, Trost &amp; Merlic, 1990, Merlic, 1988). Chiral ligands employed in Merlic (1988) also gave low e.e.&apos;s in the product. In contrast, the reactions reported herein typically proceed in 2-3 h at reflux and less than 24 h at room temperature, and give high enantioselectivity. </paragraph>
<paragraph id="P-0148" lvl="0"><number>&lsqb;0148&rsqb;</number> The reaction also shows great versatility in terms of substrate, as shown above, giving good results with polyenes, halogenated substrates, various aryl substrates, and unprecedented success with non-aromatic substrates. The selectivity and versatility of the reaction make the method ideal for the synthesis of pharmaceutical compounds, or compounds employed as intermediates in the synthesis of pharmaceutical compounds. The method is also applicable to preparing other biologically active compounds where chirality is important to activity. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLES </heading>
<paragraph id="P-0149" lvl="0"><number>&lsqb;0149&rsqb;</number> The following examples are intended to illustrate but not in any way limit the invention. </paragraph>
<paragraph id="P-0150" lvl="7"><number>&lsqb;0150&rsqb;</number> Materials and Methods All reactions were carried out in flame-dried flasks or test tubes under a positive pressure of nitrogen. Solvents were generally distilled prior to use and transferred via syringe to the reaction vessel. <highlight><superscript>1</superscript></highlight>H NMR and <highlight><superscript>13</superscript></highlight>C NMR spectra were recorded on Varian Gemini-200 or 300. Optical Rotations were determined using a JASCO DIP-1000 polarimeter and were measured in 50 mm cells at 25&plusmn;2&deg; C. Infrared (IR) spectra &lsqb;cm<highlight><superscript>&minus;1</superscript></highlight>&rsqb; were obtained using a Perkin-Elmer FT-IR spectrometer. Melting points (mp) were determined in open capillary tubes using a Thomas-Hoover apparatus and are uncorrected. Thin-layer chromatography (TLC) was performed on precoated glass plates (Merck). Flash chromatography was performed by the method of Still (Still, et al., 1978) using silica gel 60, 230-400 mesh. The enantiomeric excess was determined by analytical, enantioselective HPLC using the following columns with chiral stationary phases:Daicel Chiralcel&reg; OD, Daicel Chiralpak&reg; AD, and Daicel Chiralcel&reg; OJ. Unless otherwise indicated, reported e.e. refers to major isomer. Solvent systems, flow rates (in mLmin<highlight><superscript>&minus;1</superscript></highlight>) and retention times (in min) are as indicated; UV-detection (220 nm). High-resolution Mass spectra were provided by the Mass Spectronomy Facility of the School of Pharmacy (University of California, San Francisco), and combustion analyses were performed by M-H-W Laboratories, Phoenix, Ariz. </paragraph>
<paragraph id="P-0151" lvl="0"><number>&lsqb;0151&rsqb;</number> Substrates were synthesized according to published procedures or using standard synthetic methods well known in the art. Reactions frequently employed were addition of vinylmagnesium bromide to aldehydes (e.g. Hammen et al., 1991), the Wadsworth-Horner-Emmons reaction of aldehydes with triethylphosphonoacetate, and DIBAL-H reduction of unsaturated ethyl esters. The method of Hung, 1984, was used for the preparation of allylic carbonates. </paragraph>
<paragraph id="P-0152" lvl="0"><number>&lsqb;0152&rsqb;</number> All alkylation reactions were performed in degassed (with nitrogen or argon) solvents. Ratios of regioisomers (determined by <highlight><superscript>1</superscript></highlight>H NMR) and enantiomeric excess were determined from the isolated products. Absolute stereochemistry was assigned only in the cases where direct comparison of the optical rotation with literature values was possible. The <highlight><superscript>1</superscript></highlight>H NMR data of the minor isomer were normally assigned with the assistance of a <highlight><superscript>1</superscript></highlight>H NMR spectrum independently obtained by a palladium(0)-catalyzed reaction. In the palladium reactions the linear trans-isomer was always the major product, although with many substrates significant amounts of its cis-isomer and/or of the branched product were also formed. </paragraph>
</section>
<section>
<heading lvl="1">Example 1 </heading>
</section>
<section>
<heading lvl="1">General prodedure A; THF as solvent (see Trost and Hachiya, 1998). </heading>
<paragraph id="P-0153" lvl="0"><number>&lsqb;0153&rsqb;</number> A solution of Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>and ligand in THF was heated at 60-70&deg; C. for 1 h. A solution of sodiomalonate (prepared by adding the malonate to sodium hydride (60% dispersion in oil; purchased from Aldrich)) and the substrate in THF was added dropwise via syringe at 60&deg; C. and the mixture was heated at 70&deg; C. for the time indicated. The reaction mixture was diluted with ether (5 mL) and water (5 mL) was added. The layers were separated and the aqueous layer was extracted with ether (3&times;10 mL). The combined organic layers were washed with brine (10 mL), dried over magnesium sulfate and the solvent removed in vacuo. Flash chromatography (with the solvent system indicated) afforded the pure product as a mixture of the two regioisomers. </paragraph>
</section>
<section>
<heading lvl="1">Example 2 </heading>
</section>
<section>
<heading lvl="1">General procedure B; Toluene/THF 1:1 as solvent </heading>
<paragraph id="P-0154" lvl="0"><number>&lsqb;0154&rsqb;</number> A solution of Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>and ligand in toluene was heated at 60-70&deg; C. for 1 h. A solution of sodiomalonate (prepared by adding the malonate to sodium hydride (60% dispersion in oil)) and the substrate in THF was added dropwise via syringe at 60&deg; C. and the mixture was heated at 80-90&deg; C. for the time indicated. The reaction mixture was diluted with ether (5 mL) and water (5 mL) was added. The layers were separated and the aqueous layer was extracted with ether (3&times;10 mL). The combined organic layers were washed with brine (10 mL), dried over magnesium sulfate and the solvent removed in vacuo. Flash chromatography (with the solvent system indicated) afforded the product as a mixture of the two regioisomers. </paragraph>
</section>
<section>
<heading lvl="1">Examples 3A-3D </heading>
</section>
<section>
<heading lvl="1">Preparation of (S)-Methyl 2-Methoxycarbonyl-3-phenyl-4-pentenoate and Methyl (E)-2-methoxycarbonyl-5-phenyl-4-pentenoate </heading>
<paragraph id="P-0155" lvl="0"><number>&lsqb;0155&rsqb;</number> (Lloyd-Jones and Pfalz, 1995; Trost and Hachiya, 1998; Hung, 1984).  
<chemistry-cwu id="CHEM-US-00073">
<number>73</number>
<image id="EMI-C00073" he="131.06205" wi="216.027" file="US20020198383A1-20021226-C00073.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00073" file="US20020198383A1-20021226-C00073.CDX"/>
<chemistry-mol-file id="CHEMMOL-00073" file="US20020198383A1-20021226-C00073.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0156" lvl="0"><number>&lsqb;0156&rsqb;</number> A. Mo-catalyzed alkylation with pyrrolidine ligand III: </paragraph>
<paragraph id="P-0157" lvl="0"><number>&lsqb;0157&rsqb;</number> According to procedure A with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(13.0 mg, 0.038 mmol) and ligand III (21.9 mg, 0.056 mmol) in 1.5 mL THF and carbonate (72.4 mg, 0.34 mmol), dimethyl malonate (109.4 mg, 0.83 mmol) and sodium hydride (30.0 mg, 0.75 mmol) in 1.5 mL THF. The reaction mixture was heated at 70&deg; C. for 18 h. Work-up and flash chromatography (petroleum ether/ether 6:1) afforded 20 mg recovered starting material and 37 mg (40%; 55% brsm) of a colorless oil consisting of a mixture of regioisomers; a/b 82:18. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;27.1 (c 1.43, CHCl<highlight><subscript>3</subscript></highlight>). 94% ee. </paragraph>
<paragraph id="P-0158" lvl="0"><number>&lsqb;0158&rsqb;</number> B. According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(9.0 mg, 0.026 mmol) and ligand III (15.7 mg, 0.039 mmol) in 1.3 mL toluene and carbonate (50.1 mg, 0.26 mmol), dimethyl malonate (75.8 mg, 0.57 mmol) and sodium hydride (20.9 mg, 0.52 mmol) in 1.3 mL THF. The reaction mixture was heated at 90&deg; C. for 8 h. Work-up and flash chromatography (petroleum ether/ether 6:1) afforded 15 mg recovered starting material and 49.0 mg (76%; 98% brsm) of a colorless oil consisting of a mixture of regioisomers; a/b 89:11. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;25.0 (c 1.53, CHCl<highlight><subscript>3</subscript></highlight>). 94% ee. </paragraph>
<paragraph id="P-0159" lvl="0"><number>&lsqb;0159&rsqb;</number> C. Mo-catalyzed alkylation with diphenyl ligand II: </paragraph>
<paragraph id="P-0160" lvl="0"><number>&lsqb;0160&rsqb;</number> According to procedure A with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(8.3 mg, 0.024 mmol) and ligand II (15.2 mg, 0.036 mmol) in 1.5 mL THF and carbonate (46.0 mg, 0.24 mmol), dimethyl malonate (69.0 mg, 0.53 mmol) and sodium hydride (19.0 mg, 0.22 mmol) in 1 mL THF. The reaction mixture was heated at 70&deg; C. for 8 h. Work-up and flash chromatography (petroleum ether/ethyl acetate 20:1) afforded 8.0 mg recovered starting material and 43.9 mg (74%; 89% brsm) of a colorless oil consisting of a mixture of regioisomers; a/b 92:8. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;32.9 (c 2.00, CHCl<highlight><subscript>3</subscript></highlight>). 98% ee. </paragraph>
<paragraph id="P-0161" lvl="0"><number>&lsqb;0161&rsqb;</number> D. According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(7.8 mg, 0.023 mmol) and ligand II (14.3 mg, 0.034 mmol) in 1.5 mL toluene and carbonate (43.8 mg, 0.23 mmol), dimethyl malonate (66.4 mg, 0.50 mmol) and sodium hydride (18.3 mg, 0.46 mmol) in 1 mL THF. The reaction mixture was heated at 90&deg; C. for 3 h. Work-up and flash chromatography (petroleum ether/ethyl acetate 20:1) afforded 53.8 mg (95%) of a colorless oil consisting of a mixture of regioisomers; a/b 95:5. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;34.5 (c 1.92, CHCl<highlight><subscript>3</subscript></highlight>). 99% ee. </paragraph>
</section>
<section>
<heading lvl="1">Example 4 </heading>
</section>
<section>
<heading lvl="1">Preparation of Dimethyl 2-(1-phenyl-allyl)-malonate using ligand IV </heading>
<paragraph id="P-0162" lvl="0"><number>&lsqb;0162&rsqb;</number> Cycloheptyl ligand IV (10.2 mg, 0.030 mmol) and Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(6.9 mg, 0.020 mmol) were dissolved in 1.0 ml of THF at rt. The reaction mixture was heated at 60&deg; C. for 1 h. After cooling to rt, 1.0 ml of THF solution of sodium dimethylmalonate enolate, prepared from dimethyl malonate (58.0 mg, 0.44 mmol) and sodium hydride (10.2 mg, 0.40 mmol) in tetrahydrofuran, and methyl 3-phenyl-2-propenyl carbonate were added successively. The reaction mixture was heated at 65&deg; C. for 8 h. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, and the solvent was removed under reduced pressure. The ratio of 1,1-dimethoxycarbonyl-2-phenyl-3-butene and linear compound was determined by <highlight><superscript>1</superscript></highlight>H NMR (400 MHz) to be 34.2/1. The residue was chromatographed on silica (&frac18;ethyl acetate/petroleum ether, Rf&equals;0.3) to yield the mixture of branched and linear compound (36.7 mg, 74%). &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&minus;29.7&deg; (c 1.27, CHCl<highlight><subscript>3</subscript></highlight>); 99% ee. </paragraph>
</section>
<section>
<heading lvl="1">Examples 5A-B </heading>
</section>
<section>
<heading lvl="1">Preparation of dimethyl 2-(1-thiophene-2-yl-allyl)-malonate using ligands IV and VIII </heading>
<paragraph id="P-0163" lvl="0"><number>&lsqb;0163&rsqb;</number> Cycloheptyl ligand IV(10.2 mg, 0.030 mmol) and Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(6.9 mg, 0.020 mmol) were dissolved in 1.0 ml of THF at rt. The reaction mixture was heated at 60&deg; C. for 1 h. After cooling to rt., 1.0 ml of THF solution of sodium dimethylmalonate enolate, prepared from dimethyl malonate (58.0 mg, 0.44 mmol) and sodium hydride (10.2 mg, 0.40 mmol) in tetrahydrofuran, and methyl 1-(2-thienyl)-2-propenyl carbonate were added successively. The reaction mixture was heated at 65&deg; C. for 4.5 h. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, and the solvent was removed under reduced pressure. The ratio of dimethyl 2-(1-thiophene-2-yl-allyl)-malonate and linear compound was determined by <highlight><superscript>1</superscript></highlight>H NMR (400 MHz) to be 16.0/1. The residue was chromatographed on silica ({fraction (1/7)}ethyl acetate/petroleum ether, Rf&equals;0.3) to yield the mixture of branched and linear compound. (40.3 mg, 78%) &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&minus;31.1&deg; (c 1.35, CHCl<highlight><subscript>3</subscript></highlight>); 92% e.e. for major isomer. </paragraph>
<paragraph id="P-0164" lvl="0"><number>&lsqb;0164&rsqb;</number> When the reaction was repeated using ligand VIII, the regioisomer ratio of the product, obtained in 83% yield, was determined to be 12.7/1. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&plus;30.2&deg;; 84% e.e. for major isomer. </paragraph>
</section>
<section>
<heading lvl="1">Example 6 </heading>
</section>
<section>
<heading lvl="1">Preparation of Methyl (4E)-2-Methoxycarbonyl-5-phenyl-3-vinyl-4-pentenoate <highlight><bold>12</bold></highlight><highlight><italic>a </italic></highlight>and Methyl (4E,6E)-2-Methoxycarbonyl-7-phenyl-4,6-heptadienoate <highlight><bold>12</bold></highlight><highlight><italic>b </italic></highlight></heading>
<paragraph id="P-0165" lvl="0"><number>&lsqb;0165&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00074">
<number>74</number>
<image id="EMI-C00074" he="192.75165" wi="216.027" file="US20020198383A1-20021226-C00074.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00074" file="US20020198383A1-20021226-C00074.CDX"/>
<chemistry-mol-file id="CHEMMOL-00074" file="US20020198383A1-20021226-C00074.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0166" lvl="0"><number>&lsqb;0166&rsqb;</number> According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(6.4 mg, 0.0188 mmol) and ligand IV (11.7 mg, 0.0282 mmol) in 1 mL toluene and carbonate <highlight><bold>8</bold></highlight> (40.5 mg, 0.185 mmol), dimethyl malonate (53.9 mg, 0.41 mmol) and sodium hydride (14.8 mg, 0.37 mmol) in 1 mL THF. The reaction mixture was heated at 90&deg; C. for 3 h. Work-up and flash chromatography (petroleum ether/ether 10:1) afforded 48.5 mg (95%) of <highlight><bold>12</bold></highlight> as a colorless oil consisting of a mixture of regioisomers; <highlight><bold>12</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>12</bold></highlight><highlight><italic>b </italic></highlight>86:14. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;15.7 (c 2.51, CHCl<highlight><subscript>3</subscript></highlight>). 98% ee, major isomer. </paragraph>
</section>
<section>
<heading lvl="1">Examples 7A-7B </heading>
</section>
<section>
<heading lvl="1">Preparation of Methyl (4E,6E)-2-Methoxycarbonyl-7-phenyl-3-vinyl-4,6-heptadienoate <highlight><bold>13</bold></highlight><highlight><italic>a </italic></highlight>and Methyl (4E,6E,8E)-2-Methoxycarbonyl-9-phenyl-4,6,8-nonatrienoate <highlight><bold>13</bold></highlight><highlight><italic>b </italic></highlight></heading>
<paragraph id="P-0167" lvl="0"><number>&lsqb;0167&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00075">
<number>75</number>
<image id="EMI-C00075" he="146.9097" wi="216.027" file="US20020198383A1-20021226-C00075.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00075" file="US20020198383A1-20021226-C00075.CDX"/>
<chemistry-mol-file id="CHEMMOL-00075" file="US20020198383A1-20021226-C00075.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0168" lvl="0"><number>&lsqb;0168&rsqb;</number> A. According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(3.1 mg, 0.009 mmol) and ligand II (5.7 mg, 0.014 mmol) in 0.7 mL toluene and carbonate <highlight><bold>9</bold></highlight> (21.9 mg, 0.090 mmol), dimethyl malonate (26.1 mg, 0.198 mmol) and sodium hydride (7.2 mg, 0.180 mmol) in 0.7 mL THF. The reaction mixture was heated at 90&deg; C. for 4 h. Work-up and flash chromatography (petroleum ether/ether 6:1) afforded 8.1 mg of starting material and 15.6 mg (58%; 92% brsm) of <highlight><bold>13</bold></highlight> as a colorless oil consisting of a mixture of regio-isomers; <highlight><bold>13</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>13</bold></highlight><highlight><italic>b </italic></highlight>84:16. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;42.1 (c 0.51, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). 97% ee. </paragraph>
<paragraph id="P-0169" lvl="0"><number>&lsqb;0169&rsqb;</number> B. According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(5.4 mg, 0.016 mmol) and ligand (R,R)-I (7.6 mg, 0.024 mmol) in 1 mL toluene and carbonate <highlight><bold>9</bold></highlight> (25.5 mg, 0.104 mmol), dimethyl malonate (30.2 mg, 0.23 mmol) and sodium hydride (8.4 mg, 0.21 mmol) in 1 mL THF. The reaction mixture was heated at 85&deg; C. for 3.5 h. Work-up and flash chromatography (petroleum ether/ether 6:1) afforded 11.8 mg of starting material and 21.4 mg (68%; 94% brsm) of <highlight><bold>13</bold></highlight> as a colorless oil consisting of a mixture of regio-isomers; <highlight><bold>13</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>13</bold></highlight><highlight><italic>b </italic></highlight>86:14. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&minus;44.9 (c 0.40, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). &gt;99% ee. </paragraph>
</section>
<section>
<heading lvl="1">Example 8 </heading>
</section>
<section>
<heading lvl="1">Preparation of Methyl (4E)-2-Methoxycarbonyl-4-methyl-3-vinyl-4-hexenoate <highlight><bold>21</bold></highlight><highlight><italic>a </italic></highlight>and Methyl (4E, 6E)-2-Methoxycarbonyl-6-methyl-4,6-octadienoate <highlight><bold>21</bold></highlight><highlight><italic>b </italic></highlight></heading>
<paragraph id="P-0170" lvl="0"><number>&lsqb;0170&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00076">
<number>76</number>
<image id="EMI-C00076" he="176.42205" wi="216.027" file="US20020198383A1-20021226-C00076.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00076" file="US20020198383A1-20021226-C00076.CDX"/>
<chemistry-mol-file id="CHEMMOL-00076" file="US20020198383A1-20021226-C00076.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0171" lvl="0"><number>&lsqb;0171&rsqb;</number> According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(7.5 mg, 0.022 mmol) and ligand (R,R)-I (10.7 mg, 0.035 mmol) in 1 mL toluene and carbonate <highlight><bold>15</bold></highlight> (37.0 mg, 0.217 mmol), dimethyl malonate (63.2 mg, 0.48 mmol) and sodium hydride (17.4 mg, 0.44 mmol) in 1 mL THF. The reaction mixture was heated at 90&deg; C. for 3 h. Work-up and flash chromatography (petroleum ether/ether 8:1) afforded 43.8 mg (89%; 94% brsm) of <highlight><bold>21</bold></highlight> as a colorless oil consisting of a mixture of regioisomers; <highlight><bold>21</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>21</bold></highlight><highlight><italic>b </italic></highlight>98:2. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&plus;10.3 (c 0.06, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). 98% ee. </paragraph>
</section>
<section>
<heading lvl="1">Example 9 </heading>
</section>
<section>
<heading lvl="1">Preparation of Methyl 3-(1-Cyclopenten-1-yl)-2-methoxycarbonyl-4-pentenoate <highlight><bold>23</bold></highlight><highlight><italic>a </italic></highlight>and Methyl (E)-5-(1-Cyclopenten-1-yl)-2-methoxycarbonyl-4-pentenoate <highlight><bold>23</bold></highlight><highlight><italic>b </italic></highlight></heading>
<paragraph id="P-0172" lvl="0"><number>&lsqb;0172&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00077">
<number>77</number>
<image id="EMI-C00077" he="162.729" wi="216.027" file="US20020198383A1-20021226-C00077.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00077" file="US20020198383A1-20021226-C00077.CDX"/>
<chemistry-mol-file id="CHEMMOL-00077" file="US20020198383A1-20021226-C00077.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0173" lvl="0"><number>&lsqb;0173&rsqb;</number> According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(10.5 mg, 0.030 mmol) and ligand (R,R)-I (14.8 mg, 0.046 mmol) in 1.5 mL toluene and carbonate <highlight><bold>17</bold></highlight> (58.4 mg, 0.32 mmol), dimethyl malonate (88.4 mg, 0.67 mmol) and sodium hydride (24.3 mg, 0.61 mmol) in 1.5 mL THF. The reaction mixture was heated at 90&deg; C. for 2 h. Work-up and flash chromatography (petroleum ether/ether 10:1) afforded 72.0 mg (94%) of <highlight><bold>23</bold></highlight> as a colorless oil consisting of a mixture of regioisomers; <highlight><bold>23</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>23</bold></highlight><highlight><italic>b </italic></highlight>92:8. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;52.1 (c 3.15, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>).87% ee. </paragraph>
</section>
<section>
<heading lvl="1">Example 10 </heading>
</section>
<section>
<heading lvl="1">Preparation of Methyl 3-(2-Dihydropyranyl)-2-methoxycarbonyl-4-pentenoate <highlight><bold>25</bold></highlight><highlight><italic>a </italic></highlight>and Methyl (5E)-6-(2-Dihydropyranyl)-2-methoxycarbonyl-5-hexenoate <highlight><bold>25</bold></highlight><highlight><italic>b </italic></highlight></heading>
<paragraph id="P-0174" lvl="0"><number>&lsqb;0174&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00078">
<number>78</number>
<image id="EMI-C00078" he="258.52365" wi="216.027" file="US20020198383A1-20021226-C00078.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00078" file="US20020198383A1-20021226-C00078.CDX"/>
<chemistry-mol-file id="CHEMMOL-00078" file="US20020198383A1-20021226-C00078.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0175" lvl="0"><number>&lsqb;0175&rsqb;</number> According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(12.5 mg, 0.036 mmol) and ligand (R,R)-I (17.6 mg, 0.054 mmol) in 1.8 mL toluene and carbonate <highlight><bold>19</bold></highlight> (35.9 mg, 0.18 mmol), dimethyl malonate (52.6 mg, 0.40 mmol) and sodium hydride (14.5 mg, 0.36 mmol) in 1.0 mL THF. The reaction mixture was heated at 90&prop;C. for 1.5 h. Work-up and flash chromatography (petroleum ether/ether 6:1) afforded 42.8 mg (93%) of <highlight><bold>25</bold></highlight> as a colorless oil consisting of a mixture of regioisomers; <highlight><bold>25</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>25</bold></highlight><highlight><italic>b </italic></highlight>93:7. &lsqb;&agr;&rsqb;<highlight><subscript>D </subscript></highlight>&equals;&minus;11.9 (c 2.00, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). 96% ee. </paragraph>
</section>
<section>
<heading lvl="1">Example 11 </heading>
</section>
<section>
<heading lvl="1">Methyl (4E,6E)-2-Methoxycarbonyl-3-vinyl-4,6-octadienoate <highlight><bold>29</bold></highlight><highlight><italic>a </italic></highlight>and Methyl (4E,6E,8E)-2-Methoxycarbonyl-4,6,8-decatrienoate <highlight><bold>29</bold></highlight><highlight><italic>b </italic></highlight></heading>
<paragraph id="P-0176" lvl="0"><number>&lsqb;0176&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00079">
<number>79</number>
<image id="EMI-C00079" he="186.2595" wi="216.027" file="US20020198383A1-20021226-C00079.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00079" file="US20020198383A1-20021226-C00079.CDX"/>
<chemistry-mol-file id="CHEMMOL-00079" file="US20020198383A1-20021226-C00079.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0177" lvl="0"><number>&lsqb;0177&rsqb;</number> According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(9.8 mg, 0.028 mmol) and ligand (R,R)-I (13.8 mg, 0.043 mmol) in 1.5 mL toluene and carbonate <highlight><bold>27</bold></highlight> (51.7 mg, 0.28 mmol), dimethyl malonate (82.5 mg, 0.63 mmol) and sodium hydride (22.7 mg, 0.57 mmol) in 1.5 mL THF. The reaction mixture was heated at 85&deg; C. for 3 h. Workup and flash chromatography (petroleum ether/ether 8:1) afforded besides 2.5 mg starting material 54.5 mg (81%; 85% brsm) of <highlight><bold>29</bold></highlight> as a colorless oil consisting of a mixture of regioisomers; <highlight><bold>29</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>29</bold></highlight><highlight><italic>b </italic></highlight>91:9. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;15.0 (c 2.00, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). 98% ee. </paragraph>
<paragraph id="P-0178" lvl="0"><number>&lsqb;0178&rsqb;</number> Examples 12A-B </paragraph>
<paragraph id="P-0179" lvl="0"><number>&lsqb;0179&rsqb;</number> Preparation of Methyl 2-Methoxycarbonyl-5-phenyl-3-vinyl-4-pentynoate <highlight><bold>31</bold></highlight><highlight><italic>a </italic></highlight>and Methyl (4E)-2-Methoxycarbonyl-7-phenyl-hept-4-en-6-ynoate <highlight><bold>31</bold></highlight><highlight><italic>b </italic></highlight> 
<chemistry-cwu id="CHEM-US-00080">
<number>80</number>
<image id="EMI-C00080" he="217.9548" wi="216.027" file="US20020198383A1-20021226-C00080.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00080" file="US20020198383A1-20021226-C00080.CDX"/>
<chemistry-mol-file id="CHEMMOL-00080" file="US20020198383A1-20021226-C00080.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0180" lvl="0"><number>&lsqb;0180&rsqb;</number> A. According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(6.2 mg, 0.018 mmol) and ligand (R,R)-I (8.7 mg, 0.027 mmol) in 1 mL toluene and carbonate <highlight><bold>30</bold></highlight> (36.4 mg, 0.17 mmol), dimethyl malonate (52.2 mg, 0.40 mmol) and sodium hydride (14.4 mg, 0.36 mmol) in 1.0 mL THF. The reaction mixture was heated at 85&deg; C. for 2.5 h. Work-up and flash chromatography (petroleum ether/ether 8:1) afforded besides 5 mg starting material 37.6 mg (82%; 95 brsm) of <highlight><bold>31</bold></highlight> as a colorless oil consisting of a mixture of regioisomers; <highlight><bold>31</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>31</bold></highlight><highlight><italic>b </italic></highlight>84:16. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;86.6 (c 1.40, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). 99% ee. </paragraph>
<paragraph id="P-0181" lvl="0"><number>&lsqb;0181&rsqb;</number> B. Pd-catalyzed reaction:To solution of Pd<highlight><subscript>2</subscript></highlight>(dba)<highlight><subscript>3</subscript></highlight>&middot;CHCl<highlight><subscript>3 </subscript></highlight>(9.5 mg, 0.0092 mmol) and triphenylphosphine (12.1 mg, 0.046 mmol) in 2 mL THF was added a solution of <highlight><bold>30</bold></highlight> (39.8 mg, 0.184 mmol) and dimethyl malonate (48.7 mg, 0.37 mmol) in 2 mL THF. After 2 h at r.t. the mixture was diluted with ether (5 mL) and water (5 mL) was added. The layers were separated and the aqueous layer was extracted with ether (3&times;10 mL). The combined organic layers were washed with brine (10 mL), dried over magnesium sulfate the solvent removed in vacuo. Flash chromatography (petroleum ether/ether 8:1) afforded 48.0 mg (96%) of a mixture of <highlight><bold>31</bold></highlight><highlight><italic>b </italic></highlight>and <highlight><bold>31</bold></highlight><highlight><italic>c </italic></highlight>in a ratio of 58:42. </paragraph>
</section>
<section>
<heading lvl="1">Example 13 </heading>
</section>
<section>
<heading lvl="1">Preparation of Methyl 3-(2-Bromophenyl)-2-methoxycarbonyl-4-pentenoate <highlight><bold>36</bold></highlight><highlight><italic>a </italic></highlight>and Methyl (E)-5-(2-Bromophenyl)-2-methoxycarbonyl-4-pentenoate <highlight><bold>36</bold></highlight><highlight><italic>b </italic></highlight></heading>
<paragraph id="P-0182" lvl="0"><number>&lsqb;0182&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00081">
<number>81</number>
<image id="EMI-C00081" he="292.60035" wi="216.027" file="US20020198383A1-20021226-C00081.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00081" file="US20020198383A1-20021226-C00081.CDX"/>
<chemistry-mol-file id="CHEMMOL-00081" file="US20020198383A1-20021226-C00081.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0183" lvl="0"><number>&lsqb;0183&rsqb;</number> According to procedure B with MO(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(4.8 mg, 0.0139 mmol) and ligand (S,S)-I (6.8 mg, 0.021 mmol) in 0.6 mL toluene and carbonate <highlight><bold>35</bold></highlight> (37.7 mg, 0.14 mmol), dimethyl malonate (40.4 mg, 0.306 mmol) and sodium hydride (11.1 mg, 0.28 mmol) in 0.8 mL THF. The reaction mixture was heated at 90&deg; C. for 3 h. Work-up and flash chromatography (petroleum ether/ethyl acetate 10:1) afforded 43.5 mg (96%) of <highlight><bold>36</bold></highlight> as a colorless oil consisting of a mixture of regioisomers; <highlight><bold>36</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>36</bold></highlight><highlight><italic>b </italic></highlight>96:4. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&plus;42.5 (c 2.60, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). 91% ee. </paragraph>
</section>
<section>
<heading lvl="1">Example 14 </heading>
</section>
<section>
<heading lvl="1">Preparation of Methyl 2-Methoxycarbonyl-3-phenyl-4-pentenoate a and Methyl (E)-2-Methoxycarbonyl-5-phenyl-4-pentenoate b using a variety of leaving groups </heading>
<paragraph id="P-0184" lvl="0"><number>&lsqb;0184&rsqb;</number> According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(7.5 mg, 0.022 mmol) and ligand (S,S)-I (4.2 mg, 0.013 mmol) in 1 mL toluene and carbonate <highlight><bold>37</bold></highlight> (41.8 mg, 0.22 mmol), dimethyl malonate (62.9 mg, 0.48 mmol) and sodium hydride (17.3 mg, 0.44 mmol) in 1 mL THF. The reaction mixture was heated at 80&deg; C. for 2 h. Work-up and flash chromatography (petroleum ether/ether 6:1) afforded 51.8 mg (96%) of a colorless oil consisting of a mixture of regioisomers; a/b 96:4. 99% ee. </paragraph>
<paragraph id="P-0185" lvl="0"><number>&lsqb;0185&rsqb;</number> According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(7.6 mg, 0.022 mmol) and ligand (S,S)-I (10.7 mg, 0.039 mmol) in 1.0 mL toluene and carbamate <highlight><bold>38</bold></highlight> (45.0 mg, 0.22 mmol), dimethyl malonate (63.4 mg, 0.48 mmol) and sodium hydride (17.6 mg, 0.44 mmol) in 1 mL THF. The reaction mixture was heated at 90&deg; C. for 24 h. Work-up and flash chromatography (petroleum ether/ether 6:1) afforded 41.0 mg (75%; 91% brsm) of a colorless oil consisting of a mixture of regioisomers; a/b 93:7. 99% ee. </paragraph>
<paragraph id="P-0186" lvl="0"><number>&lsqb;0186&rsqb;</number> According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(3.0 mg, 0.0087 mmol) and ligand (S,S)-I (4.2 mg, 0.013 mmol) in 0.5 mL toluene and trifluoroacetate <highlight><bold>39</bold></highlight> (20.0 mg, 0.087 mmol), dimethyl malonate (25.1 mg, 0.19 mmol) and sodium hydride (7.0 mg, 0.17 mmol) in 0.8 mL THF. The reaction mixture was heated at 80&deg; C. for 4 h. Work-up and flash chromatography (petroleum ether/ether 6:1) afforded 20.2 mg (94%) of a colorless oil consisting of a mixture of regioisomers; a/b 93:7. 99% ee. </paragraph>
</section>
<section>
<heading lvl="1">Examples 15A-B </heading>
</section>
<section>
<heading lvl="1">Preparation of Methyl 2-Methoxycarbonyl-5-(1-cyclohexen-1-yl)-3-vinyl-4-pentynoate <highlight><bold>34</bold></highlight><highlight><italic>a </italic></highlight>and Methyl (4E)-2-Methoxycarbonyl-7-(1-cyclohexen-1-yl)-hept-4-en-6-ynoate <highlight><bold>34</bold></highlight><highlight><italic>b </italic></highlight>using different leaving groups </heading>
<paragraph id="P-0187" lvl="0"><number>&lsqb;0187&rsqb;</number> A. According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(8.1 mg, 0.024 mmol) and ligand (R,R)-I (11.4 mg, 0.035 mmol) in 1.2 mL toluene and carbonate <highlight><bold>32</bold></highlight> (25.8 mg, 0.12 mmol), dimethyl malonate (34.1 mg, 0.26 mmol) and sodium hydride (9.4 mg, 0.24 mmol) in 1.0 mL THF. The reaction mixture was heated at 85&deg; C. for 4.5 h. Work-up and flash chromatography (petroleum ether/ether 8:1) afforded besides 4.2 mg starting material 26.2 mg (81%; 97% brsm) of <highlight><bold>34</bold></highlight> as a colorless oil consisting of a mixture of regioisomers; <highlight><bold>34</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>34</bold></highlight><highlight><italic>b </italic></highlight>88:12. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;63.9 (c 1.25, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). 99% ee. </paragraph>
<paragraph id="P-0188" lvl="0"><number>&lsqb;0188&rsqb;</number> B. According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(7.5 mg, 0.022 mmol) and ligand (R,R)-I (10.6 mg, 0.033 mmol) in 1 mL toluene and phosphate <highlight><bold>33</bold></highlight> (64.8 mg, 0.22 mmol), dimethyl malonate (63.2 mg, 0.48 mmol) and sodium hydride (17.4 mg, 0.44 mmol) in 1.0 mL THF. The reaction mixture was heated at 90&prop;C. for 2 h. Work-up and flash chromatography (petroleum ether/ether 5:1) afforded 49.8 mg (82%; 95% brsm) of <highlight><bold>34</bold></highlight> as a colorless oil consisting of a mixture of regioisomers; <highlight><bold>34</bold></highlight><highlight><italic>a</italic></highlight>/<highlight><bold>34</bold></highlight><highlight><italic>b </italic></highlight>66:34. 96% ee. </paragraph>
</section>
<section>
<heading lvl="1">Example 16 </heading>
</section>
<section>
<heading lvl="1">Reaction of methyl 3-(3-phenylpropenyl) carbonate with sodio methyl acetoacetate </heading>
<paragraph id="P-0189" lvl="0"><number>&lsqb;0189&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00082">
<number>82</number>
<image id="EMI-C00082" he="53.298" wi="157.4559" file="US20020198383A1-20021226-C00082.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00082" file="US20020198383A1-20021226-C00082.CDX"/>
<chemistry-mol-file id="CHEMMOL-00082" file="US20020198383A1-20021226-C00082.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0190" lvl="0"><number>&lsqb;0190&rsqb;</number> S, S-ligand I (19.4 mg, 0.060 mmol) and Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(13.8 mg, 0.04 mmol) were dissolved in 1.0 ml of tetrahydrofuran at rt, and the reaction mixture was heated at 60&deg; C. for 1 h. After cooling to rt., a solution of sodio methyl acetoacetate in 1.0 ml of tetrahydrofuran, prepared from methyl acetoacetate (51.1 mg, 0.44 mmol) and sodium hydride (10.2 mg, 0.40 mmol) in tetrahydrofuran, and methyl 1-phenyl-allyl carbonate (38.6 mg, 0.201 mmol) were added successively. The reaction mixture was stirred at 65&deg; C. for 8 h, poured into water and extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, and the solvent was removed under reduced pressure to give a mixture of branched products (the ratio of diastereomers was 1.2/1) and linear product. The ratio of methyl 2-acetyl-3-phenyl-pent-4-enoate and linear compound was determined to be 52.8/1 by <highlight><superscript>1</superscript></highlight>H NMR (400 MHz). The residue was chromatographed on silica (&frac18;ethyl acetate/petroleum ether, Rf&equals;0.3) to yield the mixture of diastereomers and linear compound. (30.6 mg, 66%, 72% BRSM) &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&plus;28.7&deg; (c 1.21, CHCl<highlight><subscript>3</subscript></highlight>) </paragraph>
</section>
<section>
<heading lvl="1">Example 17 </heading>
</section>
<section>
<heading lvl="1">Reaction of cinnamyl diethyl phosphate with sodio methyl acetoacetate using 20 mol % catalyst </heading>
<paragraph id="P-0191" lvl="0"><number>&lsqb;0191&rsqb;</number> S, S-ligand I (19.4 mg, 0.060 mmol) and Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(13.8 mg, 0.04 mmol) were dissolved in 1.0 ml of tetrahydrofuran at rt., and the reaction mixture was heated at 60&deg; C. for 1 h. After cooling to rt., a solution of sodio methyl acetoacetate in 1.0 ml of tetrahydrofuran, prepared from methyl acetoacetate (51.1 mg, 0.44 mmol) and sodium hydride (10.1 mg, 0.40 mmol) in tetrahydrofurane and cinnamyl diethyl phosphate (54.2 mg, 0.201 mmol) were added successively. The reaction mixture was stirred at 65&deg; C. for 4 h, poured into water and extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, and the solvent was removed under reduced pressure to give a mixture of branched products (diastereomeric ratio 1.2/1) and linear product. The ratio of methyl 2-acetyl-3-phenyl-pent-4-enoate and linear compound was determined to be 45.7/1 by <highlight><superscript>1</superscript></highlight>H NMR (400 MHz). The residue was chromatographed on silica (&frac18;ethyl acetate/petroleum ether, Rf&equals;0.3) to yield a mixture of diastereomers and linear compound. (39.8 mg, 85%) &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&plus;33.60&deg; (c 1.38, CHCl<highlight><subscript>3</subscript></highlight>). </paragraph>
</section>
<section>
<heading lvl="1">Example 18 </heading>
</section>
<section>
<heading lvl="1">Methyl 2-(4-methoxy-benzoyl)-3-Phenyl-pent-4-en-1-one </heading>
<paragraph id="P-0192" lvl="0"><number>&lsqb;0192&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00083">
<number>83</number>
<image id="EMI-C00083" he="127.6884" wi="216.027" file="US20020198383A1-20021226-C00083.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00083" file="US20020198383A1-20021226-C00083.CDX"/>
<chemistry-mol-file id="CHEMMOL-00083" file="US20020198383A1-20021226-C00083.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0193" lvl="0"><number>&lsqb;0193&rsqb;</number> S, S-ligand I (9.7 mg, 0.030 mmol) and Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(6.9 mg, 0.020 mmol) were reacted with sodio methyl 4-methoxy-benzoacetate, prepared from methyl 4-methoxy-benzoacetate (92 mg, 0.44 mmol) and sodium hydride (10.1 mg, 0.40 mmol), cinnamyl diethyl phosphate (54.1 mg, 0.200 mmol) as described for Examples 16 and 17. The reaction yielded a mixture of branched products (diastereomeric ratio 1/1) and linear product. The ratio of methyl 2-(4-methoxy-benzoyl)-3-phenyl-pent-4-en-1-one and linear compound was determined to be 30.3/1 by <highlight><superscript>1</superscript></highlight>H NMR (400 MHz). Purification gave 55.6 mg (86%); &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&plus;65.8&deg; (c 1.00, CHCl<highlight><subscript>3</subscript></highlight>). </paragraph>
</section>
<section>
<heading lvl="1">Examples 19A-B </heading>
</section>
<section>
<heading lvl="1">Alkylation of 1-(2-furyl)-2-propenyl acetate with dimethyl sodioallylmalonate and subsequent Diels-Alder reaction </heading>
<paragraph id="P-0194" lvl="0"><number>&lsqb;0194&rsqb;</number> A. A solution of Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(14.2 mg, 0.0411 mmol) and chiral ligand I (19.9 mg, 0.0613 mmol) in THF (2.0 mL) was stirred at 60&deg; C. for 1 h. A solution of dimethyl sodioallylmalonate, <highlight><bold>3</bold></highlight><highlight><italic>c </italic></highlight>(prepared from dimethyl allylmalonate (149 mg, 0.865 mmol) and 60% NaH (32.0 mg, 0.800 mmol) in THF (2.0 mL)) and 1-(2-furyl)-2-propenyl acetate, <highlight><bold>2</bold></highlight><highlight><italic>b </italic></highlight>(68.0 mg, 0.410 mmol) were successively added at room temperature. The mixture was stirred at room temperature for 12 h. Water (4 mL) was added to quench the reaction at room temperature. The mixture was extracted with diethyl ether (15 mL&times;3). The combined organic layer was washed with brine (10 mL&times;1) and dried (MgSO<highlight><subscript>4</subscript></highlight>). The solvents were evaporated in vacuo, and the residue was purified by chromatography on silica gel (petroleum ether/ethyl acetate) to give the mixture of <highlight><bold>4</bold></highlight> and <highlight><bold>5</bold></highlight> (57.0 mg, 50% yield, 4:5 &equals;99:1). </paragraph>
<paragraph id="P-0195" lvl="0"><number>&lsqb;0195&rsqb;</number> B. The mixture of <highlight><bold>4</bold></highlight><highlight><italic>c </italic></highlight>and <highlight><bold>5</bold></highlight><highlight><italic>c </italic></highlight>(predominantly <highlight><bold>4</bold></highlight><highlight><italic>c</italic></highlight>) generated in Example 19A was stirred at 80&deg; C. in ethanol-water (9.8 ml, 2:5) for 44 h. The mixture was cooled and extracted with diethyl ether (15 ml&times;3), and the combined organic layer was washed with brine (10 ml&times;1) and dried (MgSO<highlight><subscript>4</subscript></highlight>). The solvents were evaporated in vacuo, and the residue was purified by chromatography on silica gel (petroleum ether/ethyl acetate &equals;30/1-20/1-10/1) to give the mixture of <highlight><bold>43</bold></highlight> and <highlight><bold>44</bold></highlight> (44.4 mg, 79% yield (84% yield based on the recovered starting material), <highlight><bold>43</bold></highlight>:<highlight><bold>44</bold></highlight> &equals;76:24). The enantiomeric excesses were determined after isolating <highlight><bold>43</bold></highlight> and <highlight><bold>44</bold></highlight> by chromatography on silica gel (petroleum ether/ethyl acetate 30/1-20/1), respectively. </paragraph>
<paragraph id="P-0196" lvl="0"><number>&lsqb;0196&rsqb;</number> Diels-Alder Adduct <highlight><bold>43</bold></highlight> (major): &lsqb;&agr;&rsqb;<highlight><superscript>24 8</superscript></highlight><highlight><subscript>D</subscript></highlight>&equals;&minus;182&deg; (c 2.09, CHCl<highlight><subscript>3</subscript></highlight>). <highlight><superscript>1</superscript></highlight>H NMR (300 MHz, CDCl<highlight><subscript>3</subscript></highlight>): &dgr;6.38 (d, J&equals;5.8 Hz, 1H), 6.29 (dd, J&equals;5.8, 1.6 Hz, 1H), 5.73 (dt, J&equals;17.1, 10.0 Hz, 1H), 5.25 (dd, J&equals;17.1, 2.0 Hz, 1H), 5.15 (dd, J&equals;10.0, 2.0 Hz, 1H), 5.04 (dd, J&equals;4.4, 1.6 Hz, 1 H), 4.02 (d, J&equals;10.0 Hz, 1H), 3.76 (s, 3H), 3.66 (s, 3H), 2.45 (d, J&equals;5.8 Hz, 1H), 2.42 (d, J&equals;2.5 Hz, 1H), 1.72-1.79 (m, 2H), 1.44 (dd, J&equals;11.2, 8.8 Hz, 1H). <highlight><superscript>13</superscript></highlight>C NMR (75 MHz, CDCl<highlight><subscript>3</subscript></highlight>): &dgr;172.9, 169.8, 136.5, 136.4, 132.9, 118.8, 98.9, 80.1, 67.1, 52.9, 52.2, 49.3, 41.6, 38.9, 32.4. Diels-Alder Adduct <highlight><bold>44</bold></highlight> (minor): &lsqb;&agr;&rsqb;<highlight><superscript>26 0</superscript></highlight><highlight><subscript>D</subscript></highlight>&equals;&minus;47.7&deg; (c 0.57, CHCl<highlight><subscript>3</subscript></highlight>). <highlight><superscript>1</superscript></highlight>H NMR (300 MHz, CDCl<highlight><subscript>3</subscript></highlight>): &dgr; 6.28-6.32 (m,2H), 5.69 (dt, J&equals;17.0, 10.2 Hz, 1H), 5.34 (dd, J&equals;17.0, 1.8 Hz, 1H), 5.23 (dd, J&equals;10.2, 1.8 Hz, 1H), 4.98 (d, J&equals;3.9 Hz, 1H), 3.90 (d, J&equals;10.2 Hz, 1H), 3.74 (s, 3H), 3.67 (s, 3H), 2.88 (dd, J&equals;13.7, 9.1 Hz, 1H), 2.20-2.27 (m, 1H), 2.06 (dd, J&equals;13.7, 8.4 Hz, 1H), 1.70-1.76 (m, 1H), 1.54 (dd, J&equals;11.5, 7.7 Hz, 1H). <highlight><superscript>13</superscript></highlight>C NMR (75 MHz, CDCl<highlight><subscript>3</subscript></highlight>): &dgr;171.8, 171.0, 136.3, 134.3, 133.7, 119.8, 99.9, 79.7, 67.6, 52.7, 52.4, 51.2, 41.8, 38.0, 34.6. </paragraph>
</section>
<section>
<heading lvl="1">Examples 20A-B </heading>
</section>
<section>
<heading lvl="1">Preparation of methyl(4E,6E)-2-methoxycarbonyl-2-&lsqb;(1-phenyl)-2-propen-1-yl&rsqb;-4,6-octadienoate <highlight><bold>45</bold></highlight> and subsequent Diels-Alder reaction </heading>
<paragraph id="P-0197" lvl="0"><number>&lsqb;0197&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00084">
<number>84</number>
<image id="EMI-C00084" he="259.2324" wi="216.027" file="US20020198383A1-20021226-C00084.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00084" file="US20020198383A1-20021226-C00084.CDX"/>
<chemistry-mol-file id="CHEMMOL-00084" file="US20020198383A1-20021226-C00084.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0198" lvl="0"><number>&lsqb;0198&rsqb;</number> A. According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(10.4 mg, 0.030 mmol) and ligand (R,R)-I (14.7 mg, 0.045 mmol) in 1.5 mL toluene and methyl cinnamyl carbonate (57.9 mg, 0.30 mmol), dimethyl (2E, 4E)-2,4-hexadienyl malonate &lsqb;46&rsqb; (140.7 mg, 0.66 mmol) and sodium hydride (24.1 mg, 0.61 mmol) in 1.5 mL THF. The reaction mixture was heated at 90&deg; C. for 3 h. Work-up and flash chromatography (petroleum ether/ether 12:1) afforded 59.1 mg (60%) of the malonate adduct <highlight><bold>45</bold></highlight> as a colorless oil (isomeric purity &gt;94:6; <highlight><superscript>1</superscript></highlight>H NMR). &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;2.0 (c 2.21, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). &gt;94% ee. </paragraph>
<paragraph id="P-0199" lvl="0"><number>&lsqb;0199&rsqb;</number> B. Intramolecular Diels-Alder reaction of malonate <highlight><bold>45</bold></highlight>: </paragraph>
<paragraph id="P-0200" lvl="0"><number>&lsqb;0200&rsqb;</number> A solution of malonate <highlight><bold>45</bold></highlight> (22.8 mg, 0.069 mmol) in 1 mL toluene was heated in a sealed tube at 150&deg; C. for 48 h. The mixture was concentrated and the residue purified by flash chromatography (petroleum ether/ether 11:1) to afford 16.5 mg (72%) of a product tentatively identified as hydrindane <highlight><bold>46</bold></highlight>, as a colorless oil consisting of a mixture of 3 stereoisomers in a ratio of 49:44:7 (<highlight><superscript>1</superscript></highlight>H NMR; integration of the methoxycarbonyl signals). &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&plus;64.9 (c 0.45, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). <highlight><superscript>1</superscript></highlight>H and <highlight><superscript>13</superscript></highlight>C NMR of the two major isomers: <highlight><superscript>1</superscript></highlight>H NMR (500 MHz, CDCl<highlight><subscript>3</subscript></highlight>)&dgr;:7.19-7.33 (m, 10 H), 5.81 (d, J&equals;9.5 Hz, 1 H), 5.75 (ddd, J&equals;10.0, 6.5, 2.7 Hz, 1 H), 5.57-5.65 (m, 2 H), 3.95 (d, J&equals;5.0 Hz, 1 H), 3.81 (d, J&equals;12.5 Hz, 1 H), 3.78 (s, 3 H), 3.73 (s, 3 H), 3.22-3.31 (m, 1 H), 3.09 (s, 3 H), 3.03 (s, 3 H), 2.81 (dd, J&equals;13.3, 6.7 Hz, 1 H), 2.36-2.56 (m, 4 H), 2.02-2.18 (m, 3 H), 1.84 (dt,j&equals;13.0, 4.6 Hz, 1 H), 1.78 (t, J&equals;6.3 Hz, 1 H), 1.52-1.61 (m, 1 H), 1.44-1.49 (m, 1 H), 1.01-1.13 (m, 1 H), 1.05 (d, J&equals;7.5 Hz, 3 H), 0.99 (d, J&equals;7.0 Hz, 3 H). <highlight><superscript>13</superscript></highlight>C NMR (75 MHz, CDCl<highlight><subscript>3</subscript></highlight>) &dgr;:173.48, 172.62, 171.16, 171.02, 141.91, 138.48, 134.34, 134.16, 128.85, 128.71, 127.96, 127.77, 127.19, 126.83, 126.64, 66.08, 65.46, 57.73, 54.84, 52.73, 52.62, 51.86, 51.66, 44.72, 42.10, 41.58, 39.30, 38.56, 35.92, 32.57, 30.47, 30.39, 21.98, 21.46. The 3rd isomer was identified by its two <highlight><superscript>1</superscript></highlight>H NMR signals for the malonate methyl groups at 3.74 (s, 3 H) and 3.10 (s, 3 H). </paragraph>
</section>
<section>
<heading lvl="1">Examples 21A-B </heading>
</section>
<section>
<heading lvl="1">Preparation of methyl (4E)-5-(1-Cyclohexen-1-yl)-2-methoxycarbonyl-2-(2-propenyl)-3-vinyl-4-pentenoate <highlight><bold>47</bold></highlight> and subsequent Diels-Alder reaction </heading>
<paragraph id="P-0201" lvl="0"><number>&lsqb;0201&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00085">
<number>85</number>
<image id="EMI-C00085" he="259.94115" wi="216.027" file="US20020198383A1-20021226-C00085.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00085" file="US20020198383A1-20021226-C00085.CDX"/>
<chemistry-mol-file id="CHEMMOL-00085" file="US20020198383A1-20021226-C00085.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0202" lvl="0"><number>&lsqb;0202&rsqb;</number> A. According to procedure B with Mo(CO)<highlight><subscript>3</subscript></highlight>(EtCN)<highlight><subscript>3 </subscript></highlight>(12.2 mg, 0.035 mmol) and ligand (R,R)-I (17.2 mg, 0.053 mmol) in 2 mL toluene and carbonate <highlight><bold>26</bold></highlight> (78.6 mg, 0.35 mmol), dimethyl allylmalonate (133.9 mg, 0.78 mmol) and sodium hydride (28.3 mg, 0.71 mmol) in 2 mL THF. The reaction mixture was heated at 90&deg; C. for 2.5 h. Two isomers in a ratio of 5:1 were obtained, according to <highlight><superscript>1</superscript></highlight>H NMR spectroscopy (integration of the methoxycarbonyl signals) of the crude mixture. Purification by flash chromatography (petroleum ether/ether 12:1) afforded 79.9 mg (71%) of pure <highlight><bold>47</bold></highlight> as a colorless oil. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;52.0 (c 0.38, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). The ee could not be determined. </paragraph>
<paragraph id="P-0203" lvl="0"><number>&lsqb;0203&rsqb;</number> B. Intramolecular Diels-Alder reaction of malonate <highlight><bold>47</bold></highlight>: </paragraph>
<paragraph id="P-0204" lvl="0"><number>&lsqb;0204&rsqb;</number> A solution of malonate <highlight><bold>47</bold></highlight> (15.0 mg, 0.047 mmol) in 2 mL toluene was heated in a sealed tube at 150&deg; C. for 15 h. The mixture was concentrated and the residue purified by flash chromatography (petroleum ether/ether 12:1) to afford 14.5 mg (97%) of a product tentatively identified as tricycle <highlight><bold>63</bold></highlight>, as a colorless oil consisting of a mixture of 4 stereoisomers in a ratio of 3:3:1:1 (<highlight><superscript>1</superscript></highlight>H NMR; integration of the methoxycarbonyl signals). &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&equals;&minus;67.4 (c 0.44, CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>). <highlight><superscript>1</superscript></highlight>H NMR (300 MHz, CDCl<highlight><subscript>3</subscript></highlight>) &dgr;: 4.95-5.77 (m, 4 H), 3.75, 3.74, 3.73, 3.71, 3.67, 3.65, 3.62, 3.60 (8s, 6 H), 2.68-3.07 (m, 1 H), 0.80-2.54 (m, 15 H). <highlight><superscript>13</superscript></highlight>C NMR (75 MHz, CDCl<highlight><subscript>3</subscript></highlight>) &dgr;:173.27, 172.96, 172.14, 171.89, 143.50, 141.57, 141.09, 137.32, 136.73, 135.97, 135.89, 135.39, 119.45, 119.28, 118.79, 118.63, 117.71, 117.53, 117.42, 63.85, 63.75, 54.92, 54.20, 53.96, 52.64, 52.63, 52.46, 52.10, 51.92, 47.49, 47.28, 42.91, 42.34, 40.35, 39.46, 39.22, 39.11, 39.00, 38.80, 38.67, 37.85, 37.23, 36.26, 36.16, 35.97, 35.16, 34.84, 34.79, 34.72, 34.30, 34.00, 29.69, 28.75, 28.51, 27.12, 27.04, 25.94. </paragraph>
</section>
<section>
<heading lvl="1">Example 22 </heading>
</section>
<section>
<heading lvl="1">Synthesis of Ligand XIII </heading>
<paragraph id="P-0205" lvl="0"><number>&lsqb;0205&rsqb;</number> The amino group of (S)-phenylglycinol was protected as the benzyl carboxamate by reaction with benzyl chloroformate, and the hydroxy group was converted to the mesylate by reaction with mesyl chloride and triethylamine in dichloromethane. Reaction of the mesylate with NaN<highlight><subscript>3 </subscript></highlight>in DMF gave the corresponding azide.  
<chemistry-cwu id="CHEM-US-00086">
<number>86</number>
<image id="EMI-C00086" he="111.38715" wi="216.027" file="US20020198383A1-20021226-C00086.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00086" file="US20020198383A1-20021226-C00086.CDX"/>
<chemistry-mol-file id="CHEMMOL-00086" file="US20020198383A1-20021226-C00086.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0206" lvl="0"><number>&lsqb;0206&rsqb;</number> The azide was reduced to the diamine by catalytic hydrogenation, and reaction with picolinic acid yielded ligand XIII.  
<chemistry-cwu id="CHEM-US-00087">
<number>87</number>
<image id="EMI-C00087" he="163.21095" wi="216.027" file="US20020198383A1-20021226-C00087.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00087" file="US20020198383A1-20021226-C00087.CDX"/>
<chemistry-mol-file id="CHEMMOL-00087" file="US20020198383A1-20021226-C00087.MOL"/>
</chemistry-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">Example 23 </heading>
</section>
<section>
<heading lvl="1">Synthesis of (&plus;)-(1S,2S)-Pyridine-2&prime;-carboxylic acid (2-benzoylamino) cyclohexyl amide (Ligand XIV) </heading>
<paragraph id="P-0207" lvl="0"><number>&lsqb;0207&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00088">
<number>88</number>
<image id="EMI-C00088" he="209.30805" wi="216.027" file="US20020198383A1-20021226-C00088.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00088" file="US20020198383A1-20021226-C00088.CDX"/>
<chemistry-mol-file id="CHEMMOL-00088" file="US20020198383A1-20021226-C00088.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0208" lvl="0"><number>&lsqb;0208&rsqb;</number> To a solution of picolinic acid (389 mg, 3.16 mmol) and pyridine (1.0 g, 12.6 mmol) in 10 mL of methylene chloride was added thionyl chloride (359 mg, 3.02 mmol) at &minus;78&deg; C. After stirring for 20 min, benzoyl chloride (383 mg, 2.73 mmol) and (S,S)-cyclohexyl diamine (328.2 mg, 2.87 mmol) were added successively. Then the reaction mixture was allowed to warm to room temperature. To the reaction mixture was added satd. sodium bicarbonate and then was extracted with methylene chloride (2&times;30 mL). </paragraph>
<paragraph id="P-0209" lvl="0"><number>&lsqb;0209&rsqb;</number> The combined organic layers were dried over sodium sulfate, and the solvent was removed under reduced pressure. The residue was chromatographed on silica (1/1 ethyl acetate/petroleum ether, Rf&equals;0.3) to yield the ligand. (198.2 mg, 21%) </paragraph>
<paragraph id="P-0210" lvl="7"><number>&lsqb;0210&rsqb;</number> &lsqb;&agr;&rsqb;D&plus;90.2&deg; (c 0.54, CHCl<highlight><subscript>3</subscript></highlight>); mp 202-203 &deg; C.; IR (neat): 3274, 2939, 2862, 1648, 1530, 1325, 996, 753, 696 cm<highlight><superscript>&minus;1</superscript></highlight>; <highlight><superscript>1</superscript></highlight>H NMR (300 MHz, CDCl<highlight><subscript>3</subscript></highlight>) &dgr;: 8.53 (d, J&equals;4.6 Hz, 1H), 8.18 (s, 1H), 8.14 (d, J&equals;7.8 Hz, 1H), 7.85-7.73 (m, 3H), 7.47-7.33 (m, 4H), 7.28-7.22 (m, 1H), 4.17-3.98 (m, 1H), 3.98-3.84 (m, 1H), 2.45-2.32 (m, 1H), 2.19-2.07 (m, 1H), 1.97-1.73 (m, 2H), 1.68-1.22 (m, 4H); <highlight><superscript>13</superscript></highlight>C NMR (75 MHz, CDCl<highlight><subscript>3</subscript></highlight>) &dgr;: 167.1, 165.5, 149.2, 148.2, 137.3, 134.3, 131.1, 128.3, 127.0, 126.3, 122.1, 56.3, 52.2, 32.4, 32.1, 25.0, 24.4; HRMS: Calc&apos;d for C<highlight><subscript>19</subscript></highlight>H<highlight><subscript>21</subscript></highlight>N<highlight><subscript>3</subscript></highlight>O<highlight><subscript>2</subscript></highlight>: 323.1634, found: .323.1627. </paragraph>
</section>
<section>
<heading lvl="1">Example 24 </heading>
</section>
<section>
<heading lvl="1">Synthesis of (1S,2S)-(&plus;)-N-(2&prime;-picolinoyl)-N&prime;-(3&prime;-picolinoyl)-1,2-trans-diaminocyclohexane (Ligand XV) </heading>
<paragraph id="P-0211" lvl="0"><number>&lsqb;0211&rsqb;</number> A. Synthesis of &lcub;2-&lsqb;(Pyridine-2-carbonyl)-amino&rsqb;-cyclohexyl&rcub; carbamic acid tert-butyl ester  
<chemistry-cwu id="CHEM-US-00089">
<number>89</number>
<image id="EMI-C00089" he="83.5191" wi="84.96495" file="US20020198383A1-20021226-C00089.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00089" file="US20020198383A1-20021226-C00089.CDX"/>
<chemistry-mol-file id="CHEMMOL-00089" file="US20020198383A1-20021226-C00089.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0212" lvl="0"><number>&lsqb;0212&rsqb;</number> This intermediate was synthesized from mono Boc cyclohexyl diamine (Lagriffoule, <highlight><italic>Chem. Eur. J. </italic></highlight>1997, 3, 912.) (2.49 g, 11.6 mmol) and 2-picolinic acid (1.57 g, 12.8 mmol) by Vagg&apos;s method. (2.75 g, 74%). </paragraph>
<paragraph id="P-0213" lvl="7"><number>&lsqb;0213&rsqb;</number> &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&plus;25.7&deg; (c 0.52, CHCl<highlight><subscript>3</subscript></highlight>); mp 78-79 &deg; C.; IR (neat): 3346, 2935, 1705, 1664, 1528, 1365, 1174, 1014 cm <highlight><superscript>&minus;1</superscript></highlight>; <highlight><superscript>1</superscript></highlight>H NMR (300 MHz, CDCl<highlight><subscript>3</subscript></highlight>) &dgr;:8.56 (d, J&equals;4.4 Hz, 1H), 8.27 (d, J&equals;5.6 Hz, 1H), 8.17 (d, J&equals;1H), 7.82 (ddd, J&equals;1.5, 7.6, 7.6 Hz, 1H), 7.39 (dd, J&equals;5.4, 6.6 Hz, 1H), 4.75 (d, J&equals;8.8 Hz, 1H), 3.88-3.74 (m, 2H), 3.62-3.46 (m, 2 H), 2.20-2.04 (m, 2H), 1.86-1.72 (m, 2H), 1.48-1.30 (m, 2H); <highlight><superscript>13</superscript></highlight>C NMR (75 MHz, CDCl<highlight><subscript>3</subscript></highlight>) &dgr;: 164.6, 156.1, 149.7, 148.1, 137.0, 129.5, 125.9, 122.0, 79.0, 54.3, 54.1, 32.8, 32.5, 28.0, 24.9, 24.7; Anal: Calc&apos;d for C<highlight><subscript>17</subscript></highlight>H<highlight><subscript>25</subscript></highlight>N<highlight><subscript>3</subscript></highlight>O<highlight><subscript>3</subscript></highlight>: C, 63.93; H, 7.89; N, 13.16. Found: C, 63.76; H, 7.78; N, 12.98. </paragraph>
<paragraph id="P-0214" lvl="0"><number>&lsqb;0214&rsqb;</number> B. (1S,2S)-(&plus;)-N-(2-picolinoyl)-N&prime;-(3 -picolinoyl)-1,2-trans-diaminocycloheptane (ligand XV)  
<chemistry-cwu id="CHEM-US-00090">
<number>90</number>
<image id="EMI-C00090" he="129.6162" wi="86.6376" file="US20020198383A1-20021226-C00090.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00090" file="US20020198383A1-20021226-C00090.CDX"/>
<chemistry-mol-file id="CHEMMOL-00090" file="US20020198383A1-20021226-C00090.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0215" lvl="0"><number>&lsqb;0215&rsqb;</number> To &lcub;2-&lsqb;(pyridine-2-carbonyl)-amino&rsqb;-cyclohexyl&rcub; carbamic acid tert-butyl ester, above (416 mg, 1.30 mmol), was added TFA at rt. After 1 h, the TFA was removed under reduced pressure. To the mixture was added 1N HCl (10 mL), and the solvent was removed under reduced pressure. To the residue were added triethyl amine (620 mg, 5.21 mmol), triphenyl phosphite (606 mg, 1.95 mmol), 3-picolinic acid (240 mg, 1.95 mmol) and pyridine (5 mL). The resulting mixture was heated at 100&deg; C. for 15 h and then taken up with CHCl<highlight><subscript>3</subscript></highlight>. The solution was washed with aq. NaHCO<highlight><subscript>3 </subscript></highlight>which was extracted with CHCl<highlight><subscript>3 </subscript></highlight>(2&times;30 mL). The combined organic layer was dried over Na<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight>, and the solvent was removed under reduced pressure. Purification by silica gel chromatography (EtOAc/hexane&equals;1.5/1, Rf&equals;0.3) Yielded 274 mg (65%) of the ligand. &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&plus;70.1&deg; (c 0.63, CHCl<highlight><subscript>3</subscript></highlight>); mp 201-202 &deg; C.; IR (neat): 3439, 3338, 3270, 2938, 1655, 1535, 1326, 712 cm<highlight><superscript>&minus;1</superscript></highlight>; <highlight><superscript>1</superscript></highlight>H NMR (300 MHz, CDCl<highlight><subscript>3</subscript></highlight>) &dgr;:9.00 (d, J&equals;1.5 Hz, 1H), 8.66 (dd, J &equals;1.2, 4.6 Hz, 1H), 8.54 (d, J &equals;4.6 Hz, 1H), 8.23-8.12 (m, 2H), 8.07 (d, J&equals;8.1 Hz, 1H), 7.82 (ddd, J&equals;1.5, 7.6, 7.8 Hz, 1H), 7.57 (d, J&equals;6.1 Hz, 1H), 7.42 (ddd, J&equals;1.5, 6.3,6.4 Hz, 1H), 7.31 (dd, J&equals;4.9, 7.8 Hz, 1H); <highlight><superscript>13</superscript></highlight>C NMR (75 MHz, CDCl<highlight><subscript>3</subscript></highlight>) &dgr;: 165.9, 165.2, 151.8, 149.0, 148.6, 148.2, 137.4, 134.7, 129.9, 126.5, 123.2, 122.2, 57.0, 52.2, 32.2, 32.0, 25.0, 24.2; HRMS. Calc&apos;d for C<highlight><subscript>18</subscript></highlight>H<highlight><subscript>20</subscript></highlight>N<highlight><subscript>4</subscript></highlight>O<highlight><subscript>2</subscript></highlight>: 324.1586, found: 324.1584. </paragraph>
</section>
<section>
<heading lvl="1">Example 25 </heading>
</section>
<section>
<heading lvl="1">Allylic alkylation using ligand XIV </heading>
<paragraph id="P-0216" lvl="0"><number>&lsqb;0216&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00091">
<number>91</number>
<image id="EMI-C00091" he="241.23015" wi="216.027" file="US20020198383A1-20021226-C00091.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00091" file="US20020198383A1-20021226-C00091.CDX"/>
<chemistry-mol-file id="CHEMMOL-00091" file="US20020198383A1-20021226-C00091.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0217" lvl="0"><number>&lsqb;0217&rsqb;</number> (S,S)-ligand XIV (9.7 mg, 0.03 mmol) and Mo(CO)<highlight><subscript>3</subscript></highlight>(&eegr;<highlight><superscript>3</superscript></highlight>-C<highlight><subscript>7</subscript></highlight>H<highlight><subscript>8</subscript></highlight>) (5.4 mg, 0.02 mmol) were dissolved in 1.0 mL of THF at rt, and the reaction mixture was heated at 60 &deg; C. for 30 min. After cooling to rt, a solution of sodio dimethyl molonate in 1.0 mL of THF (prepared from dimethyl malonate (58 mg, 0.44 mmol) and sodium hydride (10.1 mg, 0.40 mmol) in THF) and cinnamyl methyl carbonate (38.0 mg, 0.198 mmol) were added successively. The reaction mixture was stirred at 65&deg; C. for 7 h, then poured into water and extracted with ether (2&times;30 mL). The combined organic layers were dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was chromatographed on silica (1/10 ethyl acetate/petroleum ether, Rf&equals;0.3) to yield a mixture of branched and linear compound. (45.5 mg, 93%) The ratio of branched and linear compound was determined to be 50/1 by <highlight><superscript>1</superscript></highlight>H NMR (300 Mhz). </paragraph>
<paragraph id="P-0218" lvl="7"><number>&lsqb;0218&rsqb;</number> (2&times;PhC<highlight><uline>H</uline></highlight>(CHE<highlight><subscript>2</subscript></highlight>)CHCH<highlight><subscript>2</subscript></highlight>/PhCHCHC<highlight><uline>H</uline></highlight><highlight><subscript>2</subscript></highlight>CHCHE<highlight><subscript>2</subscript></highlight>) </paragraph>
<paragraph id="P-0219" lvl="7"><number>&lsqb;0219&rsqb;</number> &lsqb;&agr;&rsqb;<highlight><subscript>D</subscript></highlight>&plus;35.1&deg; (c 1.19, CHCl<highlight><subscript>3</subscript></highlight>); 99% ee, HPLC (Daicel Chiralpak OJ, flow rate&equals;1.0 mL/min, heptane/iPrOH&equals;96/4, detection at 220 nm); t<highlight><subscript>R </subscript></highlight>21.29 min (minor), t<highlight><subscript>R </subscript></highlight>23.50 min (major). </paragraph>
</section>
<section>
<heading lvl="1">Example 26 </heading>
</section>
<section>
<heading lvl="1">Allylic alkylation using ligand XV </heading>
<paragraph id="P-0220" lvl="0"><number>&lsqb;0220&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00092">
<number>92</number>
<image id="EMI-C00092" he="116.66025" wi="215.54505" file="US20020198383A1-20021226-C00092.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00092" file="US20020198383A1-20021226-C00092.CDX"/>
<chemistry-mol-file id="CHEMMOL-00092" file="US20020198383A1-20021226-C00092.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0221" lvl="0"><number>&lsqb;0221&rsqb;</number> (S,S)-ligand XV (9.7 mg, 0.03 mmol) and Mo(CO)<highlight><subscript>3</subscript></highlight>(&eegr;<highlight><superscript>3</superscript></highlight>-C<highlight><subscript>7</subscript></highlight>H<highlight><subscript>8</subscript></highlight>) (5.4 mg, 0.02 mmol) were dissolved in 1.0 mL of THF at rt, and the reaction mixture was heated at 60&deg; C. for 30 min and then cooled to rt. A solution of sodio dimethyl malonate in 1.0 mL of THF (prepared from dimethyl malonate (58 mg, 0.44 mmol) and sodium hydride (10.1 mg, 0.40 mmol) in THF) and cinnamyl methyl carbonate (38.6 mg, 0.201 mmol) were added successively. The reaction mixture was stirred at 65&deg; C. for 6 h, then poured into water and extracted with ether (2&times;30 mL). The combined organic layers were dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was chromatographed on silica (1/10 ethyl acetate/petroleum ether, Rf&equals;0.3) to yield a mixture of branched and linear compound. (46.2 mg, 93%) The ratio of branched and linear compound was determined to be 46/1 by <highlight><superscript>1</superscript></highlight>H NMR (300 Mhz). (2&times;PhC<highlight><uline>H</uline></highlight>(CHE<highlight><subscript>2</subscript></highlight>)CHCH<highlight><subscript>2</subscript></highlight>/PhCHCHC<highlight><uline>H</uline></highlight><highlight><subscript>2</subscript></highlight>CHCHE<highlight><subscript>2</subscript></highlight>) 99% ee, HPLC (Daicel Chiralpak OJ, flow rate 1.0 mL/min, heptane/<highlight><superscript>i</superscript></highlight>PrOH&equals;96/4, detection at 220 nm); t<highlight><subscript>R </subscript></highlight>19.61 min (minor), t<highlight><subscript>R </subscript></highlight>22.25 min (major). </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">It is claimed: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A catalytic organometallic composition, effective to catalyze the enantioselective alkylation of an allyl group bearing a leaving group at an allylic position, said composition comprising: a metal atom selected from the group consisting of molybdenum, tungsten, and chromium, and coordinated thereto, a chiral ligand L<highlight><superscript>1 </superscript></highlight>comprising: 
<claim-text>a chiral component derived from a chiral diamine, said component comprising first and second carbon atoms, each bearing a binding group &mdash;NH&mdash;(C&boxH;O)&mdash;B, wherein </claim-text>
<claim-text>said carbon atoms are connected by a direct bond or by a chain of one to three atoms comprising linkages selected from alkyl, alkyl ether, alkyl amino, and combinations thereof; </claim-text>
<claim-text>each group B is independently selected from alkyl, cycloalkyl, heterocycle, aryl, and aralkyl; </claim-text>
<claim-text>at least one group B is a N-heterocyclic or N-heteroaryl group CyN having an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen atom effective to coordinate to said metal atom; and </claim-text>
<claim-text>at least one of said carbon atoms is a chiral carbon atom bearing a further substituent, wherein said substituent or substituents are independently selected from aryl, aralkyl, carbocycle, heterocycle, and secondary or tertiary alkyl having 3 or more carbons, and where substituents on adjacent chiral carbon atoms may together form a ring. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein 
<claim-text>(i) each said group B is a group CyN as defined in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or </claim-text>
<claim-text>(ii) each said carbon atom is a chiral carbon atom bearing a substituent as defined in claim <highlight><bold>1</bold></highlight>; or </claim-text>
<claim-text>(iii) both (i) and (ii) are present. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein at least one group B is a group CyN having an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen which is &agr; to a ring carbon atom which is linked to the carbonyl (C&boxH;O) carbon of said binding group. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein each said carbon atom is a chiral carbon atom bearing a substituent, and said substituents are independently aryl or together form a ring. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference>, wherein said ring is a carbocyclic ring having 5-7 ring atoms, or a 5- to 7-membered heterocyclic ring having 1 to 3 ring atoms selected from oxygen, nitrogen and sulfur and the remaining ring atoms carbon, and may be fused to an additional ring. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference>, wherein said heterocyclic ring has 1 to 2 ring atoms selected from oxygen and nitrogen. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said group or groups CyN are independently selected from pyridyl, quinolinyl, isoquinolyl, pyrimidyl, triazinyl, tetrazinyl, pyrazinyl, pyrazolyl, triazolyl, tetrazolyl, oxazinyl, oxazolyl, thiazolyl, imidazolyl, benzoxazole, benzimidazole, and dihydro derivatives of the above. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00003">claim 3</dependent-claim-reference>, wherein said group or groups CyN are independently selected from 2-pyridyl, 2-quinolinyl, 1- or 3-isoquinolyl, 2- or 4-pyrimidyl, 2-triazinyl, 4-tetrazinyl, 2-pyrazinyl, 3- or 5-pyrazolyl, 3- or 5-triazolyl, 2-tetrazolyl, 2-oxazinyl, 2- or 5-oxazolyl, 2- or 5-thiazolyl, 2- or 4-imidazolyl, 2-benzoxazole, 2-benzimidazole, and dihydro derivatives of the above. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said carbon atoms are connected by a direct bond. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein said chiral component is selected from 1R,2R-trans-diaminocyclohexane, 1R,2R-trans-diphenyl-1 ,2-ethanediamine, 3R, 4R-trans-3,4-diamino-N-benzylpyrrolidine, 1R,2R-trans-diaminocycloheptane, 5R,6R-trans-5,6-diaminoindan, 1 S-phenyl-1,2-ethanediamine, and the mirror image counterpart of any of the above. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said ligand L<highlight><superscript>1 </superscript></highlight>is selected from ligands represented herein as I through XV and the mirror image counterpart of any of the above. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said metal atom is molybdenum. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. A catalytic organometallic composition, effective to catalyze the enantioselective alkylation of an allyl group bearing a leaving group at an allylic position, wherein the composition is the product of a process which comprises: 
<claim-text>contacting with a chiral ligand L<highlight><superscript>1</superscript></highlight>, in a suitable solvent, a soluble complex of a metal selected from tungsten (0), chromium (0), and molybdenum(0), having ligands which form a stable complex with the metal and are displaceable by ligand L<highlight><superscript>1 </superscript></highlight>under the conditions of said contacting, </claim-text>
<claim-text>wherein said ligand L<highlight><superscript>1 </superscript></highlight>comprises: 
<claim-text>a chiral component derived from a chiral diamine, said component comprising first and second carbon atoms, each bearing a binding group &mdash;NH&mdash;(C&boxH;O)&apos;B, wherein </claim-text>
<claim-text>said carbon atoms are connected by a direct bond or by a chain of one to three atoms comprising linkages selected from alkyl, alkyl ether, alkyl amino, and combinations thereof; </claim-text>
<claim-text>each group B is selected from alkyl, cycloalkyl, heterocycle, aryl, and aralkyl; </claim-text>
<claim-text>at least one group B is a N-heterocyclic or N-heteroaryl group CyN having an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen atom effective to coordinate to said metal atom; and </claim-text>
<claim-text>at least one of said carbon atoms is a chiral carbon atom bearing a further substituent, wherein said substituent or substituents are independently selected from aryl, aralkyl, carbocycle, heterocycle, and secondary or tertiary alkyl having 3 or more carbons, and where substituents on adjacent chiral carbon atoms may together form a ring; </claim-text>
</claim-text>
<claim-text>whereby said complex undergoes a ligand exchange reaction, such that chiral ligand L<highlight><superscript>1 </superscript></highlight>becomes coordinated to said metal atom. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The composition of claim <highlight><bold>14</bold></highlight>, wherein in said process said metal is molybdenum (0). </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The composition of claim <highlight><bold>14</bold></highlight>, wherein in said process said soluble complex comprises ligands selected from the group consisting of CO, cycloheptatriene, lower alkyl nitrile, and lower alkyl isonitrile. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The composition of claim <highlight><bold>14</bold></highlight>, wherein 
<claim-text>(i) each said group B is a group CyN as defined in claim <highlight><bold>14</bold></highlight>, or </claim-text>
<claim-text>(ii) each said carbon atom is a chiral carbon atom bearing a substituent as defined in claim <highlight><bold>14</bold></highlight>; or </claim-text>
<claim-text>(iii) both (i) and (ii) are present. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The composition of claim <highlight><bold>14</bold></highlight>, wherein at least one group B is a group CyN having an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen which is a to a ring carbon atom which is linked to the carbonyl (C&boxH;O) carbon of said binding group. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The composition of claim <highlight><bold>14</bold></highlight>, wherein each said carbon atom is a chiral carbon atom bearing a substituent, and said substituents are independently aryl or together form a ring. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The composition of claim <highlight><bold>19</bold></highlight>, wherein said ring is a 5- to 7- membered carbocyclic ring, or a 5- to 7-membered heterocyclic ring having 1 to 3 ring atoms selected from oxygen, nitrogen and sulfur and the remaining ring atoms carbon, and may be fused to an additional ring. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference>, wherein said heterocyclic ring has 1 to 2 ring atoms selected from oxygen and nitrogen. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The composition of claim <highlight><bold>14</bold></highlight>, wherein said group or groups CyN are independently selected from pyridyl, quinolinyl, isoquinolyl, pyrimidyl, triazinyl, tetrazinyl, pyrazinyl, pyrazolyl, triazolyl, tetrazolyl, oxazinyl, oxazolyl, thiazolyl, imidazolyl, benzoxazole, benzimidazole, and dihydro derivatives of the above. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The composition of claim <highlight><bold>18</bold></highlight>, wherein said group or groups CyN are independently selected from 2-pyridyl, 2-quinolinyl, 1- or 3-isoquinolyl, 2- or 4-pyrimidyl, 2-triazinyl, 4-tetrazinyl, 2-pyrazinyl, 3- or 5-pyrazolyl, 3- or 5-triazolyl, 2-tetrazolyl, 2-oxazinyl, 2- or 5-oxazolyl, 2- or 5-thiazolyl, 2- or 4-imidazolyl, 2-benzoxazole, 2-benzimidazole, and dihydro derivatives of the above. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The composition of claim <highlight><bold>14</bold></highlight>, wherein said carbon atoms are connected by a direct bond. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The composition of <dependent-claim-reference depends_on="CLM-00022">claim 24</dependent-claim-reference>, wherein said chiral component is selected from 1R,2R-trans-diaminocyclohexane, 1R,2R-trans-diphenyl-1,2-ethanediamine, 3R,4R-trans-3,4-diamino-N-benzylpyrrolidine, 1R,2R-trans-diaminocycloheptane, 5R,6R-trans-5,6-diaminoindan, 1 S-phenyl-1,2-ethanediamine, and the mirror image counterpart of any of the above. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The composition of claim <highlight><bold>14</bold></highlight>, wherein said ligand L<highlight><superscript>1 </superscript></highlight>is selected from ligands represented herein as I through XV and the mirror image counterpart of any of the above. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. A method of selective alkylation of an allyl group bearing a leaving group at an allylic position, said method comprising 
<claim-text>reacting a substrate containing said allyl group with an alkylating agent in the presence of a catalytic composition formed by contacting, in a suitable solvent, catalytic amounts of: (i) a chiral ligand L<highlight><superscript>1</superscript></highlight>, and (ii) a soluble complex of a metal selected from the group consisting of molybdenum (0), tungsten (0), and chromium (0), having ligands which form a stable complex with the metal and are displaceable by ligand L<highlight><superscript>1 </superscript></highlight>under the conditions of said contacting, </claim-text>
<claim-text>under conditions effective to produce an alkylated substrate which is enriched in one of the possible isomeric products of such alkylation, </claim-text>
<claim-text>wherein said chiral ligand L<highlight><superscript>1 </superscript></highlight>comprises: 
<claim-text>a chiral component derived from a chiral diamine, said component comprising first and second carbon atoms, each bearing a binding group &mdash;NH&mdash;(C&boxH;O)&mdash;B, wherein </claim-text>
<claim-text>said carbon atoms are connected by a direct bond or by a chain of one to three atoms comprising linkages selected from alkyl, alkyl ether, alkyl amino, and combinations thereof; </claim-text>
<claim-text>each group B is selected from alkyl, cycloalkyl, heterocycle, aryl, and aralkyl; </claim-text>
<claim-text>at least one group B is a N-heterocyclic or N-heteroaryl group CyN having an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen atom effective to coordinate to said metal atom; and </claim-text>
<claim-text>at least one of said carbon atoms is a chiral carbon atom bearing a further substituent, wherein said substituent or substituents are independently selected from aryl, aralkyl, carbocycle, heterocycle, and secondary or tertiary alkyl having 3 or more carbons, and where substituents on adjacent chiral carbon atoms may together form a ring. </claim-text>
</claim-text>
</claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein said alkylation is enantioselective, and produces an alkylated substrate having an enantiomeric excess greater than 75%. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein said allyl group is nonsymmetrically substituted at its termini, and said alkylating is regioselective, such that said allyl group is alkylated predominantly at its more sterically hindered terminus. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein, in said ligand L<highlight><superscript>1</superscript></highlight>, 
<claim-text>(i) each said group B is a group CyN as defined in <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, or </claim-text>
<claim-text>(ii) each said carbon atom is a chiral carbon atom bearing a substituent as defined in claim <highlight><bold>27</bold></highlight>; or </claim-text>
<claim-text>(iii) both (i) and (ii) are present. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein at least one group B is a group CyN having an sp<highlight><superscript>2 </superscript></highlight>hybridized ring nitrogen which is &agr; to a ring carbon atom which is linked to the carbonyl (C&boxH;O) carbon of said binding group. </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein said carbon atoms are connected by a direct bond. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 32</dependent-claim-reference>, wherein each said carbon atom is a chiral carbon atom bearing a substituent, and said substituents are independently aryl or together form a ring. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein said ring is a 5- to 7-membered carbocyclic ring, or a 5- to 7-membered heterocyclic ring having 1 to 3 ring atoms selected from oxygen, nitrogen and sulfur and the remaining ring atoms carbon. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 31</dependent-claim-reference>, wherein said group or groups CyN are independently selected from 2-pyridyl, 2-quinolinyl, 1- or 3-isoquinolyl, 2- or 4-pyrimidyl, 2-triazinyl, 4-tetrazinyl, 2-pyrazinyl, 3- or 5-pyrazolyl, 3- or 5-triazolyl, 2-tetrazolyl, 2-oxazinyl, 2- or 5-oxazolyl, 2- or 5-thiazolyl, 2- or 4-imidazolyl, and dihydro derivatives of the above. </claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein neither terminus of said allyl group is aryl substituted. </claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein the alkylating agent is a stabilized carbanion of the form EE&prime;RC<highlight><superscript>&minus;</superscript></highlight> M<highlight><superscript>&plus;</superscript></highlight>, where M<highlight><superscript>&plus;</superscript></highlight> is a positively charged counterion, and each of E and E&apos; is an electron-withdrawing substituent selected from keto, carboxylic ester, cyano, and sulfonyl, or an aromatic or heteroaromatic group capable of stabilizing an &agr;-carbanion. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 37</dependent-claim-reference>, wherein at least one of E and E&prime; is a carboxylic ester. </claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein said metal atom is molybdenum. </claim-text>
</claim>
<claim id="CLM-00040">
<claim-text><highlight><bold>40</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference>, wherein said soluble molybdenum(0) complex bears ligands selected from the group consisting of CO, cycloheptatriene, lower alkyl nitrile, and lower alkyl isonitrile. </claim-text>
</claim>
<claim id="CLM-00041">
<claim-text><highlight><bold>41</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein the mole percent of said catalytic composition with respect to said substrate is from about 0.5% to about 15%.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>1</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020198383A1-20021226-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020198383A1-20021226-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020198383A1-20021226-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020198383A1-20021226-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020198383A1-20021226-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020198383A1-20021226-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020198423A1-20021226-C00001.CDX SYSTEM "US20020198423A1-20021226-C00001.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00001.MOL SYSTEM "US20020198423A1-20021226-C00001.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00001.TIF SYSTEM "US20020198423A1-20021226-C00001.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00002.CDX SYSTEM "US20020198423A1-20021226-C00002.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00002.MOL SYSTEM "US20020198423A1-20021226-C00002.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00002.TIF SYSTEM "US20020198423A1-20021226-C00002.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00003.CDX SYSTEM "US20020198423A1-20021226-C00003.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00003.MOL SYSTEM "US20020198423A1-20021226-C00003.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00003.TIF SYSTEM "US20020198423A1-20021226-C00003.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00004.CDX SYSTEM "US20020198423A1-20021226-C00004.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00004.MOL SYSTEM "US20020198423A1-20021226-C00004.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00004.TIF SYSTEM "US20020198423A1-20021226-C00004.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00005.CDX SYSTEM "US20020198423A1-20021226-C00005.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00005.MOL SYSTEM "US20020198423A1-20021226-C00005.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00005.TIF SYSTEM "US20020198423A1-20021226-C00005.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00006.CDX SYSTEM "US20020198423A1-20021226-C00006.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00006.MOL SYSTEM "US20020198423A1-20021226-C00006.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00006.TIF SYSTEM "US20020198423A1-20021226-C00006.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00007.CDX SYSTEM "US20020198423A1-20021226-C00007.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00007.MOL SYSTEM "US20020198423A1-20021226-C00007.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00007.TIF SYSTEM "US20020198423A1-20021226-C00007.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00008.CDX SYSTEM "US20020198423A1-20021226-C00008.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00008.MOL SYSTEM "US20020198423A1-20021226-C00008.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00008.TIF SYSTEM "US20020198423A1-20021226-C00008.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00009.CDX SYSTEM "US20020198423A1-20021226-C00009.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00009.MOL SYSTEM "US20020198423A1-20021226-C00009.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00009.TIF SYSTEM "US20020198423A1-20021226-C00009.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00010.CDX SYSTEM "US20020198423A1-20021226-C00010.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00010.MOL SYSTEM "US20020198423A1-20021226-C00010.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00010.TIF SYSTEM "US20020198423A1-20021226-C00010.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00011.CDX SYSTEM "US20020198423A1-20021226-C00011.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00011.MOL SYSTEM "US20020198423A1-20021226-C00011.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00011.TIF SYSTEM "US20020198423A1-20021226-C00011.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00012.CDX SYSTEM "US20020198423A1-20021226-C00012.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00012.MOL SYSTEM "US20020198423A1-20021226-C00012.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00012.TIF SYSTEM "US20020198423A1-20021226-C00012.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00013.CDX SYSTEM "US20020198423A1-20021226-C00013.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00013.MOL SYSTEM "US20020198423A1-20021226-C00013.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00013.TIF SYSTEM "US20020198423A1-20021226-C00013.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00014.CDX SYSTEM "US20020198423A1-20021226-C00014.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00014.MOL SYSTEM "US20020198423A1-20021226-C00014.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00014.TIF SYSTEM "US20020198423A1-20021226-C00014.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00015.CDX SYSTEM "US20020198423A1-20021226-C00015.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00015.MOL SYSTEM "US20020198423A1-20021226-C00015.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00015.TIF SYSTEM "US20020198423A1-20021226-C00015.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00016.CDX SYSTEM "US20020198423A1-20021226-C00016.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00016.MOL SYSTEM "US20020198423A1-20021226-C00016.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00016.TIF SYSTEM "US20020198423A1-20021226-C00016.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00017.CDX SYSTEM "US20020198423A1-20021226-C00017.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00017.MOL SYSTEM "US20020198423A1-20021226-C00017.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00017.TIF SYSTEM "US20020198423A1-20021226-C00017.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00018.CDX SYSTEM "US20020198423A1-20021226-C00018.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00018.MOL SYSTEM "US20020198423A1-20021226-C00018.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00018.TIF SYSTEM "US20020198423A1-20021226-C00018.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00019.CDX SYSTEM "US20020198423A1-20021226-C00019.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00019.MOL SYSTEM "US20020198423A1-20021226-C00019.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00019.TIF SYSTEM "US20020198423A1-20021226-C00019.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00020.CDX SYSTEM "US20020198423A1-20021226-C00020.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00020.MOL SYSTEM "US20020198423A1-20021226-C00020.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00020.TIF SYSTEM "US20020198423A1-20021226-C00020.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00021.CDX SYSTEM "US20020198423A1-20021226-C00021.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00021.MOL SYSTEM "US20020198423A1-20021226-C00021.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00021.TIF SYSTEM "US20020198423A1-20021226-C00021.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00022.CDX SYSTEM "US20020198423A1-20021226-C00022.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00022.MOL SYSTEM "US20020198423A1-20021226-C00022.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00022.TIF SYSTEM "US20020198423A1-20021226-C00022.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00023.CDX SYSTEM "US20020198423A1-20021226-C00023.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00023.MOL SYSTEM "US20020198423A1-20021226-C00023.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00023.TIF SYSTEM "US20020198423A1-20021226-C00023.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00024.CDX SYSTEM "US20020198423A1-20021226-C00024.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00024.MOL SYSTEM "US20020198423A1-20021226-C00024.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00024.TIF SYSTEM "US20020198423A1-20021226-C00024.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00025.CDX SYSTEM "US20020198423A1-20021226-C00025.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00025.MOL SYSTEM "US20020198423A1-20021226-C00025.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00025.TIF SYSTEM "US20020198423A1-20021226-C00025.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00026.CDX SYSTEM "US20020198423A1-20021226-C00026.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00026.MOL SYSTEM "US20020198423A1-20021226-C00026.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00026.TIF SYSTEM "US20020198423A1-20021226-C00026.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00027.CDX SYSTEM "US20020198423A1-20021226-C00027.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00027.MOL SYSTEM "US20020198423A1-20021226-C00027.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00027.TIF SYSTEM "US20020198423A1-20021226-C00027.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00028.CDX SYSTEM "US20020198423A1-20021226-C00028.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00028.MOL SYSTEM "US20020198423A1-20021226-C00028.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00028.TIF SYSTEM "US20020198423A1-20021226-C00028.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00029.CDX SYSTEM "US20020198423A1-20021226-C00029.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00029.MOL SYSTEM "US20020198423A1-20021226-C00029.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00029.TIF SYSTEM "US20020198423A1-20021226-C00029.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00030.CDX SYSTEM "US20020198423A1-20021226-C00030.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00030.MOL SYSTEM "US20020198423A1-20021226-C00030.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00030.TIF SYSTEM "US20020198423A1-20021226-C00030.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00031.CDX SYSTEM "US20020198423A1-20021226-C00031.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00031.MOL SYSTEM "US20020198423A1-20021226-C00031.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00031.TIF SYSTEM "US20020198423A1-20021226-C00031.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00032.CDX SYSTEM "US20020198423A1-20021226-C00032.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00032.MOL SYSTEM "US20020198423A1-20021226-C00032.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00032.TIF SYSTEM "US20020198423A1-20021226-C00032.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00033.CDX SYSTEM "US20020198423A1-20021226-C00033.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00033.MOL SYSTEM "US20020198423A1-20021226-C00033.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00033.TIF SYSTEM "US20020198423A1-20021226-C00033.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00034.CDX SYSTEM "US20020198423A1-20021226-C00034.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00034.MOL SYSTEM "US20020198423A1-20021226-C00034.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00034.TIF SYSTEM "US20020198423A1-20021226-C00034.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00035.CDX SYSTEM "US20020198423A1-20021226-C00035.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00035.MOL SYSTEM "US20020198423A1-20021226-C00035.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00035.TIF SYSTEM "US20020198423A1-20021226-C00035.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00036.CDX SYSTEM "US20020198423A1-20021226-C00036.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00036.MOL SYSTEM "US20020198423A1-20021226-C00036.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00036.TIF SYSTEM "US20020198423A1-20021226-C00036.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00037.CDX SYSTEM "US20020198423A1-20021226-C00037.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00037.MOL SYSTEM "US20020198423A1-20021226-C00037.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00037.TIF SYSTEM "US20020198423A1-20021226-C00037.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00038.CDX SYSTEM "US20020198423A1-20021226-C00038.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00038.MOL SYSTEM "US20020198423A1-20021226-C00038.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00038.TIF SYSTEM "US20020198423A1-20021226-C00038.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00039.CDX SYSTEM "US20020198423A1-20021226-C00039.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00039.MOL SYSTEM "US20020198423A1-20021226-C00039.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00039.TIF SYSTEM "US20020198423A1-20021226-C00039.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00040.CDX SYSTEM "US20020198423A1-20021226-C00040.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00040.MOL SYSTEM "US20020198423A1-20021226-C00040.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00040.TIF SYSTEM "US20020198423A1-20021226-C00040.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00041.CDX SYSTEM "US20020198423A1-20021226-C00041.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00041.MOL SYSTEM "US20020198423A1-20021226-C00041.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00041.TIF SYSTEM "US20020198423A1-20021226-C00041.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00042.CDX SYSTEM "US20020198423A1-20021226-C00042.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00042.MOL SYSTEM "US20020198423A1-20021226-C00042.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00042.TIF SYSTEM "US20020198423A1-20021226-C00042.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00043.CDX SYSTEM "US20020198423A1-20021226-C00043.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00043.MOL SYSTEM "US20020198423A1-20021226-C00043.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00043.TIF SYSTEM "US20020198423A1-20021226-C00043.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00044.CDX SYSTEM "US20020198423A1-20021226-C00044.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00044.MOL SYSTEM "US20020198423A1-20021226-C00044.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00044.TIF SYSTEM "US20020198423A1-20021226-C00044.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00045.CDX SYSTEM "US20020198423A1-20021226-C00045.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00045.MOL SYSTEM "US20020198423A1-20021226-C00045.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00045.TIF SYSTEM "US20020198423A1-20021226-C00045.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00046.CDX SYSTEM "US20020198423A1-20021226-C00046.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00046.MOL SYSTEM "US20020198423A1-20021226-C00046.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00046.TIF SYSTEM "US20020198423A1-20021226-C00046.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00047.CDX SYSTEM "US20020198423A1-20021226-C00047.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00047.MOL SYSTEM "US20020198423A1-20021226-C00047.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00047.TIF SYSTEM "US20020198423A1-20021226-C00047.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00048.CDX SYSTEM "US20020198423A1-20021226-C00048.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00048.MOL SYSTEM "US20020198423A1-20021226-C00048.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00048.TIF SYSTEM "US20020198423A1-20021226-C00048.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00049.CDX SYSTEM "US20020198423A1-20021226-C00049.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00049.MOL SYSTEM "US20020198423A1-20021226-C00049.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00049.TIF SYSTEM "US20020198423A1-20021226-C00049.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00050.CDX SYSTEM "US20020198423A1-20021226-C00050.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00050.MOL SYSTEM "US20020198423A1-20021226-C00050.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00050.TIF SYSTEM "US20020198423A1-20021226-C00050.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00051.CDX SYSTEM "US20020198423A1-20021226-C00051.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00051.MOL SYSTEM "US20020198423A1-20021226-C00051.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00051.TIF SYSTEM "US20020198423A1-20021226-C00051.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-C00052.CDX SYSTEM "US20020198423A1-20021226-C00052.CDX" NDATA CDX>
<!ENTITY US20020198423A1-20021226-C00052.MOL SYSTEM "US20020198423A1-20021226-C00052.MOL" NDATA MOL>
<!ENTITY US20020198423A1-20021226-C00052.TIF SYSTEM "US20020198423A1-20021226-C00052.TIF" NDATA TIF>
<!ENTITY US20020198423A1-20021226-D00001.TIF SYSTEM "US20020198423A1-20021226-D00001.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020198423</doc-number>
<kind-code>A1</kind-code>
<document-date>20021226</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10092753</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020307</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C07C002/86</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>B01J031/00</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>585</class>
<subclass>454000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>502</class>
<subclass>171000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Convenient and efficient suzuki-miyaura cross-coupling catalyzed by a palladium/diazabutadiene system</title-of-invention>
</technical-information>
<continuity-data>
<non-provisional-of-provisional>
<document-id>
<doc-number>60274125</doc-number>
<document-date>20010307</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Steven</given-name>
<middle-name>P.</middle-name>
<family-name>Nolan</family-name>
</name>
<residence>
<residence-us>
<city>New Orleans</city>
<state>LA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Gabriela</given-name>
<family-name>Grasa</family-name>
</name>
<residence>
<residence-us>
<city>New Orleans</city>
<state>LA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>GARVEY SMITH NEHRBASS &amp; DOODY, LLC</name-1>
<name-2></name-2>
<address>
<address-1>THREE LAKEWAY CENTER</address-1>
<address-2>3838 NORTH CAUSEWAY BLVD., SUITE 3290</address-2>
<city>METAIRIE</city>
<state>LA</state>
<postalcode>70002</postalcode>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">A Pd(OAc)<highlight><subscript>2</subscript></highlight>/diazabutadiene system has been developed for the catalytic cross-coupling of aryl halides with arylboronic acids. A combination of the diazabutadiene DAB-Cy (1, N, N&prime;-Dicyclohexyl-1,4-dizabutadiene) and Pd(OAc)<highlight><subscript>2 </subscript></highlight>was found to form an excellent catalyst for the Suzuki-Miyaura cross-coupling of various aryl bromides and activated aryl chlorides with arylboronic acids. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">CROSS-REFERENCE TO RELATED APPLICATIONS </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> Priority of our U.S. Provisional Patent Application Serial No.60/274,125, filed Mar. 7, 2001, incorporated herein by reference, is hereby claimed.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<heading lvl="1">STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT </heading>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This material is based upon work supported by the National Science Foundation under Grant No. 9985213. The Government has certain rights in this invention. </paragraph-federal-research-statement><paragraph-federal-research-statement id="P-0003"><number>&lsqb;0003&rsqb;</number> Any opinions, findings, and conclusions or recommendations expressed in this material are those of the inventors and do not necessarily reflect the views of the National Science Foundation.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">REFERENCE TO A &ldquo;MICROFICHE APPENDIX&rdquo;</heading>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> Not applicable </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> 1. Field of the Invention </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> The present invention relates to Suzuki-Miyaura cross-coupling reactions. More particularly, the present invention relates to catalysts for Suzuki-Miyaura cross-coupling reactions. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> 2. General Background of the Invention </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> The Suzuki-Miyaura cross-coupling reaction, involving the coupling of an arylboronic acid with an organohalide, has proven to be an extremely useful synthetic tool in organic synthesis (1). Although palladium complexes bearing tertiary phosphine ligands are commonly employed (1a) (2), in Suzuki-Miyaura cross-couplings, these catalysts are often sensitive to air oxidation and therefore require air-free handling in order to minimize ligand oxidation. Nucleophilic N-heterocyclic carbenes, the imidazol-2-ylidenes, have recently been used as ancillary ligands for Suzuki-Miyauracross-coupling reactions with great success (3). </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> In the specific area of coupling chemistry, catalytic systems which contain supporting ligations other than tertiary phosphine represent a scarcely explored area of investigation. Recently, a Pd(II) cyclometallated imine catalyst able to mediate both Suzuki (4) and Heck (5) reactions has been reported by Milstein. Unfortunately, this system requires high reaction temperatures and leads to products in modest yields. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Incorporated by reference are the paper attached to our U.S. Provisional Patent Application Serial No.60/274,125 and entitled: &ldquo;Convenient and Efficient Suzuki-Miyaura Cross-Coupling Catalyzed by a Palladium/Diazabutadiene System&rdquo; by Gabriela A. Grasa, Anna C. Hillier, and Steven P. Nolan, all references cited therein, and all related papers of which the inventors are authors. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> The following US Patent is incorporated herein by reference: </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> U.S. Pat. No. 6,316,3 80 entitled &ldquo;Catalyst system comprising transition metal and imidazoline-2-ylidene or imidazolidine-2-ylidene&rdquo;</paragraph>
</section>
<section>
<heading lvl="1">BRIEF SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> The present invention includes a Pd(OAc)<highlight><subscript>2</subscript></highlight>/diazabutadiene system for the catalytic cross-coupling of aryl halides with arylboronic acids and a method of catalytic cross-coupling of aryl halides with arylboronic acids using this system.</paragraph>
</section>
</summary-of-invention>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> Based on the Milstein report, we thought a well-known family of ligands, the diazabutadienes, might possibly mediate the Suzuki-Miyaura reaction. The chelating nature of these ligands might also assist in stabilizing catalytic species. Ligands containing the 1,4-diaza-1,3-butadiene skeleton, a-diimines, (DAB-R, Scheme 1-see below) have been known for quite some time (6). The coordination versatility of these ligands, a consequence of the flexibility of the NCCN backbone and the strong s-donor and p-acceptor properties, reflects a very important feature of DAB-R-metal complexes (7). Few investigations have focused on the influence of DAB-R as a supporting ligand in catalytic processes. The most notable exceptions have been the use of metal-diimine complexes to mediate olefin polymerization (8) and alkyne cyclotrimerization (9) processes. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> Scheme 1 (see below) shows a Diazabutadiene Ligand. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> We now wish to report an additional use of these ligands in the efficient catalytic cross-coupling of aryl halides with arylboronic acids using a combination of Pd(OAc)2/diazabutadiene (DAB-R) as the catalytic system. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> Based on our previous experience in Pd/imidazolium salt catalyzed Suzuki-Miyaura reaction, 3e we observed that the coupling of 4-bromotoluene and phenylboronic acid in the presence of 3 mol % of Pd(OAc)<highlight><subscript>2</subscript></highlight>, 3 mol % DAB-Mes (4) and Cs<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3 </subscript></highlight>in dioxane, at 800 C. proceeded to give 4-methylbiphenyl in 85% isolated yield (Table 1, entry 5-see below). Investigation of other diazabutadiene ligands led to the observation that alkyl-diazabutadienes (Table 1, entries 2 and 3) are superior supporting ligands for the Pd-catalyzed Suzuki reaction compared to aryl-diazabutadienes (Table 1, entries 4-8). This reactivity trend is in agreement with the stronger donating ability of alkyl substituents making the ligand more electron rich. Other bis(nitrogen donor) ligands were investigated but considering the electronic argument presented above, it was not surprising to observe a poorer performance of the commercially available ligands 2,2&prime;-bipyridyl (Table 1, entry 9) and 1,10-phenanthroline (Table 1, entry 10). </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> Table 1 (see below) shows the influence of DAB-R Ligands on the Palladium-Catalyzed Cross-Coupling Reaction of 4-bromotoluene with Phenylboronic Acid. Reaction conditions in Table 1 were: 1.0 mmol of 4-bromotoluene, 1.5 mmol of phenylboronic acid, 2 MMol Cs<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight>, 3.0 mol % Pd(OAc)<highlight><subscript>2</subscript></highlight>, 3.0 mol % ligand, 3 mL dioxane, 80&deg; C., 3 hr. Isolated yields. All reactions were monitored by GC. Yields are average of two runs. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> An investigation of the influence of the base suggested that Cs<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3 </subscript></highlight>was the reagent of choice. In turn, K<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight>, an effective base for the cyclopalladated-imine catalyst for the Suzuki-Miyaura reaction 4 proved to be less effective, leading to a 63% isolated yield (Table 2, entry 9-see below). Other bases such as Na<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight>, Ca(OH)<highlight><subscript>2</subscript></highlight>, NaOMe, K(OtBu), KOMe and Ba(OH)<highlight><subscript>2 </subscript></highlight>proved to be ineffective for the cross-coupling of 4-bromotoluene with phenylboronic acid (Table 2, entries 2-5,7,8). Moreover, KF, a very effective additive for Pd(dba)<highlight><subscript>2</subscript></highlight>/(tBu)3P-catalyzed Suzuki-Miyaura reaction (10), also proved to be less effective in the present system. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> Table 2 (see below) shows the effect of the Base on Pd(OAc)<highlight><subscript>2</subscript></highlight>/DAB-Cy (1)&mdash;Catalyzed Cross-Coupling of 4-bromotoluene with Phenylboronic Acid. Reaction conditions in Table 2 were: 1.0 mmol of aryl bromide, 1.5 mmol of phenylboronic acid, 2 mmol base, 3.0 mol % Pd(OAc)<highlight><subscript>2</subscript></highlight>, 3.0 mol % DAB-Cy, 3 mL dioxane, 80&deg; C. Isolated yields. Entries 5,6, &amp; 7 are GC yields. All reactions were monitored by GC. Yields are average of two runs. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> As illustrated in Table 3, the palladium-catalyzed Suzuki-Miyaura reaction with the DAB-Cy (1) ancillary ligand proved exceptionally active. Not surprisingly the non-activated aryl bromides (Table 3, entry 3-see below) were easily converted. This reaction could be performed in the air as well, but requires longer reaction times (Table 3, entry 2). Moreover, ortho-substituted substrates also led to excellent yields (Table 3, entries 6 and 7). The catalytic effect was confirmed by running the standard reaction on 4-bromoacetophenone without ligand. The reaction proceeds but it requires much longer reaction times compared to the Pd(OAc)<highlight><subscript>2</subscript></highlight>/DAB-R system (Table 3, entries 4 and 5). Activated aryl chlorides led to moderate to high yields when this catalytic system was employed (Table 3, entries <highlight><bold>11</bold></highlight> and 12). Attempts to couple the electron-neutral 4-chlorotoluene and the electron-rich 4-chloroanisole were not successful. Investigations regarding the steric and electronic properties of diazabutadiene ligands able to activate the aryl chlorides are presently underway. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> Table 3 (see below) shows Pd(OAc)<highlight><subscript>2</subscript></highlight>/DAB-Cy (1)&mdash;Catalyzed Cross-Coupling of Aryl Halides with Phenylboronic Acid. Reaction conditions in Table 3 were: 1.0 mmol of aryl halide, 1.5 mmol of phenylboronic acid, 2 mmol Cs<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight>, 3.0 mol % Pd(OAc)<highlight><subscript>2</subscript></highlight>, 3.0 mol % DAB-Cy, 3 mL dioxane, 80&deg; C. Isolated yields. In entry <highlight><bold>2</bold></highlight>, the reaction was performed in the air. In entry 5, the reaction was performed using Pd(OAc)<highlight><subscript>2 </subscript></highlight>only. In entries 10, 11, 12 &amp; 13 the reaction was performed at 100&deg; C. Entries 10 &amp; 13 are GC yields. All reactions were monitored by GC. Yields are average of two runs. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> The effect of varying the aryl boronic acids in the Suzuki-Miyaura cross-coupling reactions was also investigated using 4-bromotoluene as the substrate (Table 4-see below). Para-substituted aryl boronic acids led to excellent yields of the desired products (Table 4, entries 3 and 4), while the sterically hindered 2-methylphenylboronic acid required longer reaction time before affording very good yields of the product (Table 4, entry 2). Attempts to couple 4-bromotoluene with meta-substituted aryl boronic acids like 3-cyanophenylboronic acid or 3-methoxyphenylboronic acid resulted in low yields. The lower reaction rate may be explained in terms of the different electronic properties of meta-substituted boronic acids (11). </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> Table 4 (see below) shows Pd(OAc)<highlight><subscript>2</subscript></highlight>/DAB-Cy (1)&mdash;Catalyzed Cross-Coupling of 4-bromotoluene with Various Arylboronic Acids. Reaction conditions in Table 4 were: 1.0 mmol of4-bromotoluene, 1.5 mmol of arylboronic acid, 2 mmol Cs<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight>, 3.0 mol % Pd(OAc)<highlight><subscript>2</subscript></highlight>, 3.0 mol % DAB-Cy, 3 mL dioxane, 80&deg; C. Isolated yields. All reactions were monitored by GC. Yields are average of two runs. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> In summary, an unprecedented, general and efficient methodology based on the Pd(OAc)<highlight><subscript>2</subscript></highlight>/DAB-R system has been developed. The use of DAB-R as supporting ligands for the Suzuki-Miyaura cross-coupling reaction represents an interesting alternative to existing catalytic systems based on the use of tertiary phosphine ligands. The Pd(OAc)<highlight><subscript>2</subscript></highlight>/DAB-R system is very efficient in the Suzuki-Miyaura cross-coupling reaction of aryl bromides with aryl boronic acids in terms of reactivity, reaction temperature, reaction time and air-stability. This system represents unprecedented reactivity for a bis(nitrogen) ligand system with regard to reactivity with unactivated and sterically encumbered substrates, as well as activated aryl chlorides. Investigations regarding the utility of Pd(OAc)<highlight><subscript>2</subscript></highlight>/DAB-R systems towards the activation of electron-rich and electron-neutral aryl chlorides, as well as the influence of the steric and electronic factors of DAB-R ligands are ongoing. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> Acknowledgment. The National Science Foundation, the Albermarle Corporation and the Petroleum Research Fund administered by the ACS are gratefully acknowledged for support of this research. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> Supporting Information Available. Experimental procedure and references to known compounds. This material is free of charge via the Internet at http://pubs.acs.org. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> All measurements disclosed herein are at standard temperature and pressure, at sea level on Earth, unless indicated otherwise. All materials used or intended to be used in a human being are biocompatible, unless indicated otherwise. </paragraph>
<paragraph id="P-0029" lvl="1"><number>&lsqb;0029&rsqb;</number> (1) (a) For a review see: Miyaura, N.; Suzuki, A. <highlight><italic>Chem. Rev. </italic></highlight>1995, 95, 2457-2483. (b) Suzuki, A. in <highlight><italic>Metal-Catalyzed Cross-Couplings Reactions; </italic></highlight>Diederich, F, Stang, P. J., Eds.; Wiley-VCH: Weinheim, 1998; pp 49-97 and references therein. (c) Hamann, B. C.; Hartwig, J. F. <highlight><italic>J. Am. Chem. Soc. </italic></highlight>1998, 120, 7369-7370. (d) Reetz, M. T.; Loluner, G.; Schwickardi, R. <highlight><italic>Angew. Chem., Int Ed. Engl. </italic></highlight>1998, 37, 481-483. (e) Littke, A. F.; Fu, G. C. <highlight><italic>J. Org. Chem. </italic></highlight>1999, 64, 10-11. </paragraph>
<paragraph id="P-0030" lvl="1"><number>&lsqb;0030&rsqb;</number> (2) Applications of phosphine ligands in homogeneous catalysis: (a) Parshall, G. W.; Ittel, S. <highlight><italic>Homogenous Catalysis; </italic></highlight>J. Willey and Sons: New York, 1992. (b) Pignolet, L. H., Ed. <highlight><italic>Homogenous Catalysis with Metal Phosphine Complexes; </italic></highlight>Plenum: New York, 1983. </paragraph>
<paragraph id="P-0031" lvl="1"><number>&lsqb;0031&rsqb;</number> (3) (a) Regitz, M. <highlight><italic>Angew. Chem. Int. Ed. Engl. </italic></highlight>1996, 35, 725-728. (b) Arduengo, A. J. III; Krafczyc, R. <highlight><italic>Chem. Zeit. </italic></highlight>1998, 32, 6-14. (c) Herrmann, W. A.; Kocher, C. <highlight><italic>Angew. Chem. Int. Ed. Engl. </italic></highlight>1997,36,2163-2187. (d) Herrmann, W. A.; Reisinger, C. P.; Spiegler, M. J. <highlight><italic>Organomet. Chem. </italic></highlight>1998,557, 93-96. (e) Zhang, C.; Huang, J.; Trudell, M. T.; Nolan, S. P. <highlight><italic>J. Org. Chem. </italic></highlight>1999, 64, 3804-3805. (f) B&ouml;hm, V. P. W.; Gst&ouml;mayr, C. W. K.; Weskamp. T.; Herrmann, W. A. <highlight><italic>J. Orgamomet. Chem., </italic></highlight>2000, 595, 186-190. </paragraph>
<paragraph id="P-0032" lvl="1"><number>&lsqb;0032&rsqb;</number> (4) Weissman, H.; Milstein, D. <highlight><italic>Chem. Commun. </italic></highlight>1999, 1901-1902. </paragraph>
<paragraph id="P-0033" lvl="1"><number>&lsqb;0033&rsqb;</number> (5) Ohff, M.; Ohff, A.; Milstein, D. <highlight><italic>Chem. Commun. </italic></highlight>1999, 357-358. </paragraph>
<paragraph id="P-0034" lvl="1"><number>&lsqb;0034&rsqb;</number> (6) van Koten, G.; Vrieze, K. <highlight><italic>Adv. Organomet. Chem. </italic></highlight>1982, 21, 151-239 and references cited. </paragraph>
<paragraph id="P-0035" lvl="1"><number>&lsqb;0035&rsqb;</number> (7) (a) Mathur, P.; Ghosh, S.; Sarkar, A.; Rheingold, A. L.; Guzei, I. A. <highlight><italic>J. Organomet. Chem. </italic></highlight>1998, 566, 159-164. (b)Lehmann, J. F.; Urquhart, S. G.; Ennis, L. E.; Hitchcock, A. P.; Hatano, K.; Gupta, S.;Denk, M. K. <highlight><italic>Organometallics, </italic></highlight>1999,18,1862-1872. (c) Greulich, S.; Kaim, W.; Stange, A.; Stoll, H.; Fiedler, J.; Zalis, S. <highlight><italic>Inorg. Chem. </italic></highlight>1996, 35, 3998-4002. (d) Breuer, J.; Fruhauf, H.-W.; Smeets, W. J. J.; Spek, A. L. <highlight><italic>Inorg. Chim. Acta. </italic></highlight>1999, 291, 438-447. </paragraph>
<paragraph id="P-0036" lvl="1"><number>&lsqb;0036&rsqb;</number> (8) (a) Johnson, L. K.; Killian, C. M.; Brookhart, M. S. <highlight><italic>J. Am. Chem. Soc. </italic></highlight>1995, 117, 6414-6416. (b) Killian, C. M.; Tempel, D. J.; Johnson, L. K.; Brookhart, M. S. <highlight><italic>J. Am. Chem. Soc. </italic></highlight>1996, 118, 11664-11665. </paragraph>
<paragraph id="P-0037" lvl="1"><number>&lsqb;0037&rsqb;</number> (9) van der Poel, H.; van Koten, G.; Kokkes, M.; Stam, C. H. <highlight><italic>Inorg. Chem. </italic></highlight>1981, 20,2941- 2950. </paragraph>
<paragraph id="P-0038" lvl="1"><number>&lsqb;0038&rsqb;</number> (10) Littke, A. F.; Dai, C.; Fu, G. C. <highlight><italic>J. Am. Chem. Soc. </italic></highlight>2000, 122, 4020-4028. </paragraph>
<paragraph id="P-0039" lvl="1"><number>&lsqb;0039&rsqb;</number> (11) March, J. <highlight><italic>Advanced Organic Chemistry; </italic></highlight>J. Wiley and Sons: New York, 1992, pp. 278-286.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 1</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="99.6219" wi="194.6511" file="US20020198423A1-20021226-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20020198423A1-20021226-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20020198423A1-20021226-C00001.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="21PT" align="center"/>
<colspec colname="2" colwidth="175PT" align="center"/>
<colspec colname="3" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry>entry</entry>
<entry>ligand</entry>
<entry>yield</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="21PT" align="char" char="."/>
<colspec colname="2" colwidth="175PT" align="center"/>
<colspec colname="3" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry>1</entry>
<entry>No L</entry>
<entry>30</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>2</entry>
<entry>
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="29.28555" wi="139.45365" file="US20020198423A1-20021226-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20020198423A1-20021226-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20020198423A1-20021226-C00002.MOL"/>
</chemistry-cwu>
</entry>
<entry>99</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>3</entry>
<entry>
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="53.77995" wi="139.7088" file="US20020198423A1-20021226-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20020198423A1-20021226-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20020198423A1-20021226-C00003.MOL"/>
</chemistry-cwu>
</entry>
<entry>93</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>4</entry>
<entry>
<chemistry-cwu id="CHEM-US-00004">
<number>4</number>
<image id="EMI-C00004" he="84.483" wi="139.7088" file="US20020198423A1-20021226-C00004.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00004" file="US20020198423A1-20021226-C00004.CDX"/>
<chemistry-mol-file id="CHEMMOL-00004" file="US20020198423A1-20021226-C00004.MOL"/>
</chemistry-cwu>
</entry>
<entry>80</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>5</entry>
<entry>
<chemistry-cwu id="CHEM-US-00005">
<number>5</number>
<image id="EMI-C00005" he="56.89845" wi="170.41185" file="US20020198423A1-20021226-C00005.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00005" file="US20020198423A1-20021226-C00005.CDX"/>
<chemistry-mol-file id="CHEMMOL-00005" file="US20020198423A1-20021226-C00005.MOL"/>
</chemistry-cwu>
</entry>
<entry>85</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>6</entry>
<entry>
<chemistry-cwu id="CHEM-US-00006">
<number>6</number>
<image id="EMI-C00006" he="56.89845" wi="171.6309" file="US20020198423A1-20021226-C00006.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00006" file="US20020198423A1-20021226-C00006.CDX"/>
<chemistry-mol-file id="CHEMMOL-00006" file="US20020198423A1-20021226-C00006.MOL"/>
</chemistry-cwu>
</entry>
<entry>78</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>7</entry>
<entry>
<chemistry-cwu id="CHEM-US-00007">
<number>7</number>
<image id="EMI-C00007" he="90.23805" wi="170.8938" file="US20020198423A1-20021226-C00007.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00007" file="US20020198423A1-20021226-C00007.CDX"/>
<chemistry-mol-file id="CHEMMOL-00007" file="US20020198423A1-20021226-C00007.MOL"/>
</chemistry-cwu>
</entry>
<entry>79</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>8</entry>
<entry>
<chemistry-cwu id="CHEM-US-00008">
<number>8</number>
<image id="EMI-C00008" he="56.6433" wi="139.7088" file="US20020198423A1-20021226-C00008.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00008" file="US20020198423A1-20021226-C00008.CDX"/>
<chemistry-mol-file id="CHEMMOL-00008" file="US20020198423A1-20021226-C00008.MOL"/>
</chemistry-cwu>
</entry>
<entry>60</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>9</entry>
<entry>
<chemistry-cwu id="CHEM-US-00009">
<number>9</number>
<image id="EMI-C00009" he="30.9582" wi="81.84645" file="US20020198423A1-20021226-C00009.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00009" file="US20020198423A1-20021226-C00009.CDX"/>
<chemistry-mol-file id="CHEMMOL-00009" file="US20020198423A1-20021226-C00009.MOL"/>
</chemistry-cwu>
</entry>
<entry>13</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>10</entry>
<entry>
<chemistry-cwu id="CHEM-US-00010">
<number>10</number>
<image id="EMI-C00010" he="45.1332" wi="81.84645" file="US20020198423A1-20021226-C00010.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00010" file="US20020198423A1-20021226-C00010.CDX"/>
<chemistry-mol-file id="CHEMMOL-00010" file="US20020198423A1-20021226-C00010.MOL"/>
</chemistry-cwu>
</entry>
<entry>NR</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00011">
<number>11</number>
<image id="EMI-C00011" he="70.33635" wi="142.34535" file="US20020198423A1-20021226-C00011.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00011" file="US20020198423A1-20021226-C00011.CDX"/>
<chemistry-mol-file id="CHEMMOL-00011" file="US20020198423A1-20021226-C00011.MOL"/>
</chemistry-cwu>
 
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 2</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00012">
<number>12</number>
<image id="EMI-C00012" he="99.6219" wi="192.2697" file="US20020198423A1-20021226-C00012.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00012" file="US20020198423A1-20021226-C00012.CDX"/>
<chemistry-mol-file id="CHEMMOL-00012" file="US20020198423A1-20021226-C00012.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="91PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="91PT" align="center"/>
<tbody valign="top">
<row>
<entry>entry</entry>
<entry>base</entry>
<entry>yield</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="91PT" align="char" char="."/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="91PT" align="center"/>
<tbody valign="top">
<row>
<entry>1</entry>
<entry>None</entry>
<entry>NR</entry>
</row>
<row>
<entry>2</entry>
<entry>Na<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight></entry>
<entry>NR</entry>
</row>
<row>
<entry>3</entry>
<entry>Ca(OH)<highlight><subscript>2</subscript></highlight></entry>
<entry>NR</entry>
</row>
<row>
<entry>4</entry>
<entry>NaOMe</entry>
<entry>NR</entry>
</row>
<row>
<entry>5</entry>
<entry>K(O<highlight><superscript>t</superscript></highlight>Bu)</entry>
<entry>10</entry>
</row>
<row>
<entry>6</entry>
<entry>TBAF</entry>
<entry>11</entry>
</row>
<row>
<entry>7</entry>
<entry>KOMe</entry>
<entry>14</entry>
</row>
<row>
<entry>8</entry>
<entry>Ba(OH)<highlight><subscript>2</subscript></highlight></entry>
<entry>44</entry>
</row>
<row>
<entry>9</entry>
<entry>K<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight></entry>
<entry>63</entry>
</row>
<row>
<entry>10</entry>
<entry>KF</entry>
<entry>78</entry>
</row>
<row>
<entry>11</entry>
<entry>CsF</entry>
<entry>87</entry>
</row>
<row>
<entry>12</entry>
<entry>Cs<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight></entry>
<entry>99</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number>  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="301PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 3</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00013">
<number>13</number>
<image id="EMI-C00013" he="88.3386" wi="191.5326" file="US20020198423A1-20021226-C00013.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00013" file="US20020198423A1-20021226-C00013.CDX"/>
<chemistry-mol-file id="CHEMMOL-00013" file="US20020198423A1-20021226-C00013.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="21PT" align="center"/>
<colspec colname="2" colwidth="91PT" align="center"/>
<colspec colname="3" colwidth="126PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="35PT" align="center"/>
<tbody valign="top">
<row>
<entry>entry</entry>
<entry>aryl halide</entry>
<entry>product</entry>
<entry>time (h)</entry>
<entry>yield (%)</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="21PT" align="char" char="."/>
<colspec colname="2" colwidth="91PT" align="center"/>
<colspec colname="3" colwidth="126PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="char" char="."/>
<colspec colname="5" colwidth="35PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>1</entry>
<entry>
<chemistry-cwu id="CHEM-US-00014">
<number>14</number>
<image id="EMI-C00014" he="29.28555" wi="76.80015" file="US20020198423A1-20021226-C00014.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00014" file="US20020198423A1-20021226-C00014.CDX"/>
<chemistry-mol-file id="CHEMMOL-00014" file="US20020198423A1-20021226-C00014.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00015">
<number>15</number>
<image id="EMI-C00015" he="29.28555" wi="104.63985" file="US20020198423A1-20021226-C00015.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00015" file="US20020198423A1-20021226-C00015.CDX"/>
<chemistry-mol-file id="CHEMMOL-00015" file="US20020198423A1-20021226-C00015.MOL"/>
</chemistry-cwu>
</entry>
<entry>3</entry>
<entry>99</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>2</entry>
<entry>
<chemistry-cwu id="CHEM-US-00016">
<number>16</number>
<image id="EMI-C00016" he="29.28555" wi="76.80015" file="US20020198423A1-20021226-C00016.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00016" file="US20020198423A1-20021226-C00016.CDX"/>
<chemistry-mol-file id="CHEMMOL-00016" file="US20020198423A1-20021226-C00016.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00017">
<number>17</number>
<image id="EMI-C00017" he="29.28555" wi="104.63985" file="US20020198423A1-20021226-C00017.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00017" file="US20020198423A1-20021226-C00017.CDX"/>
<chemistry-mol-file id="CHEMMOL-00017" file="US20020198423A1-20021226-C00017.MOL"/>
</chemistry-cwu>
</entry>
<entry>5</entry>
<entry>90</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>3</entry>
<entry>
<chemistry-cwu id="CHEM-US-00018">
<number>18</number>
<image id="EMI-C00018" he="29.28555" wi="80.65575" file="US20020198423A1-20021226-C00018.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00018" file="US20020198423A1-20021226-C00018.CDX"/>
<chemistry-mol-file id="CHEMMOL-00018" file="US20020198423A1-20021226-C00018.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00019">
<number>19</number>
<image id="EMI-C00019" he="29.28555" wi="108.72225" file="US20020198423A1-20021226-C00019.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00019" file="US20020198423A1-20021226-C00019.CDX"/>
<chemistry-mol-file id="CHEMMOL-00019" file="US20020198423A1-20021226-C00019.MOL"/>
</chemistry-cwu>
</entry>
<entry>5</entry>
<entry>95</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>4</entry>
<entry>
<chemistry-cwu id="CHEM-US-00020">
<number>20</number>
<image id="EMI-C00020" he="29.28555" wi="90.23805" file="US20020198423A1-20021226-C00020.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00020" file="US20020198423A1-20021226-C00020.CDX"/>
<chemistry-mol-file id="CHEMMOL-00020" file="US20020198423A1-20021226-C00020.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00021">
<number>21</number>
<image id="EMI-C00021" he="29.28555" wi="118.3329" file="US20020198423A1-20021226-C00021.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00021" file="US20020198423A1-20021226-C00021.CDX"/>
<chemistry-mol-file id="CHEMMOL-00021" file="US20020198423A1-20021226-C00021.MOL"/>
</chemistry-cwu>
</entry>
<entry>1</entry>
<entry>98</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>5</entry>
<entry>
<chemistry-cwu id="CHEM-US-00022">
<number>22</number>
<image id="EMI-C00022" he="29.28555" wi="90.23805" file="US20020198423A1-20021226-C00022.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00022" file="US20020198423A1-20021226-C00022.CDX"/>
<chemistry-mol-file id="CHEMMOL-00022" file="US20020198423A1-20021226-C00022.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00023">
<number>23</number>
<image id="EMI-C00023" he="29.28555" wi="118.3329" file="US20020198423A1-20021226-C00023.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00023" file="US20020198423A1-20021226-C00023.CDX"/>
<chemistry-mol-file id="CHEMMOL-00023" file="US20020198423A1-20021226-C00023.MOL"/>
</chemistry-cwu>
</entry>
<entry>20</entry>
<entry>99</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>6</entry>
<entry>
<chemistry-cwu id="CHEM-US-00024">
<number>24</number>
<image id="EMI-C00024" he="60.7257" wi="76.80015" file="US20020198423A1-20021226-C00024.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00024" file="US20020198423A1-20021226-C00024.CDX"/>
<chemistry-mol-file id="CHEMMOL-00024" file="US20020198423A1-20021226-C00024.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00025">
<number>25</number>
<image id="EMI-C00025" he="60.98085" wi="104.63985" file="US20020198423A1-20021226-C00025.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00025" file="US20020198423A1-20021226-C00025.CDX"/>
<chemistry-mol-file id="CHEMMOL-00025" file="US20020198423A1-20021226-C00025.MOL"/>
</chemistry-cwu>
</entry>
<entry>4</entry>
<entry>97</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>7</entry>
<entry>
<chemistry-cwu id="CHEM-US-00026">
<number>26</number>
<image id="EMI-C00026" he="45.1332" wi="53.77995" file="US20020198423A1-20021226-C00026.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00026" file="US20020198423A1-20021226-C00026.CDX"/>
<chemistry-mol-file id="CHEMMOL-00026" file="US20020198423A1-20021226-C00026.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00027">
<number>27</number>
<image id="EMI-C00027" he="45.1332" wi="81.84645" file="US20020198423A1-20021226-C00027.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00027" file="US20020198423A1-20021226-C00027.CDX"/>
<chemistry-mol-file id="CHEMMOL-00027" file="US20020198423A1-20021226-C00027.MOL"/>
</chemistry-cwu>
</entry>
<entry>1</entry>
<entry>98</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>8</entry>
<entry>
<chemistry-cwu id="CHEM-US-00028">
<number>28</number>
<image id="EMI-C00028" he="62.6535" wi="61.43445" file="US20020198423A1-20021226-C00028.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00028" file="US20020198423A1-20021226-C00028.CDX"/>
<chemistry-mol-file id="CHEMMOL-00028" file="US20020198423A1-20021226-C00028.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00029">
<number>29</number>
<image id="EMI-C00029" he="62.39835" wi="89.5293" file="US20020198423A1-20021226-C00029.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00029" file="US20020198423A1-20021226-C00029.CDX"/>
<chemistry-mol-file id="CHEMMOL-00029" file="US20020198423A1-20021226-C00029.MOL"/>
</chemistry-cwu>
</entry>
<entry>2</entry>
<entry>95</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>9</entry>
<entry>
<chemistry-cwu id="CHEM-US-00030">
<number>30</number>
<image id="EMI-C00030" he="44.87805" wi="77.53725" file="US20020198423A1-20021226-C00030.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00030" file="US20020198423A1-20021226-C00030.CDX"/>
<chemistry-mol-file id="CHEMMOL-00030" file="US20020198423A1-20021226-C00030.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00031">
<number>31</number>
<image id="EMI-C00031" he="45.1332" wi="105.60375" file="US20020198423A1-20021226-C00031.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00031" file="US20020198423A1-20021226-C00031.CDX"/>
<chemistry-mol-file id="CHEMMOL-00031" file="US20020198423A1-20021226-C00031.MOL"/>
</chemistry-cwu>
</entry>
<entry>21</entry>
<entry>98</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>10</entry>
<entry>
<chemistry-cwu id="CHEM-US-00032">
<number>32</number>
<image id="EMI-C00032" he="29.28555" wi="76.0914" file="US20020198423A1-20021226-C00032.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00032" file="US20020198423A1-20021226-C00032.CDX"/>
<chemistry-mol-file id="CHEMMOL-00032" file="US20020198423A1-20021226-C00032.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00033">
<number>33</number>
<image id="EMI-C00033" he="29.28555" wi="104.63985" file="US20020198423A1-20021226-C00033.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00033" file="US20020198423A1-20021226-C00033.CDX"/>
<chemistry-mol-file id="CHEMMOL-00033" file="US20020198423A1-20021226-C00033.MOL"/>
</chemistry-cwu>
</entry>
<entry>4.5</entry>
<entry>20</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>11</entry>
<entry>
<chemistry-cwu id="CHEM-US-00034">
<number>34</number>
<image id="EMI-C00034" he="29.28555" wi="89.78445" file="US20020198423A1-20021226-C00034.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00034" file="US20020198423A1-20021226-C00034.CDX"/>
<chemistry-mol-file id="CHEMMOL-00034" file="US20020198423A1-20021226-C00034.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00035">
<number>35</number>
<image id="EMI-C00035" he="29.28555" wi="118.3329" file="US20020198423A1-20021226-C00035.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00035" file="US20020198423A1-20021226-C00035.CDX"/>
<chemistry-mol-file id="CHEMMOL-00035" file="US20020198423A1-20021226-C00035.MOL"/>
</chemistry-cwu>
</entry>
<entry>4</entry>
<entry>98</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>12</entry>
<entry>
<chemistry-cwu id="CHEM-US-00036">
<number>36</number>
<image id="EMI-C00036" he="29.28555" wi="90.01125" file="US20020198423A1-20021226-C00036.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00036" file="US20020198423A1-20021226-C00036.CDX"/>
<chemistry-mol-file id="CHEMMOL-00036" file="US20020198423A1-20021226-C00036.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00037">
<number>37</number>
<image id="EMI-C00037" he="29.28555" wi="118.58805" file="US20020198423A1-20021226-C00037.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00037" file="US20020198423A1-20021226-C00037.CDX"/>
<chemistry-mol-file id="CHEMMOL-00037" file="US20020198423A1-20021226-C00037.MOL"/>
</chemistry-cwu>
</entry>
<entry>5</entry>
<entry>85</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>13</entry>
<entry>
<chemistry-cwu id="CHEM-US-00038">
<number>38</number>
<image id="EMI-C00038" he="29.28555" wi="80.1738" file="US20020198423A1-20021226-C00038.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00038" file="US20020198423A1-20021226-C00038.CDX"/>
<chemistry-mol-file id="CHEMMOL-00038" file="US20020198423A1-20021226-C00038.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00039">
<number>39</number>
<image id="EMI-C00039" he="29.28555" wi="108.72225" file="US20020198423A1-20021226-C00039.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00039" file="US20020198423A1-20021226-C00039.CDX"/>
<chemistry-mol-file id="CHEMMOL-00039" file="US20020198423A1-20021226-C00039.MOL"/>
</chemistry-cwu>
</entry>
<entry>24</entry>
<entry>35</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number>  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="315PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 4</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00040">
<number>40</number>
<image id="EMI-C00040" he="106.34085" wi="182.43225" file="US20020198423A1-20021226-C00040.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00040" file="US20020198423A1-20021226-C00040.CDX"/>
<chemistry-mol-file id="CHEMMOL-00040" file="US20020198423A1-20021226-C00040.MOL"/>
</chemistry-cwu>
</entry>
</row>
<row>
<entry> </entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="21PT" align="center"/>
<colspec colname="2" colwidth="98PT" align="center"/>
<colspec colname="3" colwidth="133PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="35PT" align="center"/>
<tbody valign="top">
<row>
<entry>entry</entry>
<entry>aryl boronic acid</entry>
<entry>product</entry>
<entry>time (h)</entry>
<entry>yield (%)</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="21PT" align="center"/>
<colspec colname="2" colwidth="98PT" align="center"/>
<colspec colname="3" colwidth="133PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="char" char="."/>
<colspec colname="5" colwidth="35PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>1</entry>
<entry>
<chemistry-cwu id="CHEM-US-00041">
<number>41</number>
<image id="EMI-C00041" he="29.28555" wi="68.63535" file="US20020198423A1-20021226-C00041.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00041" file="US20020198423A1-20021226-C00041.CDX"/>
<chemistry-mol-file id="CHEMMOL-00041" file="US20020198423A1-20021226-C00041.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00042">
<number>42</number>
<image id="EMI-C00042" he="29.28555" wi="104.63985" file="US20020198423A1-20021226-C00042.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00042" file="US20020198423A1-20021226-C00042.CDX"/>
<chemistry-mol-file id="CHEMMOL-00042" file="US20020198423A1-20021226-C00042.MOL"/>
</chemistry-cwu>
</entry>
<entry>3</entry>
<entry>99</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>2</entry>
<entry>
<chemistry-cwu id="CHEM-US-00043">
<number>43</number>
<image id="EMI-C00043" he="44.87805" wi="68.63535" file="US20020198423A1-20021226-C00043.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00043" file="US20020198423A1-20021226-C00043.CDX"/>
<chemistry-mol-file id="CHEMMOL-00043" file="US20020198423A1-20021226-C00043.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00044">
<number>44</number>
<image id="EMI-C00044" he="44.87805" wi="104.63985" file="US20020198423A1-20021226-C00044.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00044" file="US20020198423A1-20021226-C00044.CDX"/>
<chemistry-mol-file id="CHEMMOL-00044" file="US20020198423A1-20021226-C00044.MOL"/>
</chemistry-cwu>
</entry>
<entry>10</entry>
<entry>86</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>3</entry>
<entry>
<chemistry-cwu id="CHEM-US-00045">
<number>45</number>
<image id="EMI-C00045" he="29.28555" wi="89.5293" file="US20020198423A1-20021226-C00045.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00045" file="US20020198423A1-20021226-C00045.CDX"/>
<chemistry-mol-file id="CHEMMOL-00045" file="US20020198423A1-20021226-C00045.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00046">
<number>46</number>
<image id="EMI-C00046" he="29.28555" wi="123.86115" file="US20020198423A1-20021226-C00046.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00046" file="US20020198423A1-20021226-C00046.CDX"/>
<chemistry-mol-file id="CHEMMOL-00046" file="US20020198423A1-20021226-C00046.MOL"/>
</chemistry-cwu>
</entry>
<entry>6</entry>
<entry>99</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>4</entry>
<entry>
<chemistry-cwu id="CHEM-US-00047">
<number>47</number>
<image id="EMI-C00047" he="29.28555" wi="91.6839" file="US20020198423A1-20021226-C00047.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00047" file="US20020198423A1-20021226-C00047.CDX"/>
<chemistry-mol-file id="CHEMMOL-00047" file="US20020198423A1-20021226-C00047.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00048">
<number>48</number>
<image id="EMI-C00048" he="29.28555" wi="126.01575" file="US20020198423A1-20021226-C00048.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00048" file="US20020198423A1-20021226-C00048.CDX"/>
<chemistry-mol-file id="CHEMMOL-00048" file="US20020198423A1-20021226-C00048.MOL"/>
</chemistry-cwu>
</entry>
<entry>2.5</entry>
<entry>96</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>5</entry>
<entry>
<chemistry-cwu id="CHEM-US-00049">
<number>49</number>
<image id="EMI-C00049" he="45.1332" wi="79.69185" file="US20020198423A1-20021226-C00049.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00049" file="US20020198423A1-20021226-C00049.CDX"/>
<chemistry-mol-file id="CHEMMOL-00049" file="US20020198423A1-20021226-C00049.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00050">
<number>50</number>
<image id="EMI-C00050" he="44.87805" wi="115.69635" file="US20020198423A1-20021226-C00050.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00050" file="US20020198423A1-20021226-C00050.CDX"/>
<chemistry-mol-file id="CHEMMOL-00050" file="US20020198423A1-20021226-C00050.MOL"/>
</chemistry-cwu>
</entry>
<entry>24</entry>
<entry>67</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>6</entry>
<entry>
<chemistry-cwu id="CHEM-US-00051">
<number>51</number>
<image id="EMI-C00051" he="45.1332" wi="75.1275" file="US20020198423A1-20021226-C00051.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00051" file="US20020198423A1-20021226-C00051.CDX"/>
<chemistry-mol-file id="CHEMMOL-00051" file="US20020198423A1-20021226-C00051.MOL"/>
</chemistry-cwu>
</entry>
<entry>
<chemistry-cwu id="CHEM-US-00052">
<number>52</number>
<image id="EMI-C00052" he="44.87805" wi="111.38715" file="US20020198423A1-20021226-C00052.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00052" file="US20020198423A1-20021226-C00052.CDX"/>
<chemistry-mol-file id="CHEMMOL-00052" file="US20020198423A1-20021226-C00052.MOL"/>
</chemistry-cwu>
</entry>
<entry>24</entry>
<entry>57</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> The forgoing embodiments are presented by way of example only; the scope of the present invention is to be limited only by the following claims. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A method of catalytic cross-coupling of aryl halides with arylboronic acids using a combination of Pd(OAc)<highlight><subscript>2 </subscript></highlight>and diazabutadiene as the catalytic system. </claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the aryl halides are from the group consisting of aryl bromides and activated aryl chlorides. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The method of claims <highlight><bold>1</bold></highlight> or <highlight><bold>2</bold></highlight>, wherein the diazabutadiene is DAB-Cy (1, N, N&prime;-Dicyclohexyl-1 ,4-dizabutadiene). </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. A catalytic system for the cross-coupling of aryl halides with arylboronic acids comprising a combination of Pd(OAc)<highlight><subscript>2 </subscript></highlight>and diazabutadiene. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The system of <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference>, wherein the aryl halides are from the group consisting of aryl bromides and activated aryl chlorides. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The system of claims <highlight><bold>4</bold></highlight> or <highlight><bold>5</bold></highlight>, wherein the diazabutadiene is DAB-Cy (1, N, N&prime;-Dicyclohexyl-1 ,4-dizabutadiene). </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The invention(s) substantially as shown and/or described herein.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>NONE</representative-figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020198423A1-20021226-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
